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Abstract 
Transposons are integrally tied to the spread of antibiotic resistance among bacterial species, 
and cellular stress can cause increased transposition (which might benefit the bacteria as a 
species by increasing genetic plasticity). It is therefore important to understand how 
transposons have become integrated into bacterial regulatory networks. The goals of this 
thesis are to further investigate 1) new host-factors that regulate transposition, 2) post-
transcriptional regulation as a means of regulating transposase expression, and 3) how 
cellular stress-response is tied to transposon mobility. I use the well studied Tn10/IS10 and 
Tn5/IS50 transposons in Escherichia coli as model systems. I show that Tn10 transposition is 
strongly repressed at the level of transposase translation by the global post-transcriptional 
regulator, Hfq—an RNA chaperone that enhances the base-pairing interactions of trans-
encoded small regulatory RNAs (sRNAs) with their target mRNAs. As translation of the 
IS10 transposase mRNA (RNA-IN) is strongly repressed by an antisense regulator (RNA-
OUT), I investigated whether Hfq was enhancing this negative regulation. Further evidence 
shows that Hfq down-regulates IS10 transposase translation by two pathways, one of which 
involves RNA-OUT. Hfq had not previously been shown to function in regulation by a cis-
antisense RNA. I show that Hfq binds RNA-IN and RNA-OUT via known mRNA- and 
sRNA-binding sites, and that it enhances the rate of RNA-IN/OUT pairing in vitro. This 
ability was lost, along with in vivo regulation of transposition, to Hfq mutants lacking RNA-
binding specificity at these surfaces. Evidence is presented that Hfq alters the secondary 
structures of both RNA-IN and RNA-OUT such that inter-molecular base pairing would be 
facilitated. I also show that Hfq strongly down-regulates Tn5 transposition. Unlike Tn10, this 
regulation is exercised at the level of transposase transcription. Evidence is presented that 
Hfq and the global transcription factor Crp work in the same regulatory network to limit Tn5 
transposition. Finally, I demonstrate that Tn5 transposition is induced by nutrient starvation. 
Taken together, this work implicates Hfq as a component of a cellular defense mechanism 
against transposons and shows that Tn5 is able to respond to environmental conditions. 
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Chapter 1  
1 General Introduction 
1.1 A brief history of mobile DNA 
The geneticist Emerson postulated early in the 20th century that ‘unstable mutations’ in 
maize—which did not obey Mendelian rules of inheritance—were due to temporary locus 
restrictions caused by irregular inhibition (Emerson, 1914). In the mid-twentieth century, 
McClintock was interested in determining a pattern of inheritance in maize. She 
attributed the phenotypes to particular gene fragments that ‘moved’ which she dubbed 
‘controlling elements’ (i.e. Ac/Ds). The Ds locus, along with the unlinked Ac locus, 
tended to cause breakage of chromosome 9, which coincided with the movement (or 
‘transposition’) of Ds to a new location (McClintock, 1950; McClintock, 1956). Since 
this discovery, mobile genetic elements have been studied in almost every organism.  
In 1963 a bacteriophage was found to cause a ‘mutator’ phenotype when it 
inserted into bacterial DNA (Taylor, 1963). The phage was named Mu, and provided the 
first example of a DNA-based transposon that uses a replicative mechanism of 
transposition.  
DNA transposons have been studied most thoroughly in bacteria, although they 
have been found in most other organisms that have been examined (Galas and Chandler, 
1989). Prominent examples include P elements in Drosophila melanogaster and Tc1 in 
Caenorhabditis elegans (Engels, 1983; Levin and Moran, 2011). The simplest bacterial 
transposons are insertion sequences (IS elements), which encode the genes necessary for 
their own transposition. Composite transposons (Tn elements) are more complex, and 
encode two insertion sequences flanking ‘extra’ genes that typically confer a selective 
advantage (usually antibiotic resistance determinants). The IS elements that comprise the 
transposons are not necessarily identical—for instance, only one must encode a 
functional transposase so long as the protein recognizes the termini (often, inverted 
repeats) of the Tn element. A schematic of typical DNA transposons is shown in Figure 
1.1. 
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Figure 1.1. Schematic overview of DNA transposons in bacteria.  
(A) Insertion sequences (ISs) consist only of the DNA necessary for the act of 
transposition. An IS element consists of the transposase gene, flanked by a pair of 
inverted repeat sequences. The transposase protein recognizes the inverted repeats as the 
edges of the transposon and cuts the transposon from its initial site and inserts it into a 
target site. (B) Composite transposons (Tn elements) encode extra genes between two IS 
elements. The extra genes typically confer a selective advantage (e.g. antibiotic 
resistance, as indicated). Flanking host DNA is shown in light blue.   
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The first retrotransposons were discovered in yeast (Ty1) (Eickbush and Malik, 
2002). These elements transpose via an RNA-intermediate. Elements termed long 
terminal repeat (LTR)-containing retrotransposons are similar to animal retroviruses, but 
they lack an infection cycle and do not encode envelope (env) proteins.  
More examples of transposable elements have since been documented, such as 
mariner elements in various species, and Alu sequences in humans (Hormozdiari et al., 
2011; Kramerov and Vassetzky, 2005). 
Advancements in genome sequencing have revealed the presence of mobile 
genetic elements in the ‘junk’ DNA (i.e. non-coding DNA) of various organisms. For 
instance, almost half of the non-coding DNA in the human genome contains long-
inactive transposable elements, RNA viruses and retrotransposons (Cordaux and Batzer, 
2009; Lander et al., 2001). 
1.2 Transposition and human health 
Transposition events can cause double-strand breaks, insertions, deletions, and other 
chromosomal rearrangements through a number of complex DNA breakage and joining 
reactions. Consequently, the medical community has been interested in the direct effects 
of transposition reactions on genomic stability. There are several documented diseases in 
humans that result from rearrangements mediated by transposons and retrotransposons: 
L1 insertions cause diseases such as hemophilia, muscular dystrophy and colon cancer, 
and more than 20 different Alu element insertions have been implicated in diseases like 
Apert’s syndrome and breast cancer (Kazazian, 1998).  
Mobile genetic elements can also affect gene expression by shuffling regulatory 
elements or by inserting such that a promoter encoded by the element can drive 
transcription of otherwise poorly expressed (or promoter-less) genes. In humans, an L1 
insertion was responsible for enhancing transcription from the apolipoprotein(a) gene, 
and insertion of a segment from a LINE 3’ UTR caused transcriptional activation of a 
growth hormone gene cluster (Shewchuk et al., 2001; Yang et al., 1998). In the bacterial 
species Burkholderia cepacia, insertion of IS1490 places a transposon-encoded promoter 
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in the correct orientation to activate catabolic genes for the toxin 2,4,5-
trichlorophenoxyacetic acid, allowing the cells to survive in otherwise toxic growth 
conditions (Hubner and Hendrickson, 1997). In Escherichia coli, activation of the bgl 
operon involves insertion of IS1, IS5 and Mu (Manna et al., 2001; Reynolds et al., 1981; 
Schnetz and Rak, 1992).  
DNA transposons have potential uses in gene therapy, in that they can be used as 
vehicles for gene delivery. An advantage of using transposons rather than viruses as 
carriers is that they do not trigger immunological reactions. The Sleeping Beauty 
Transposon System (SBTS) was created as a non-viral carrier of genes to be incorporated 
into human chromosomes (Hackett et al., 2010; Hong et al., 2014; Ivics and Izsvak, 
2011). The SB transposon was generated by reassembly of inactive mariner-like elements 
in salmon to form an element that functions in humans and other eukaryotic cells, and it 
has been used to treat Fanconi anemia (Hyland et al., 2011) and haemophilia A 
(Aronovich et al., 2011; Liu et al., 2006). 
Bacterial transposons are intimately involved in antimicrobial resistance, which is 
a mounting health concern. The number of resistant organisms has increased 
dramatically, along with the geographic distribution of these organisms, in large part 
because bacteria become resistant to antimicrobial agents within a short time of exposure. 
Penicillin-resistant Staphylococcus aureus appeared only a few years after the discovery 
of penicillin (Medeiros, 1997). Over time, new species of bacteria continued to obtain 
resistance to new antibiotics and this pattern led health workers to believe that drug 
resistance is mobile—a hypothesis that was later confirmed (Levy and Marshall, 2004; 
Watanabe, 1963). Several transposons were discovered in bacterial samples taken directly 
from patients infected with antibiotic-resistant bacteria, and more transposons are 
discovered alongside antibiotic resistance to this day, such as Tn5382 (Carias et al., 
1998), Tn502 and Tn512 (Petrovski et al., 2011), and CTn6002 (Warburton et al., 2007).  
Currently, vancomycin is the preferred treatment for methicillin-resistant 
Staphylococcus aureus (MRSA)—a major cause of clinical morbidity and mortality 
(Klevens et al., 2007). As feared, vancomycin-resistant S. aureus (VRSA) have recently 
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emerged; these isolates have acquired the vanA operon encoded by Tn1546 present on a 
conjugal plasmid (Qureshi et al., 2014).  
1.3 Lateral gene transfer and mobile genetic elements in 
bacteria 
The evolution of bacteria is driven to a large extent by lateral gene transfer (LGT), a 
phenomenon wherein DNA is promiscuously transferred among the cells of one or more 
species. LGT, rather than the accumulation of point mutations over generations, is 
thought to be responsible for the high adaptability of bacteria to new environments 
(Ochman et al., 2000). Interestingly, none of the major phenotypic distinctions between 
E. coli and Salmonella enterica arose through point mutations of common ancestral genes 
(Lawrence and Ochman, 1998). Mobile genetic elements—including bacteriophage, 
plasmids and transposons—all contribute to LGT and can thus be seen as beneficial to 
microbes from an evolutionary point of view (Boucher et al., 2003). LGT is typically 
mediated by natural plasmid transformation, conjugation and/or phage transduction 
(Figure 1.2) (Thomas and Nielsen, 2005). Transduction describes the spread of DNA 
from one bacterial cell to another via a bacteriophage (such as phage λ or P1). 
Conjugation is the transfer of unique ‘F’ (fertility) plasmids from one bacterial cell to 
another through inter-cellular contact. Some bacteria can take up DNA from the 
surrounding environment through natural transformation. These processes can all mediate 
shuffling of chromosomal DNA between cells; phage can package cellular rather than 
phage-encoded DNA and subsequently introduce this genetic information by infecting 
another cell, and F plasmids can accumulate chromosomal segments and become F’ 
(Frost et al., 2005). These ‘agents’ of LGT greatly facilitate the dissemination of 
transposons between bacterial species, as transposons can insert into plasmids or phage 
genomes, which can then spread among bacterial cells. Transposition compounds the 
effects of LGT in two ways: first, transposition events occur within the host genome, 
providing a source of intrinsic mutability; second, transposition is typically autonomous 
(i.e. does not require host-encoded functions, such as homologous recombination).  
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Figure 1.2. Transfer of DNA between bacterial cells.  
Transduction (1). The DNA genome (yellow) of a temperate phage inserts into the 
chromosome (dark blue) as a prophage; it later replicates, occasionally packaging host 
DNA alone (generalized transduction) or with its own DNA (specialized transduction), 
lyses the cell, and infects a naive recipient cell in which the novel DNA recombines into 
the recipient host cell chromosome (red). Conjugation (2). Large, low copy-number 
conjugative plasmids (orange) and integrated conjugative elements (not shown) use a 
protein structure (known as a pilus) to establish a connection with the recipient cell and to 
transfer themselves to the recipient cell. Alternatively, a copy of a multi-copy plasmid, 
defective genomic island or a copy of the entire bacterial chromosome can be transferred 
to a naive cell, in which these genetic elements either insert into the chromosome or 
replicate independently if compatible with the resident plasmids (light green). 
Conjugative transposons and plasmids of Gram-positive bacteria (not shown) do not use 
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chromosomal genes, and the recognition that MGEs 
have important roles in infectious diseases, antibiotic 
resistance, bacterial symbioses, and biotransformation 
of xenobiotics, has kindled interest in the comprehensive 
genomic analysis of the MGEs. Although these genetic 
elements are potent agents of change, their contributions 
to the mode and tempo of bacterial evolution have just 
begun to be examined4. 
The following sections briefly review the most 
important genes that define these elements as agents of 
HGT, selected accessory MGE genes that are involved in 
medically, agriculturally and environmentally important 
processes, and the unique challenges of MGE genomics.
Plasmids and other conjugative elements
A plasmid is a collection of functional genetic mod-
ules that are organized into a stable, self-replicating 
entity or ‘replicon’, which is smaller than the cellular 
chromosome and which usually does not contain 
genes required for essential cellular functions. The 
classic plasmids are covalently closed, circular 
double-stranded DNA molecules (FIG. 1), but linear 
double-stranded DNA plasmids have been found in 
an increasing number of species5–7. The general anat-
omy of a plasmid includes the essential ‘backbone’ of 
genes that encode replicative functions and a variable 
assortment of accessory genes that encode processes 
that are distinct from those encoded by the bacterial 
chromosome (see below). Such accessory traits can 
be accumulated in the cell without altering the gene 
content of the bacterial chromosome8,9.
Plasmids must replicate, control their copy number, 
and ensure their inheritance at each cell-division by 
a process known as partitioning. It is impossible for 
plasmids with the same replication mechanism to co-
exist in the same cell, a phenomenon termed ‘incom-
pat ibility’ (Inc). The Inc trait provided the basis for the 
initial classification of some plasmids that is still in use 
today. Incompatibility groups have been defined for 
plasmids of the enterobacteriaceae (26 groups), the 
Figure 1 | Transfer of DNA between bacterial cells. Transduction (1). The DNA genome (yellow) of a temperate phage inserts 
into the chromosome (dark blue) as a prophage; it later replicates, occasionally packaging host DNA alone (generalized 
transduction) or with its own DNA (specialized transduction), lyses the cell, nd infects a naive recipient cell in which the novel 
DNA recombines into the recipient host cell chromosome (red). Conjugation (2). Large, low copy number conjugative plasmids 
(orange) and integrated conjugative elements (ICEs; not shown) use a protein structure (known as a pilus) to establish a 
connection with the recipient cell and to transfer themselves to the recipient cell. Alternatively, a copy of a small, multicopy plasmid 
or defective genomic island or a copy of the entire bacterial chromosome can be transferred to a naive cell, in which these genetic 
elements either insert into the chromosome or replicate independently if compatible with the resident plasmids (light green). 
C njugative transposons and plasmids of Gram-positive bacteria (no  shown) do not use pili. Transposition (3). Transposons (pi k) 
integrate into new sites on the chromosome or plasmids by non-homologous recombination. Integrons (dark green) use similar 
mechanisms to exchange single gene cassettes (brown). Details of these and other MGEs can be found in REFS 119,120.
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pili. Transposition (3). Transposons (pink) integrate into new sites on the chromosome 
or plasmids by non-homologous recombination. Integrons (dark green) use similar 
mechanisms to exchange single gene cassettes (brown). Natural transformation (not 
shown). Some bacteria can take up DNA from their immediate surroundings. Reprinted 
by permission from Macmillan Publishers Ltd: [Nature Reviews Microbiology] (Frost et 
al., 2005), copyright (2005). 
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A particular talent of transposons is to disseminate genes encoding antibiotic 
resistance (Gentry, 1991; Lupski, 1987), as transposons often encode such genes 
(Kleckner, 1981). As many as half of recent antibiotic resistance cases are thought to 
have been caused by transposons (Levy and Marshall, 2004) and the general spread of 
(multiple) antibiotic resistance factors might be viewed as transposon evolution rather 
than purely bacterial evolution (Reanney, 1976). For instance, the IncM plasmids 
encoding resistance to gentamicin were first isolated in 1972. When they were isolated 
years later, they contained many additional resistance determinants, including 
transposons such as Tn6, Tn7 and Tn9 (Datta et al., 1980). Mobile genetic elements are 
also key to the acquisition of virulence factors (reviewed in Gyles and Boerlin, 2014; 
Keen, 2012).  
The transposons mentioned above are members of the Tn family—that is, they are 
composite transposons, which encode ‘extra’ genes flanked by insertion sequences. 
While it is clear that composite transposons have been maintained in bacterial 
populations largely due to the selective advantage conferred by the extra genes they 
encode (particularly antibiotic resistance determinants), it is notable that IS elements have 
also persisted outside of the context of a Tn element. In Yersinia pestis, the causative 
agent of plague, characterization of mutations conferring immunological ‘escape’ 
phenotypes within immunized murine hosts lead to the discovery that IS1541 transposed 
into the caf1A gene. This gene encodes a cell-surface protein that was targeted by the 
host’s antibodies, and disruption of caf1A by IS1541 prevented expression of this ligand, 
enabling the bacterium to evade the immune response (Cornelius et al., 2009). It is 
tempting to speculate that IS elements can contribute to the fitness of their hosts simply 
be providing an efficient source of intrinsic mutability in times of severe cellular stress. 
LGT and transposons are thus major contributors to the acquisition of multiple-
drug resistance as well as virulence in a variety of bacterial species (Davies, 1994; 
Espedido and Gosbell, 2012; Keen, 2012; Levy and Marshall, 2004; Quesada-Gomez, 
2011).  
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1.4 Host-transposon interactions 
Mobile genetic elements are present in some form in virtually all organisms and can pose 
a threat to genomic stability if left unchecked (Curcio and Derbyshire, 2003). Therefore, 
most organisms are thought to have evolved stringent mechanisms to inhibit the mobility 
of foreign genetic elements. For instance, elaborate mechanisms like RNA interference 
(RNAi) impose post-transcriptional silencing on many genes but are widely believed to 
have evolved to silence foreign genes, including transposons (reviewed in Feschotte, 
2008).  
Frequent mobilization of transposons would be detrimental to bacteria (i.e. a 
major source of genomic instability) as well as to the transposons themselves (since they 
would kill their own host). It therefore makes sense that, in order to be maintained in 
bacterial populations, transposons have evolved mechanisms to intrinsically limit (though 
not abolish) their own mobility, which supplement the repressive strategies employed by 
the host. Moreover, it has been proposed that transposon mobilization in times of severe 
cellular stress would provide an evolutionary benefit to both the transposable element and 
its host (Boucher et al., 2003). In the case of the element, elevated transposition 
frequency would increase its chances of mobilizing into a healthy host. While individual 
bacterial cells might fall prey to increased genomic instability, the host as a population 
would benefit from increased genetic plasticity as well as increased LGT, since any one 
cell could gain the ability to survive the stress at hand and rapidly pass this advantage to 
other bacterial cells.  
Therefore, mechanisms for both repressing and activating transposition are 
employed by the transposons (‘intrinsic’ factors) and their hosts (‘extrinsic’ or ‘host-
encoded’ factors) in order to maintain transposition at low—but not altogether 
negligible—frequencies in bacteria. 
1.4.1 Intrinsic regulation of bacterial transposition 
Transposase proteins catalyze the chemical steps in bacterial transposition reactions. It 
follows that the regulation of expression of these genes is a critical feature in dictating the 
transposition frequency of most transposons.  
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In many instances, including the well-studied Tn10/IS10 and Tn5/IS50 
transposons, transposase gene promoters are inherently weak. Weak translational 
initiation, frame-shifting and protein instability can also reduce transposition. To prevent 
transposase expression due to transcriptional read-through from an adjacent gene, IS10 
and IS50 encode sequences that can form an RNA secondary structure in order to 
sequester the translation initiation signals (TIR). Inverted repeat sequences located close 
to the left end include the TIR. Transcripts from the resident transposase promoter 
include only one repeat (which cannot form the secondary structure by itself) while 
transcripts from neighbouring DNA include both repeats (Kleckner, 1990; Mahillon and 
Chandler, 1998; Nagy and Chandler, 2004).  
There are also examples where translation of transposase transcripts is subject to 
intrinsic regulation. In the case of IS10 transposase, the ribosome binding site is 
inherently weak and the transposon encodes an antisense RNA (RNA-OUT) that binds 
the translation initiation region (TIR) of the transposase mRNA (RNA-IN), blocking 
ribosome binding (Ma and Simons, 1990; Simons and Kleckner, 1983).  
At the ‘post-translational’ level (i.e. after synthesis of the transposase protein), 
Tn5 encodes an inhibitor protein that forms inactive dimers with transposase (de la Cruz 
et al., 1993).  
Finally, formation of the transpososome (the higher order complex of transposase 
with transposon DNA) and the reactions catalyzed by transposase are often inefficient, 
due to sub-optimal binding sites for transposase proteins and inefficient catalysis by 
transposase itself (Gueguen et al., 2005).  
1.4.2 Host-imposed regulation of bacterial transposition 
DNA Adenine Methyltransferase (Dam)-methylation is a major mechanism by which 
bacteria limit transcription of transposase messages (Yoder et al., 1997). For instance, 
Dam methylase limits initiation of IS10 and IS50 transposase gene transcription by 
methylating promoter elements, and Dam-methylation of transposon ends also reduces 
transposition by interfering with transposase binding to the ends (Roberts et al., 1985; 
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Yin et al., 1988). This represents a cooperation between intrinsic and extrinsic regulation, 
since the Dam-recognition sequences (GATC) are encoded by the transposons but Dam 
methylase is a host-encoded enzyme. There is evidence that IS50 transposase expression 
is also negatively regulated by LexA, an SOS-inducible transcriptional repressor (Kuan 
and Tessman, 1991). However, there is little else known with regard to host proteins that 
influence either transposase transcription or translation in bacteria.    
Several nucleoid-associated proteins impact on transposition. Examples include 
IHF (integration host factor), HU (histone-like, strain U93), Fis (factor for inversion 
stimulation) and H-NS (histone-like nucleoid structuring protein). IHF, HU, and H-NS 
have all been shown to bind directly to transposon sequences in vitro or in vivo and 
directly stimulate transpososome assembly or transposition (e.g. Mu, Tn10, Tn5, Tn1000) 
(Lavoie and Chaconas, 1993; Signon and Kleckner, 1995; Surette et al., 1989; Wardle et 
al., 2005; Whitfield et al., 2009). Alternatively, H-NS indirectly affects IS1 transposition 
by stabilizing the IS1 transposase insAB’ (Rouquette et al., 2004). Regulation of Mu is 
also mediated by H-NS, which stabilizes the Mu repressor-DNA complex that controls 
transposase activity (Falconi et al., 1991).  
While many examples exist of host-encoded factors influencing transpososome 
dynamics or other aspects of transposition in the context of a mature transposase protein, 
an exhaustive search of the literature failed to turn up examples of transposase expression 
being regulated by host-factors at the post-transcriptional level in bacteria. Post-
transcriptional machinery thus represents a previously unrecognized means for the 
bacterial host to regulate transposase expression. Given that expression of the transposase 
protein is essential for transposition, such mechanisms have powerful potential for 
transposon regulation.   
1.5 Post-transcriptional regulation in bacteria 
Like eukaryotes, bacteria have innate defense systems (e.g. restriction endonucleases). 
More recently, CRISPR elements (clustered regularly interspaced short palindromic 
repeats) and Argonaut-based systems have emerged as a form of bacterial adaptive 
immune response (see reviews by Olovnikov et al., 2013; Raivio, 2011; van der Oost et 
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al., 2009; Wiedenheft et al., 2012) for degrading foreign DNA. Bacteria have also 
evolved a system for post-transcriptional regulation with functional similarities to 
eukaryotic microRNAs (miRNAs). The actuators of this system are small regulatory 
RNAs (sRNAs); these are a major component of bacterial gene regulation, and tend to 
mediate cellular response to a wide variety of external stress stimuli (Gottesman and 
Storz, 2011; Vogel and Papenfort, 2006). Small RNAs can be categorized as cis-encoded 
(classical antisense RNAs, which are expressed from the strand opposite their target) or 
trans-encoded (i.e. expressed from distinct genes on the bacterial chromosome). The 
latter is thought to represent the major class of bacterial regulatory RNAs, although an 
increasing number of cis-encoded antisense RNAs are being shown to have a defined 
physiological role (see reviews by Gottesman and Storz, 2011; Waters and Storz, 2009). 
Note that ‘sRNAs’ will hereafter refer to the trans-encoded variety, while cis-encoded 
sRNAs will be referred to as ‘antisense RNAs’ (asRNAs). An important feature of 
sRNAs is that they share only partial sequence complementarity to their mRNA targets, 
with small ‘seed regions’ reminiscent of eukaryotic miRNAs. Also like miRNAs, sRNAs 
can regulate multiple mRNAs (Lease et al., 1998) and, conversely, multiple sRNAs can 
converge on one mRNA (reviewed in Repoila and Darfeuille, 2009).  
The consequence of base pairing between an sRNA and its mRNA target can be 
either activation or, more commonly, repression of translation. The paradigm for 
activation has been established largely from studies of the sRNA:mRNA pair DsrA:rpoS. 
In this case, secondary structure in the 5’ un-translated region (5’ UTR) of the rpoS 
mRNA sequesters the Shine-Dalgarno (SD) ribosome-binding site, preventing translation 
initiation. Cold-shock induces DsrA-expression, and this sRNA base pairs with the 5’ 
UTR of rpoS to relieve the self-inhibitory stem-loop structure by an ‘anti-antisense’ 
mechanism, allowing expression of the rpoS-encoded σS protein (Majdalani et al., 1998; 
Soper et al., 2010). More recently, a new mechanism for activation was established for 
the sRNA SgrS, which was shown to activate YigL synthesis in a translation-independent 
manner by selectively stabilizing a decay intermediate of the dicistronic pldB-yigL 
transcript (Papenfort et al., 2013).  
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The consequence of sRNA:mRNA pairing is usually repression rather than 
activation. Repression is almost always due to sequestration of the TIR of the mRNA 
target, although enhanced mRNA turnover through ribonuclease recruitment is also 
observed in many cases (Waters and Storz, 2009). 
1.6 Hfq: a global post-transcriptional regulator 
In eukaryotes, miRNAs or siRNAs are responsible for targeting RNA but ultimately, 
elaborate protein machinery is responsible for silencing (reviewed in Hammond, 2005). 
Conversely, as discussed above, bacterial sRNAs themselves are usually directly 
responsible for translational silencing (or activation) due to base-pairing interactions with 
specific regions of their mRNA targets. Nevertheless, the major class of sRNAs functions 
alongside an abundant Sm-like protein called Hfq (Moller et al., 2002; Valentin-Hansen 
et al., 2004). Originally identified as the host factor for replication of phage Qβ, Hfq has 
become recognized as a central player in post-transcriptional regulation in bacteria (De 
Lay et al., 2013). The most intensely studied function of Hfq is to facilitate base pairing 
between sRNAs and their targets. However, other functions of Hfq have come to light 
(reviewed in De Lay et al., 2013; Vogel and Luisi, 2011). The diverse regulatory 
functions of Hfq (some of which are illustrated in Figure 1.3) make it central to 
expression of up to half of all proteins in model organisms like S. enterica (Ansong et al., 
2009). Hfq homologues have been found in more than half of all sequenced Gram-
negative and Gram-positive bacteria, and there is at least one Hfq-like protein in an 
archaeal species (Sun et al., 2002). While it is not essential for viability under optimal 
growth conditions, hfq- cells display highly pleiotropic phenotypes, including slow 
growth and sensitivity to multiple stresses (Tsui et al., 1994). Given that Hfq is central to 
most sRNA regulatory circuits, which are themselves effectors of cellular stress-response, 
Hfq is a hub for the regulation of multiple stress-response pathways (Gottesman and 
Storz, 2011; Guisbert et al., 2007; Muffler et al., 1996; Vogel and Papenfort, 2006). 
Notably, Hfq is required for the proper expression of virulence genes; indeed, Hfq-
encoding pathogenic bacteria lose virulence when mutated to hfq- (Ding et al., 2004; 
Sittka et al., 2007). 
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Figure 1.3. Widely accepted modes of Hfq activity. 
(A) Hfq, in association with a small RNA (sRNA), can sequester the ribosome-binding 
site (RBS) of a target mRNA, thus blocking binding of the 30S and 50S ribosomal 
subunits and repressing translation. (B) In some mRNAs, a secondary structure in the 5′ 
un-translated region (UTR) can mask the RBS and inhibit translation. Hfq and an sRNA 
can activate the translation of such mRNAs by exposing the translation initiation region 
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the RNA–DNA duplex during 
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the proximal side and single-stranded ARN or ARNN 
motifs for the distal side) are consistent with the results 
of a systematic mutagenesis of E. coli Hfq; this analysis 
identified face-selective binding of natural RNA mol-
ecules and established a model of how Hfq can simulta-
neously bind an sRNA and its target mRNA37. However, 
the two Hfq surfaces may not be exclusively an ‘sRNA 
face’ and an ‘mRNA face’, and some RNAs may bind 
to both faces38. Nonetheless, having distinct binding 
faces promotes the recruitment of multiple RNAs on 
one Hfq molecule. The repetitive nature of each surface 
enables contact at several sites with the same RNA 
to give rise to cooperative effects39, and facilitates the 
recruitment of competitor RNAs to favour exchange 
with stably bound RNA38.
Recognition of different RNA species. Diverse RNA spe-
cies co-immunoprecipitate with Hfq, but the greatest 
enrichment is typically for sRNAs and mRNAs9–11, despite 
the tremendous excess of potential competitor cellu-
lar RNAs such as tRNAs and rRNAs. Even remote Hfq 
homologues (from the bacteria Neisseria meningitidis and 
Aquifex aeolicus, and the archaeon Methanocaldococcus 
jannaschii) preferentially interact with sRNAs when 
expressed heterologously in S. enterica11. So, what are the 
determinants of sRNAs and mRNAs that are preferentially 
recognized by Hfq?
Hfq-associated sRNAs are diverse in length (50–250 
nucleotides) and, although commonly devoid of ORFs, 
they still exceed the size of the regions in which they 
would be accommodated on the proximal and dis-
tal faces of Hfq, according to the crystal structures of 
Hfq–RNA complexes. These sRNAs seem to fold into 
stem–loops and are likely to bear modular domains for 
sRNA biogenesis or function (FIG. 3). Highly conserved 
regions within homologous sRNAs occur at the 5′ end 
or internally and typically serve as target recognition 
domains that select the regulated mRNAs by short 
pairing40–46; we refer to these as ‘seed’ regions, in loose 
analogy with the cognate elements of eukaryotic micro-
RNAs. The common stem–loop structure at the 3′ end 
of sRNAs, followed by a short poly(U) stretch, is part of 
a Rho-independent transcription terminator and probably 
serves the additional function of preventing attack by 
3′ exonucleases (provided that it is not too long). In 
several cases, Hfq binds in an AU-rich single-stranded 
region upstream of the terminator25,47–50, and this bind-
ing might then expose the target-binding domain of 
sRNAs for the interrogation of potential mRNA part-
ners. However, as most sRNAs are short and structured, 
the proximity of the stem–loop might be coincidental. 
In contrast with the mRNA-binding ‘seed’ domain, the 
potential contact sites of Hfq in sRNAs seem to have 
weak conservation at the nucleotide level and therefore 
remain elusive to prediction.
A representative Hfq-binding site in an mRNA is the 
repetitive sequence AANAANAANAAN, found in 
the 5′ untranslated region (UTR) of the rpoS transcript 
(encoding RNA polymerase σ-factor S) in E. coli. This 
element matches well with the aforementioned ARN 
motif for b nding to the distal face of Hfq (as deduced 
from the crystallographic data35), and it is critically 
required by the various sRNAs that activate rpoS transla-
tion51. Regulation mediated by this site seems to depend 
on context, as another high-affinity Hfq site nearby, an 
AAAAAA motif, cannot support an sRNA response51.
Pattern searches in the 5′ UTRs of E. coli mRNAs 
indicate the frequent occurrence of ARN motifs, espe-
cially overlapping the ribosome-binding site (RBS), 
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for 30S binding. (C) Hfq protects some sRNAs from ribonuclease cleavage, which is 
carried out by ribonuclease E (RNase E) in many cases. (D) Hfq can induce the cleavage 
(often by RNase E) of some sRNAs and their target mRNAs. (E) Hfq can stimulate the 
polyadenylation of an mRNA by poly(A) polymerase (PAP), which in turn triggers 3′-to-
5′ degradation by an exoribonuclease (Exo). In E. coli, the exoribonuclease can be 
polynucleotide phosphorylase, RNase R or RNase II. Adapted by permission from 
Macmillan Publishers Ltd: [Nature Reviews Microbiology] (Vogel and Luisi, 2011), 
copyright (2011) 
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1.6.1 Canonical regulation: Hfq-dependent sRNAs 
The canonical function of Hfq is to enhance the rate and/or stability of base-pairing 
interactions between sRNAs and their target mRNAs (reviewed in De Lay et al., 2013; 
Vogel and Luisi, 2011). 
The exact mechanism by which Hfq facilitates these interactions remains unclear. 
Crystal structures have shed some light on its multiple RNA-binding surfaces. Hfq forms 
a homo-hexameric ring or ‘toroid’ structure. U-rich RNA winds around the central cavity 
of the ring structure on one face of Hfq termed the ‘proximal’ face (Schumacher et al., 
2002), while A-rich RNA preferentially binds the opposite face, termed the ‘distal’ face 
(Link et al., 2009). Analyses of Hfq mutants have confirmed the RNA-binding specificity 
of these two surfaces (Mikulecky et al., 2004).  
The proximal face is thought to be the site for sRNA interactions. One basis for 
this interaction may be rho-independent terminators with poly(U) tails, which are 
characteristic of sRNAs (Ishikawa et al., 2012; Otaka et al., 2011; Sauer and 
Weichenrieder, 2011). Additionally, ‘internal’ binding sites for Hfq have been identified 
in many sRNAs, such as OxyS, DsrA and RyhB (Brescia et al., 2003; Geissmann and 
Touati, 2004; Zhang et al., 2002). This internal binding motif was further characterized in 
a study on SgrS, which required an internal U-rich sequence adjacent to a stem-loop—in 
addition to its rho-independent terminator—for stable Hfq binding and subsequent 
regulation of its target mRNA (Ishikawa et al., 2012). This motif is present in many of 
the currently characterized sRNAs. Studies with mutant forms of Hfq suggest that these 
interactions are abrogated upon mutation of proximal site residues, and these mutations 
also lead to reduced sRNA accumulation in vivo (Zhang et al., 2013).  
Studies on the distal face of Hfq have further characterized it as a site for binding 
A-rich RNA/mRNA (Mikulecky et al., 2004; Sauer et al., 2012). The distal surface has a 
high affinity for mRNAs containing an ‘ARN’ binding motif (where R is a purine and N 
is any base) (Link et al., 2009). The ARN motif was first reported to be required for Hfq 
binding and sRNA-mediated gene regulation in the DsrA:rpoS system (Soper and 
Woodson, 2008), and subsequent studies have confirmed the importance of this motif for 
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other sRNA/mRNA pairs (Beisel et al., 2012; Salim and Feig, 2010; Salim et al., 2012). 
Moreover, mutations in the distal surface disrupt regulation by Hfq-dependent sRNAs 
(Zhang et al., 2013).  
A third site for interaction has been characterized on the rim of the Hfq ring, 
termed the ‘lateral’ surface. This surface is rich in positively charged residues and has 
been implicated in sRNA binding. The lateral surface is thought to play an important role 
in the association with sRNAs that leads to sRNA:mRNA pairing and dissociation of the 
pair from Hfq (Panja et al., 2013; Sauer et al., 2012; Zhang et al., 2013).  
As previously mentioned, the mechanism by which Hfq facilitates sRNA-mRNA 
pairing remains unclear. One hypothesis for the role of Hfq is to increase the local 
concentration of the RNAs in the cell, thereby increasing the likelihood of base pairing. 
This simply requires that a given Hfq hexamer bind both the sRNA and its mRNA target 
simultaneously. Additionally, Hfq may play a more active role, by restructuring the 
RNAs to make the appropriate sequences available for base pairing (Geissmann and 
Touati, 2004; Soper et al., 2011). Both models (or other models) could apply for different 
sRNA/mRNA systems. 
While Hfq is an abundant protein, recent studies suggest that there is competition 
for binding to Hfq (Hussein and Lim, 2011; Moon and Gottesman, 2011; Olejniczak, 
2011). Each Hfq hexamer appears to bind one sRNA and one mRNA at a time 
(Updegrove et al., 2011). The implication is that an imbalance of sRNA or mRNA 
concentration (such as increased expression of a particular sRNA during a stress-
response) could essentially sequester intra-cellular Hfq, thus reducing regulation by other 
Hfq-dependent sRNA/mRNA systems.    
1.6.2 Alternative regulatory mechanisms employed by Hfq 
Hfq is known to stabilize sRNAs by protecting them against the action of ribonucleases 
(Moller et al., 2002; Sledjeski et al., 2001). Additionally, Hfq has been shown to directly 
repress translation of an mRNA by competing with ribosomes for binding the TIR; this 
activity is enhanced by sRNAs, which recruit Hfq to the mRNA, but interference can 
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occur even without the sRNA partners (Desnoyers and Masse, 2012; Salvail et al., 2013). 
One case of such repression by Hfq is the autoregulation of its own mRNA (Vecerek et 
al., 2005). Hfq also participates in sRNA-induced mRNA degradation. Hfq is believed to 
recruit RNA-degradation machinery to targeted mRNAs, as Hfq interacts with both 
sRNAs and RNase E (Ikeda et al., 2011; Masse et al., 2003; Morita et al., 2005). Hfq also 
enhances processivity of poly(A) polymerase I (PAPI), increasing turnover of certain 
mRNA targets (Folichon et al., 2003; Hajnsdorf and Regnier, 2000; Mohanty et al., 
2004). The diverse mechanisms utilized by Hfq highlight the complexity of Hfq 
regulation within a bacterial cell. Interestingly, Hfq has been shown to function in one 
cis-encoded antisense system. In the case of GadY, Hfq stabilizes the asRNA, but it was 
not determined if Hfq plays any role in antisense pairing (Opdyke et al., 2004). A role for 
Hfq in facilitating base pairing in a classical antisense regulatory system (such as the 
RNA-IN/RNA-OUT system of Tn10) has not yet been established. 
1.7 Bacterial stress-response and transposons 
Bacteria can dynamically alter their gene expression profiles in order to survive adverse 
and fluctuating conditions in their immediate surroundings. A bacterial cell can react 
simultaneously to a wide variety of stresses and the various stress-response systems 
interact with each other in a complex global regulatory network. Classic examples 
include the SOS response to DNA damage, stringent response to amino acid starvation 
(and other forms of stress) and the stationary phase/general stress response.  
A transcriptional repressor protein, LexA, negatively regulates the expression of 
SOS genes during normal growth by sequestering these specific promoters. When RecA 
senses DNA damage, it stimulates autoproteolysis of LexA, leading to activation of SOS 
genes. These genes encode proteins for processes like nucleotide excision repair, 
recombination and inhibition of cell division, allowing the cell to repair the DNA damage 
before continuing with replication (reviewed in Friedberg et al., 2006).  
The stringent response is signaled by (p)ppGpp and can modulate the 
transcription of up to one third of all genes in the cell, in order to divert cellular resources 
away from growth and division and toward amino acid synthesis. Low amino acid 
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concentration is sensed by RelA, which synthesizes (p)ppGpp. In conjunction with the 
protein DksA, (p)ppGpp regulates its target genes by interfering with transcription by 
RNA polymerase (RNAP) until amino acid levels recover, leading to the breakdown of 
(p)ppGpp by SpoT (reviewed in Potrykus and Cashel, 2008).  
Sigma factors recognize specific promoters, and the promoter-binding activity of 
RNAP holoenzyme is determined by which sigma factor is bound to the RNAP core 
enzyme. For instance, holoenzyme primarily contains the ‘housekeeping’ sigma factor 
(σ70) during normal growth. During the transition to stationary phase or due to various 
stresses (including starvation), σ70 becomes sequestered by its ‘anti-sigma factor’, while 
levels of the stationary phase sigma factor (σS) increase dramatically. Consequently, 
holoenzyme contains primarily σS under such conditions, which alters the promoter 
specificity of RNAP and therefore the gene expression profile of the cell (reviewed in 
Landini et al., 2014).  
Crp (cAMP-response protein) is a well-studied global transcription factor that 
enacts a coordinated shift in gene transcription in response to glucose levels. Low glucose 
concentration leads to high intra-cellular cyclic AMP (cAMP), which then binds to (and 
activates) Crp (Popovych et al., 2009). Crp-cAMP binds to specific promoters, leading 
either to transcriptional activation or repression. Activation is typified by the lac operon: 
cAMP-Crp binds upstream of the promoter and interacts with RNAP, enhancing 
transcription initiation (Hudson et al., 2009). Repression also occurs for many genes (e.g. 
glutamine synthetase) (Mallick and Herrlich, 1979; Prusiner et al., 1972); Crp-cAMP 
binds in close proximity to the transcription initiation site and/or -10 sequence, 
interfering with RNAP binding and transcription initiation. Crp regulates dozens of other 
genes, many of which encode local transcription factors. The net effect is a decrease in 
expression of genes for utilizing glucose and an increase in expression of genes for using 
alternative carbon sources, such as lactose (reviewed in Busby and Ebright, 1999; Kolb et 
al., 1993). Interestingly, cAMP-Crp also has a modest repressive effect on Hfq expression 
(Lin et al., 2011).  
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As previously mentioned, Hfq-dependent sRNAs have emerged as a major 
component of bacterial stress-response. An advantage of post-transcriptional regulation is 
that it allows very rapid and reversible response to stress, since sRNAs can be quickly 
induced and act on existing mRNA, and also experience a more rapid turnover than 
protein regulators when the stress is removed (Gottesman and Storz, 2011; Vogel and 
Papenfort, 2006). Hfq and its sRNA accomplices are important mediators of several 
different cellular stress-response pathways, including oxidative (Zhang et al., 1998), 
phosphosugar (Vanderpool and Gottesman, 2004), iron (Masse and Gottesman, 2002), 
osmotic (Vytvytska et al., 1998) and low-temperature stress (Hankins et al., 2010; Soper 
and Woodson, 2008). In each of these pathways, the stress induces transcription of at 
least one Hfq-dependent sRNA. Subsequently, Hfq interacts with the sRNA to mediate 
the stress-response by promoting the interaction of the sRNA with its mRNA target(s) 
(Gottesman et al., 2006; Vogel and Papenfort, 2006; Vogel and Luisi, 2011; Waters and 
Storz, 2009). For example, phosphosugar stress (triggered by the abnormal intracellular 
accumulation of glucose-6-phosphate or analogues thereof) induces the sRNA, SgrS. 
Levels of this sRNA increase by at least 10-fold under these conditions (Vanderpool and 
Gottesman, 2007). SgrS down-regulates glucose import by base pairing to the ptsG 
mRNA, repressing translation of the primary glucose transporter; SgrS also encodes a 
small peptide (SgrT) which blocks the glucose transporter at the protein level 
(Vanderpool and Gottesman, 2004; Wadler and Vanderpool, 2007). Additionally, SgrS 
up-regulates expression of a phosphatase (YigL) that de-phosphorylates glucose-6-
phosphate (Papenfort et al., 2013), which reduces glucose retention in the cell. 
Ultimately, the consequence of SgrS-induction is to reduce intra-cellular glucose-6-
phosphate levels, thus alleviating the stress. 
 As discussed above, increased transposition could provide an evolutionary 
advantage during bacterial stress-response, perhaps explaining why host factors are often 
positive regulators of transposition. Interestingly, there is evidence that some transposons 
are mobilized by environmental stresses. For example, UV radiation has been shown to 
induce IS10 transposition in E. coli, as a component of the SOS DNA-damage response 
(Eichenbaum and Livneh, 1998). In human colonic Bacteroides, exposure to tetracycline 
increased the rates of excision of the conjugal tetracycline resistance element, CTnDOT, 
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from the host chromosome (Shoemaker and Salyers, 1988). Another example is IS1. In 
this case, levels of the IS1 transposase mRNA (insA-insB’) increase in E.coli as part of a 
cellular response to high levels of divalent metal ions (Brocklehurst and Morby, 2000). In 
Pseudomonas putida, entry into stationary phase (where nutrients are growth limiting) 
was found to induce transposition of Tn4652 by up-regulating transposase transcription. 
This response was found to be dependent on the general stress-responsive sigma factor, 
σS, although it was not established if σS bound directly to the transposase promoter under 
these growth conditions (Ilves et al., 2001). The phenomenon of stress-induced 
mobilization is not limited to bacteria; in the eukaryote Saccharomyces cerevisiae, severe 
adenine starvation induces Ty1 transcription and retrotransposition (Todeschini et al., 
2005).  
Post-transcriptional regulation of transposition may provide a previously 
unrecognized means to link bacterial stress-response to transposon mobilization. 
1.8 Topics addressed in this thesis 
Despite the wealth of data concerning the chemical steps of excision and joining in 
bacterial transposition, and the various host-encoded factors that have been implicated as 
regulators of transposition, there are relatively few examples of host factors that influence 
transposase expression by a well-defined mechanism. Similarly, there are relatively few 
examples where increased transposition has been linked to a specific cellular stress-
response. Furthermore, the host-encoded machinery for post-transcriptional regulation 
has not yet been implicated in regulating a transposition system. Chapter 2 describes 
experiments aimed at expanding the current understanding of host-imposed regulation of 
transposition, using Tn10/IS10 in E. coli as a model system. I determined that Hfq is a 
potent repressor of transposase expression at the post-transcriptional level, and that this 
regulation was exercised via two pathways, one of which involves the intrinsic antisense 
regulator (RNA-OUT). Given that Hfq—or any other components of the sRNA-based 
post-transcriptional regulatory network in E. coli—had never before been implicated in 
regulation of transposition, I sought to further define the mechanism by which Hfq acts in 
the Tn10/IS10 antisense system. In Chapter 3, I show that Hfq plays a role in 
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restructuring RNA-IN and RNA-OUT, and generally acts to enhance base pairing in this 
antisense system in analogous fashion to a canonical sRNA/mRNA system. Notably, Hfq 
had not previously been implicated as a positive regulator of base pairing in cis-antisense 
systems. In Chapter 4, I show that a second transposition system (Tn5/IS50) is also 
repressed by Hfq. Unlike Tn10, the Tn5 system is regulated by Hfq at the level of 
transposase transcription and I provide evidence that this regulation is exercised 
indirectly, via Crp. Additionally, I show in Chapter 4 that Tn5 transposition is activated 
by nutrient starvation, providing a new example of stress-induction of transposition. In 
Chapter 5, I further discuss the implications of post-transcriptional regulation of DNA 
transposition, the possible role of Hfq as a general repressor of transposons, and the 
interplay between stress response and transposition. I also address the broader impact of 
my work, and discuss future directions.  
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Chapter 2 1 
2 Tn10/IS10 transposition is down-regulated at the level 
of transposase expression by the RNA-binding protein 
Hfq 
2.1 Introduction 
Within bacterial populations there is often promiscuous transfer of DNA between species, 
a phenomenon referred to as lateral gene transfer (LGT). In bacteria LGT is typically 
mediated by natural plasmid transformation, conjugation and/or phage transduction. The 
dissemination of transposons between bacterial species is greatly facilitated by insertion 
of transposons into the ‘agents’ of LGT (i.e. plasmids and phage). Moreover, since many 
transposons encode antibiotic resistance genes, LGT represents a major pathway through 
which bacteria become resistant to (multiple) antibiotics (Davies, 1994). Since 
transposons are key players in the acquisition of antibiotic resistance genes and are often 
tightly regulated by their hosts, it is important to understand mechanisms of host 
regulation of bacterial transposition. Interestingly, there is existing evidence that host 
regulation of transposition can be tied into cellular stress response pathways, raising the 
possibility that certain transposons may be mobilized by environmental stresses 
(Eichenbaum and Livneh, 1998; Brocklehurst and Morby, 2000; Todeschini et al., 2005; 
Twiss et al., 2005).  
Tn10 (and its component insertion sequence IS10 – see Figure 2.1) is an example 
of a bacterial transposon that is subject to strong negative and positive regulation by its 
host. In Escherichia coli, Dam methylation down-regulates both the expression of the 
transposase gene at the transcriptional level and the binding of transposase to the inside 
end (defined in Figure 2.1) (Roberts et al., 1985). Integration host factor (IHF) acts as a  
                                                
1
 A version of this chapter has been published: Ross,J.A., Wardle,S.J. and Haniford,D.B. (2010) Tn10/IS10 
transposition is downregulated at the level of transposase expression by the RNA-binding protein Hfq. 
Molecular microbiology, 78(3), 607-621. 
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Figure 2.1. Structure of Tn10/IS10 including a ‘marked’ IS10 and summary of the 
major steps in Tn10/IS10 transposition.  
OE and IE are outside and inside ends, respectively, and include binding sites for the 
IS10-encoded transposase protein. For IS10-Kan promoters pIN and pOUT (blue and 
black squares respectively) and the corresponding RNA transcripts, RNA-IN and RNA-
OUT (blue and black lines with arrows), are shown. RNA-OUT is an anti-sense RNA to 
RNA-IN (transposase transcript) and pairing of these RNAs blocks ribosome binding to 
RNA-IN by sequestering the ribosome binding site (RBS). Translation of RNA-IN 
generates the transposase protein, which binds transposon ends to form a transpososome. 
Subsequent to transpososome assembly the chemical steps in transposition are initiated. 
For details see Kennedy et al. (1998). 
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positive regulator of Tn10/IS10 transposition by binding outside end DNA (defined in 
Figure 2.1) and promoting transpososome assembly (Sakai et al., 1995). However, the 
continued presence of IHF in the transpososome acts to inhibit intermolecular 
transposition (Chalmers et al., 1998). The ejection of IHF from the transpososome is 
promoted by a second host protein, H-NS (histone-like nucleoid structuring protein) 
(Wardle et al., 2005), which also has a more general role in promoting LGT through the 
transient down-regulation of laterally acquired genes (Navarre et al., 2007).  
Tn10/IS10 transposition is also tightly negatively regulated by an anti-sense RNA 
encoded by the transposon itself. The anti-sense RNA (RNA-OUT) is complementary to 
the 5′ end of the transposase mRNA (RNA-IN) and pairing between the two RNAs 
reduces translation of the transposase message through sequestration of the ribosome 
binding site (Simons and Kleckner, 1983; Ma and Simons, 1990). In addition, pairing 
increases the sensitivity of RNA-IN to RNase E-mediated degradation (Case et al., 1990). 
The anti-sense system plays a particularly important role in limiting Tn10/IS10 
transposition when the transposon is present on a multi-copy plasmid. For example, 
introduction of IS10 on a multi-copy plasmid actually reduces the frequency of 
transposition of a chromosomal copy of Tn10 by about 10-fold and IS10 transposition 
itself (present on a multi-copy plasmid) does not increase significantly relative to a 
situation where IS10 is present in single copy (Simons and Kleckner, 1983). This 
phenomenon is called multi-copy inhibition (mci) and can be reconciled by the fact that 
RNA-OUT, which is expressed at a much higher level than RNA-IN (Simons et al., 
1983), is freely diffusible in the cell and thus can act in trans as an inhibitor of 
transposase expression. In contrast, the transposase protein is largely cis-acting because it 
tends to associate with transposon ends present on the element that encodes it (Morisato 
et al., 1983). Thus, increasing the copy number of Tn10/IS10 effectively results in an 
increased cellular concentration of the trans-acting inhibitor without altering the 
propensity of transposase protein to act on the element that encodes it. To date, host 
factor involvement in mci has not been established. Importantly, it should be recognized 
that interference with mci has the potential to greatly increase the frequency of 
Tn10/IS10 transposition when the transposon is present on a multi-copy plasmid as the 
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frequency of Tn10/IS10 transposition is roughly proportional to the amount of 
transposase protein synthesized (Morisato et al., 1983). 
In the current work we set out to further evaluate the importance of H-NS in the 
regulation of Tn10/IS10 transposition. Our initial objective was to determine if 
modulating H-NS expression levels had a significant impact on transposition frequencies. 
Regulation of H-NS gene expression is complex. H-NS is a potent transcriptional 
repressor and transcription of the hns gene is autoregulated by H-NS protein (Williams 
and Rimsky, 1997). It follows that simply increasing hns gene copy number may not be 
sufficient to increase cellular levels of H-NS protein. However, H-NS expression is also 
regulated post-transcriptionally. The small non-coding RNA (sRNA) DsrA binds 
segments at the 5′ and 3′ ends of hns mRNA through complementary base-pairing and in 
so doing promotes degradation of hns RNA (Lease and Belfort, 2000). Pairing of DsrA 
RNA to hns RNA is facilitated by Hfq, an RNA-binding protein (Sledjeski et al., 2001). 
Notably, Hfq binds to the majority of the sRNAs encoded by E. coli (of which there are 
over 100) and stabilizes these RNAs and/or promotes the pairing of these RNAs with 
partner mRNAs possessing partial sequence complementarity (Majdalani et al., 2005; 
Storz et al., 2005; Brennan and Link, 2007). Accordingly, we chose to up-regulate H-NS 
expression by disrupting the dsrA gene. As a control we also disrupted (in a separate 
strain) the hfq gene. We report here that disrupting the hfq gene results in a large increase 
in IS10 transposition but disrupting the dsrA gene has essentially no effect on IS10 
transposition. Since Hfq is essentially an auxiliary factor in DsrA mediated regulation of 
hns gene expression (Sledjeski et al., 2001), these results are consistent with Hfq acting 
as a negative regulator of IS10 transposition by a mechanism that is not related to cellular 
H-NS levels. Evidence is presented that Hfq negatively regulates Tn10/IS10 transposition 
by inhibiting expression of the IS10 transposase protein. Interestingly, while Hfq appears 
to contribute to the mci pathway (which inhibits transposase translation), we also provide 
evidence that Hfq negatively regulates transposition under conditions where the IS10 
anti-sense regulatory system is not functional. Together, these results suggest that Hfq 
can inhibit two distinct steps in Tn10/IS10 transposition. 
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2.2 Results 
2.2.1 Hfq acts as a potent negative regulator of IS10 transposition 
independent of its effects on H-NS gene expression  
H-NS has previously been shown to act as a positive regulator of Tn10 transposition 
(Swingle et al., 2004; Wardle et al., 2005). To examine the possibility that up-regulating 
the expression of H-NS influences IS10 transposition we measured the frequency of IS10 
transposition in strains of E. coli where genes encoding negative regulators of hns 
expression (dsrA and hfq) were disrupted. Disruption strains (hereafter referred to as hfq- 
and dsrA-) were generated by transducing NK5830 (recA- F+) with either hfq-1::Ωcat or 
dsrA::Ωcat alleles as previously described (Swingle et al., 2004). We then introduced a 
marked IS10 (IS10-Kan – see Figure 2.1) (Bender et al., 1991) on a multi-copy plasmid 
into NK5830 and the respective hfq- (DBH16) and dsrA- (DBH23) NK5830 derivatives 
and measured the frequency of IS10-Kan transposition via the conjugal mating out assay 
(described in Experimental procedures). As shown in Table 2.1, IS10-Kan transposition 
was greatly increased (86-fold) in hfq- compared with the wild-type (WT) strain. In 
contrast, disrupting dsrA had essentially no effect on the frequency of IS10-Kan 
transposition. Notably, the relatively low level of transposition (~3 x 10-4) for multi-copy 
IS10 observed in the WT strain is typical for an IS10 element that possesses intact mci 
functions (Shen et al., 1987). In fact, the IS10-Kan transposition frequency in hfq+ was 
only 20-fold above background for the mating out assay. This was determined using an 
IS10-Kan construct (pNK2727) containing an in-frame deletion in transposase that 
destroys transposase function (Haniford et al., 1989). Importantly, ‘background’ events 
did not go up in hfq- as the transposition frequency of the same in-frame deletion was 
slightly reduced in hfq- versus hfq+ (Table 2.1). Thus, the increase in transposition seen 
for IS10-Kan (WT transposase) in hfq- versus hfq+ cannot be explained by an increase in 
the frequency of background events in the hfq- strain. In addition, the increase in 
transposition in hfq- cannot be accounted for by an increase in IS10-Kan plasmid copy 
number as there was actually a slight decrease in plasmid copy number in hfq- versus hfq+ 
(Figure 2.2). 
 
43 
 
Table 2.1. In vivo transposition of IS10-Kan in isogenic WT, hfq- and dsrA- strains.  
 
Strain/Genotype Transposase  
Source 
Transposition 
frequencya 
Normalized 
frequencyb  
 
NK5830 (WT) 
 
 
DBH16 (hfq-1::Ωcat) 
 
 
DBH23 (dsrA::Ωcat) 
 
pNK1219 (WT) 
pNK2727 (Nco∇) 
 
pNK1219 (WT) 
pNK2727 (Nco∇) 
 
pNK1219 (WT) 
pNK2727 (Nco∇) 
 
 
3.3 (±1.5) x10-4 
1.8 (±1.3) x10-5 
 
2.8 (±1.5) x10-2 
6.6 (±2.2) x10-6 
 
3.9 (±2.2) x10-4 
1.3 (±0.1) x10-5 
 
  1.0 
     0.055 
 
86 
  0.020 
 
  1.2 
     0.039 
 
a Transposition frequency represents an average value obtained from 3 representative 
experiments wherein matings with at least 4 different donor transformants were carried 
out in each experiment 
b Transposition frequencies were normalized to the level of transposition in the WT strain 
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Figure 2.2. The copy number of a plasmid encoding IS10-Kan is decreased in hfq- vs 
hfq+ cells. 
1 mL aliquots of hfq+/- donor cells transformed with pNK1219 were removed from 
cultures to be used for a mating out experiment and mixed with 1 mL aliquots of DH5α 
cells containing pBR322; both cultures were at an OD600 of approximately 0.4. Plasmid 
DNA was then isolated from each of the mixed cultures using the plasmid mini-prep kit 
from Sigma and analyzed on a 1% agarose gel. Lanes 1-7 contain DNA isolated from 
separate cultures of NK5830/pNK1219 plus DNA from one culture of DH5α/pBR322 
and lanes 8-14 contain DNA isolated from separate cultures of DBH16/pNK1219 plus the 
aforementioned culture of DH5α/pBR322. 
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To ensure that the large increase in transposition we observed in hfq- is due 
specifically to the loss of Hfq function in the hfq- strain we introduced the hfq gene on a 
low-copy plasmid into the hfq- strain (DBH16) and measured IS10-Kan transposition via 
the mating out assay. We show in Table 2.2 that under these conditions the frequency of 
IS10-Kan transposition was essentially equivalent to that observed in the WT strain. This 
indicates that it is the disruption of the hfq gene, as opposed to possible polar effects of 
the hfq disruption on downstream genes that is having the large impact on IS10 
transposition. We also monitored H-NS protein levels in hfq+/- strains used for mating out 
experiments by Western blotting and did not see a significant difference (data not 
shown). 
Taken together, the results in this section show that disruption of the hfq but not 
the dsrA gene greatly increased the frequency of IS10-Kan transposition in E.coli. 
Because DsrA RNA is the primary mediator of post-transcriptional regulation of the hns 
gene and Hfq is essentially an accessory factor in this pathway, we conclude that the 
large increase in IS10-Kan transposition observed in hfq- is indicative of Hfq functioning 
as a negative regulator of IS10 transposition independent of its effects on H-NS protein 
levels. Below, we present the results of studies aimed at elucidating the mechanism by 
which Hfq down-regulates Tn10/IS10 transposition. 
2.2.2 Hfq can act independent of the mci pathway to suppress 
Tn10/IS10 transposition 
The naturally occurring antisense RNA system operating in Tn10/IS10 transposition 
mediates mci (see Introduction). Since disruption of mci is known to cause large 
increases in Tn10/IS10 transposition when Tn10/IS10 is present on a multi-copy plasmid 
(Case et al., 1989) and Hfq is known to promote the pairing of RNA molecules that share 
at least partial complementarity, we hypothesized that the large increase in IS10 
transposition observed in the hfq- strain reflects a role for Hfq in mci. To test this idea 
genetically we compared the transposition frequency of IS10-Kan in hfq-, mci- and hfq- / 
mci- backgrounds. Our expectation was that if Hfq acts in the mci pathway, the 
transposition frequency of IS10-Kan in the double mutant would be no greater than that  
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Table 2.2. Complementation of the hfq- effect on in vivo transposition of IS10-Kan 
 
Strain/Genotype Plasmid(s) Transposition 
frequencya 
Normalized 
frequencyb  
 
NK5830 (WT) 
 
DBH16 (hfq-1::Ωcat) 
 
NK5830 (WT) 
 
 
DBH16 (hfq-1::Ωcat) 
 
pDH602 
 
pDH602 
 
pDH602/ 
pDH614 (Hfq source) 
 
pDH602/ 
pDH614 (Hfq source) 
 
 
1.6 (±0.6) x10-3 
 
8.1 (±5.9) x10-2 
 
2.7 (±1.3) x10-3 
 
 
5.1 (±3.8) x10-4 
 
  1.0 
 
50 
 
  1.6 
 
 
  0.31 
 
a Transposition frequency represents an average value obtained from a representative 
experiment wherein matings with at least 4 different donor transformants were carried out 
b Transposition frequencies were normalized to the level of transposition in the WT strain 
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in hfq- or mci-. For this experiment an mci- phenotype was conferred by introducing into 
cells a plasmid that expressed a high level of truncated RNA-IN. This effectively titrates 
out the RNA-OUT produced by IS10-Kan (Jain, 1995). Contrary to our expectation the 
results show that combining mci- with hfq- mutations had a synergistic effect, increasing 
IS10-Kan transposition approximately 10-fold relative to mci- and hfq- in isolation (Table 
2.3). This result implies that Hfq can function outside of the mci pathway to negatively 
regulate IS10 transposition. It should be noted that the above synergy does not rule out 
the possibility that Hfq also plays a role in the mci pathway. 
 To estimate the impact of the hfq- phenotype on IS10 transposition independent of 
mci, we measured the transposition frequency of a single-copy IS10-Kan located in the 
chromosome; notably, when IS10 is present in single copy the anti-sense system has little 
effect on transposase expression (Kleckner, 1989). To do this we crossed IS10-Kan from 
a plasmid onto bacteriophage λ and subsequently made λ lysogens in isogenic hfq+/- 
strains. We then measured the transposition frequency of the single-copy IS10-Kan as 
previously described. As shown in Table 2.4, IS10-Kan transposition increased about 
sevenfold in hfq- versus hfq+. While significant, this increase is substantially smaller, at 
least 12-fold, compared with what we observed for hfq- in the situation where the same 
transposon is present on a multi-copy plasmid. 
 We also used a papillation assay to follow the transposition frequency of a single-
copy Tn10 derivative from the chromosome of isogenic hfq+/- strains. In this setup the 
experimental readout for transposition is a ‘LacZ turn-on’ event that results from 
mobilization of a Tn10 derivative encoding a truncated lacZ gene into an expressed gene. 
When plated on MacConkey lactose indicator plates, cells having a Tn10 transposition 
event that results in LacZ turn-on form red papillae (or outgrowths) on a background of 
white (LacZ-) cells (Haniford et al., 1989). The number of LacZ+ papillae formed per 
colony is roughly proportional to the frequency of Tn10 transposition within the colony 
(Huisman and Kleckner, 1987). To drive transposition we provided a copy of the 
transposase gene under the control of a heterologous promoter (pTac) on a multi-copy 
plasmid – this construct does not encode functional RNA-OUT. We show in Figure 2.3  
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Table 2.3. In vivo transposition of IS10-Kan in hfq+/hfq- strains containing a vector 
control or an RNA-OUT ‘titrator’. 
 
Strain/Genotype Plasmids Transposition 
frequencya 
Normalized 
frequencyb  
NK5830 (WT) 
 
 
NK5830 (WT) 
 
 
DBH16 (hfq-1::Ωcat) 
 
 
DBH16 (hfq-1::Ωcat) 
pNK1219/ 
pACYC184 (vector) 
 
pNK1219/ 
pNK2197 (titrator) 
 
pNK1219/ 
pACYC184 (vector) 
 
pNK1219/ 
pNK2197 (titrator) 
 
4.7 (±2.7) x10-4 
 
 
1.3 (±0.6) x10-2 
 
 
1.5 (±0.9) x10-2 
 
 
1.7 (±1.1) x10-1 
    1.0 
 
 
  28 
 
 
  31 
 
 
370 
 
 
a Transposition frequency represents an average value obtained from 2 representative 
experiments wherein matings with at least 4 different donor transformants were carried 
out in each experiment 
b Transposition frequencies were normalized to the level of transposition in the WT strain 
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Table 2.4. In vivo transposition of chromosomal IS10-Kan in hfq+/hfq- strains. 
 
Strain/Genotype Transposase Transposition 
frequencya 
Normalized 
frequencyb  
 
DBH99 (WT) 
 
DBH100 (WT) 
 
DBH93 (hfq-1::Ωcat) 
 
DBH94 (hfq-1::Ωcat) 
 
 
WT 
 
Nco∇ 
 
WT 
 
Nco∇ 
 
3.7 (±1.3) x10-5 
 
< 9 x10-7 
 
2.5 (±0.87) x10-4 
 
< 2 x10-6 
 
   1.0 
 
   < 0.02 
 
   6.9 
 
   < 0.01 
 
a Transposition frequency represents an average value obtained from a representative 
experiment wherein matings with at least 4 different donor transformants were carried out 
b Transposition frequencies were normalized to the level of transposition in the WT strain 
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Figure 2.3. Papillation assay showing the relative transposition frequency of a Tn10 
derivative in hfq+/- strains. 
A plasmid (pNK629) encoding IS10 transposase expressed from a pTac promoter and 
lacking DNA sequences encoding functional RNA-OUT was transformed into isogenic 
hfq+/- strains (NK8044 and DBH15) containing a single chromosomal copy of mini-
Tn10LK; the lacZ gene in mini-Tn10LK is only expressed when the mini-Tn10LK 
transposes into a transcriptionally active gene in the correct orientation and reading 
frame. Transformants were selected on MacConkey lactose plates containing tetracycline 
and grown for 3 days. Representative colonies from the different transformation mixes 
plated on different halves of the same MacConkey lactose plate are shown. 
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that hfq- transformants formed substantially more papillae than did hfq+ transformants. 
For example, after 72 h of growth on the ‘papillation’ plates there were on average 12 
papillae on hfq- colonies versus 2 papillae on hfq+ colonies, even though the hfq+ colonies 
grew at close to twice the rate of hfq- colonies. 
 In addition to showing that Tn10 transposition is up-regulated in hfq-, the 
papillation experiment shows that Hfq can function totally independent of the naturally 
occurring anti-sense system in Tn10/IS10 to inhibit transposition. The papillation assay 
result also shows that we can detect an increase in transposition (in this case of a Tn10 
derivative) in hfq- versus hfq+ in an assay that does not depend on bacterial conjugation. 
This is relevant because it has been shown that Hfq negatively regulates F plasmid 
mating efficiency (Will and Frost, 2006), although this is not a factor in our mating out 
experiments because all of our mating out data is normalized for mating efficiency. 
2.2.3 Hfq down-regulates transposase expression 
To further delve into the mechanism by which Hfq down-regulates Tn10/IS10 
transposition, we looked at the impact of knocking out Hfq on both steady-state levels of 
RNA-IN and on expression of RNA-IN in transcriptional and translational fusions. For 
measuring steady-state levels of RNA-IN we performed semi-quantitative RT-PCR. 
Using primers (see Table 2.5) designed to amplify a segment at the 3′ end of RNA-IN 
and RNA isolated from donor strains grown as in the mating out protocol, we amplified 
an RT-PCR product of the expected size (212 bp) for RNA-IN. As a control for the 
quality and concentration of RNA prepared from hfq+ and hfq- strains we also amplified a 
16S rRNA RT-PCR product in a separate reaction. We show in Figure 2.4 that while 
there appeared to be a small increase (1.6-fold) in the steady-state level of RNA-IN in the 
Hfq- versus the hfq+ strain, this difference was not statistically significant. Note that we 
could not detect RNA-IN by either primer extension or RNase protection in hfq+ or hfq- 
cells transformed with the IS10-Kan plasmid (either pNK1219 or pDH602) and this 
precluded us from directly measuring RNA-IN stability under conditions comparable to 
our transposition assays.  
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Table 2.5. Oligonucleotides used in this study. 
Name Sequence (5’ to 3’) Use 
 
JR1 
 
 
JR2 
 
JR3 
 
 
JR4 
 
JR5 
 
JR6 
 
JR7 
 
JR8 
 
JR9 
 
JR10 
 
JR11 
 
 
JR12 
 
TAATACGACTCACTATAGGCGAAAAAT
CAATAATCAGACAACAAG 
 
GGGGCAGAATTGGTAAAGAGAGTCG 
 
TAATACGACTCACTATAGGCTCGCACAT
CTTGTTGTC 
 
GGATACACATCTTGTCATATGATCA 
 
ACAAGGTTGGGACAAGCACTTCCAG 
 
CTGAGAGATCCCCTCATAATT 
 
CGTGTTGTGAAATGTTGGGTTAAGT 
 
AACCCACTCCCATGGTGTGACGGGC 
 
GGAAAAGAGCATATGGCTAAGGGGC 
 
AAAACAGCCCGGATCCTTATTCGGT 
 
NNNACTAGTNNNTTGAGACGTATCGTG 
 
 
NNNAAGCTTNNNGCGTATAACCCTCTA 
 
Forward primer (includes T7 promoter) for in vitro 
transcription template (RNA-IN) 
 
Reverse primer for above synthesis 
 
Forward primer (includes T7 promoter) for in vitro 
transcription template (RNA-OUT) 
 
Reverse primer for above synthesis 
 
Forward primer for RT-PCR of RNA-IN 
 
Reverse primer for RT-PCR of RNA-IN 
 
Forward primer for RT-PCR of rrsb (16S rRNA) 
 
Reverse primer for RT-PCR of rrsb (16S rRNA) 
 
Forward primer for cloning hfq onto pDH631; NdeI cut site 
 
Reverse primer for above synthesis; BamHI cut site 
 
Forward primer for cloning hfq (with native promoter) onto 
pDH614; SpeI cut site 
 
Reverse primer for above synthesis; HindIII cut site 
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Figure 2.4. Steady-state RNA-IN levels in hfq+/- strains as determined by RT-PCR. 
Isogenic hfq+/- strains (NK5830 and DBH16) transformed with an IS10-Kan containing 
plasmid (pNK1219) were grown in LB supplemented with kanamycin as described for 
donor strains in the mating out protocol. At the point where donor cells would normally 
be mixed with recipient cells, RNA was extracted from donor cells (separate cultures 
derived from three independent transformants of each strain) and used for RT-PCR with 
primers suitable for amplifying cDNAs from RNA-IN and 16S rRNA, in separate 
reactions. (A) Ethidium bromide-stained agarose gels corresponding to separate primer 
pairs and control reactions are shown. Lanes 1 and 2: amplification using genomic DNA 
(+ and - refers to genomic DNA isolated from DBH16 either containing or not containing 
pNK1219 respectively). Lanes 3 and 4: RT-PCR performed in the absence of RNA and in 
the presence of RNA but the absence of reverse transcriptase (RT) respectively. Lanes 5 
and 6: RT-PCR performed with only the forward (For) or reverse (Rev) primer 
respectively. Lanes 7–9: complete RT-PCR reactions performed on RNA isolated from 
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hfq+ cells. Lanes 10–12: complete RT-PCR reactions performed on RNA isolated from 
hfq- cells. RNA-IN and 16S rRNA amplicons are predicted to be 212 and 355 base pairs 
respectively. (B) Quantification of the gel image shown in (A). The band intensity of the 
RNA-IN amplicon was divided by the band intensity of the 16S rRNA amplicon for each 
of three hfq+ and hfq- isolates and the average value for this ratio for each of the two sets 
was calculated. Error bars indicate standard deviation on the mean. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
55 
 
To look at possible effects of Hfq on transcription and translation of RNA-IN, we 
analyzed the expression of transposase–lacZ fusions in hfq+/- cells. We introduced into 
hfq+/- cells plasmids encoding a portion of IS10 including pIN and pOUT (pNK774) or 
only pIN (pNK772) fused to a promoter-less lacZ gene (Simons et al., 1983). We then 
measured β-galactosidase activity in these strains and observed only a very small 
difference (less than twofold) in hfq- versus hfq+ (Figure 2.5). This suggests that Hfq does 
not influence transcription of RNA-IN. Next we introduced a translational fusion that 
encodes pIN, pOUT plus the first 183 nucleotides of RNA-IN into hfq+/- cells and 
measured β-galactosidase activity (Figure 2.6A). In one configuration translational 
fusions were present on a multi-copy plasmid; the IS10 component was either mci+ or 
mci- (Jain, 1995). In this case mci- status was conferred by the R5 mutation, which 
destabilizes RNA-OUT (Simons and Kleckner, 1983; Case et al., 1989). We show in 
Figure 2.6B that in hfq-, mci- and hfq- mci- β-galactosidase activity increased an average 
of 5-, 9- and 51-fold respectively. 
In a second configuration the transposase–lacZ translation fusion was present in 
single copy on the chromosome and the IS10 segment contained two mutations, HH104 
and G8. The HH104 mutation increases the level of transposase transcript (RNA-IN) 
relative to WT IS10 (Simons et al., 1983) and the G8 mutation increases the level of 
RNA-OUT transcript relative to WT IS10 (Simons and Kleckner, 1983; Case et al., 
1989). Together these mutations allow detection of transposase expression from a single-
copy IS10 derivative and ensure that the system is sensitive to anti-sense RNA regulation 
by RNA-OUT (Case et al., 1989). The results were very similar to those observed in the 
multi-copy system, as hfq-, mci- and hfq- mci- conferred moderate, strong and very strong 
increases in β-galactosidase activity respectively (Figure 2.6C). 
The results in this section are consistent with Hfq inhibiting transposase 
expression at the post-transcriptional level. In addition, as we observed synergy between 
hfq- and mci- mutations in both transposase expression and transposition assays, the data 
are entirely consistent with the higher transposition frequencies observed in hfq- strains 
being due to increased transposase expression. At this point the data (Figures 2.4 - 2.6) 
are also consistent with hfq status influencing transposase translation, but as we have not  
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Figure 2.5. β-galactosidase activity for hfq+/- strains containing IS10-lacZ 
transcriptional fusions. 
(A) Schematic of an IS10-LacZ transcriptional fusion used in this work (present in 
pNK774). The first 181 basepairs of IS10 (includes pIN, the first 101 nucleotides of 
RNA-IN, pOUT and RNA-OUT) plus the last 265 basepairs of IS10 are fused to a 
promoterless lacZ gene with intact lacZ translational sequences (including the ribosome 
binding site and start codon – approximate position indicated by red asterisks). A second 
transcriptional fusion (present in pNK772) has the first 118 basepairs of IS10 plus the last 
265 basepairs of IS10 fused to a promoterless lacZ gene as above. This transcriptional 
fusion encodes pIN, the first 38 nucleotides of RNA-IN but does not encode RNA-OUT. 
(B) β-galactosidase activity (given in Miller units) for strains containing the 
transcriptional fusions described in (A). A plasmid (pNK678) encoding the promoter-less 
lacZ gene was used to assess background β-galactosidase activity. The bar graph presents 
the results of average values from two independent experiments wherein 4 independent 
transformants were tested for each of the indicated strains. The error bars represent the 
standard deviation on the mean for each of these sets. 
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Figure 2.6. β-Galactosidase activity for hfq+/- strains containing an IS10–lacZ 
translational fusion. 
(A) Schematic of the IS10–lacZ translational fusion used in this work. The first 291 base 
pairs of IS10 (includes pIN, the 5′UTR of RNA-IN, the first 61 codons of transposase, 
pOUT and RNA-OUT) was fused to the tenth codon of the lacZ gene. (B) β-
Galactosidase activity (given in Miller units) for strains containing the IS10–lacZ fusion 
on a multi-copy plasmid. Mci- status was conferred by using a version of the IS10–lacZ 
fusion containing the R5 mutation; this mutation destabilizes RNA-OUT. (C) β-
Galactosidase activity for strains containing a single copy of the IS10–lacZ fusion in the 
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chromosome. To facilitate detection of β-galactosidase activity above background a 
promoter-up mutation was present in pIN (HH104). To maintain antisense control a 
promoter-up mutation (G8) was also present in pOUT. Mci- status was conferred by 
transforming in a plasmid (pNK2197) that produces high levels of a truncated RNA-IN. 
In both (B) and (C) five independent isolates were tested for each of the indicated strains 
and the error bars represent the standard deviation on the mean for each of these sets. 
Two additional experiments analogous to those shown in each of (B) and (C) were 
performed and the general trends presented here were maintained.  
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yet directly measured RNA-IN half-life in hfq+/- strains, we cannot rule out the possibility 
that Hfq influences RNA-IN stability as well (see Discussion). 
2.2.4 Hfq binds both RNA-IN and RNA-OUT and accelerates the 
rate of pairing of these species 
To this point we have not looked directly at the ability of Hfq to function in the mci 
pathway. Attempts to do so genetically are complicated by the finding that Hfq can 
inhibit Tn10/IS10 transposition independent of mci (Table 2.4 and Figure 2.3). 
Accordingly, we looked at the potential of Hfq to function as a co-factor in the mci 
pathway by asking if Hfq affects the pairing of RNA-IN and RNA-OUT in vitro. 
Taking advantage of the fact that the RNA-IN:RNA-OUT binary complex has a 
reduced mobility on a polyacrylamide gel versus the individual RNA species, we used a 
gel shift assay to measure the rate and efficiency of RNA-IN:RNA-OUT pairing. 32P-
labeled RNA-OUT was mixed with an excess of unlabeled RNA-IN in the presence and 
absence of Hfq for varying amounts of time. Reactions were terminated by treatment with 
a phenol/water mixture. Phenol extraction was included to disrupt any Hfq–RNA 
complexes formed. This simplified the analysis by ensuring that the paired species in the 
different treatment groups had a uniform mobility. Dilution in water was included to 
reduce the monovalent cation concentration below the amount optimal for RNA-
IN:RNA-OUT pairing (Kittle et al., 1989). 
We show in Figure 2.7 that Hfq addition had a significant positive effect on the 
rate of RNA-IN:RNA-OUT pairing in vitro. In the presence of Hfq, RNA-IN:RNA-OUT 
pairing reached half maximal levels (t1/2) at a rate approximately eight times faster than in 
the absence of Hfq. Thus, this experiment shows that Hfq is capable of accelerating the 
rate of RNA-IN:RNA-OUT pairing and therefore has the potential to act as an accessory 
factor in the mci pathway. Notably, at very low concentrations of RNA-IN – that is, 
under suboptimal pairing conditions – binary complex formation became almost fully 
dependent on Hfq (Figure 2.8). This could be particularly relevant because RNA-IN is 
typically expressed at very low levels in vivo (Raleigh and Kleckner, 1986). 
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Figure 2.7. Effect of Hfq addition on the rate of RNA-OUT:RNA-IN pairing in vitro. 
In vitro transcribed RNA-OUT (3.5 nM) and RNA-IN (54 nM) were mixed where 
indicated with purified Hfq (1430 nM); RNA-OUT was 32P-labeled. At the indicated time 
points pairing reactions were stopped by treatment with phenol and water. Reactions 
were analyzed on a polyacrylamide gel, which was then subject to phosphorimaging 
analysis to detect reactants and products. The amount of RNA-OUT:RNA-IN complex 
versus the amount of total RNA-OUT was determined for each time point and plotted as 
a function of time. The time-course was performed three times; error bars indicate 
standard deviation on the mean for each time point. From the above plots we calculated 
the half-time (i.e. the time after mixing at which half the maximal RNA-OUT:RNA-IN 
complex has formed) for each reaction (see Experimental procedures). 
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Figure 2.8. Hfq is required for RNA-IN:RNA-OUT pairing under suboptimal 
pairing conditions in vitro. 
In vitro transcribed 32P-RNA-OUT (7 nM) and RNA-IN (7 nM) were mixed where 
indicated with purified Hfq (1430 nM), except that RNA-IN was diluted such that the 
RNA species were present at a 1:1 molar ratio as opposed to a 15:1 ratio (RNA-IN in 
excess) as in Figure 2.7. (A) At the indicated time points, pairing reactions were stopped 
by treatment with phenol/water and analyzed on a polyacrylamide gel. Upper panel: free 
32P-RNA-OUT (OUT*) and RNA-IN:RNA-OUT binary complex (IN:OUT*) are shown. 
Lower panel: over-exposure of the region of the gel containing binary complex. (B) The 
gel was subject to phosphorimaging analysis to detect reactants and products. The 
amount of RNA-OUT:RNA-IN complex versus the amount of total RNA-OUT was 
determined for each time point and plotted as a function of time. In the absence of Hfq, 
binary complex was not quantifiable above background. In the presence of Hfq, binary 
complex increases from ~ 0.19% of total RNA-OUT at 15 seconds to ~ 0.88% at 8 
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minutes after mixing all components. Since the amount of binary complex formed after 8 
minutes (-Hfq) is lower than the amount of binary complex formed after 15 seconds 
(+Hfq), we conclude that after 8 minutes at least 4.6-fold more binary complex was 
formed in the presence versus the absence of Hfq. 
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For purposes of comparison the above rate enhancement in RNA pairing is 
roughly 3.5-fold less than what has been observed for the pairing of RpoS and DsrA 
RNA in the presence of Hfq (Soper andWoodson, 2008). It is also notable that in both 
systems Hfq is required in a fairly substantial molar excess relative to at least one of the 
RNA species in the pairing reaction to promote pairing; 50-fold in the RpoS:DsrA system 
and 400-fold in the Tn10/IS10 system. This presumably reflects the relatively weak 
binding of Hfq to one of the RNA species in the respective pairing reactions; for example 
the Kd for Hfq binding to RpoS RNA is approximately 280 nM (Soper and Woodson, 
2008) and we show below the Hfq binds relatively weakly to RNA-OUT. A more trivial 
explanation for the requirement of a large excess of Hfq in our pairing reaction would be 
that a significant portion of the Hfq in our preparation is inactive. Note that the RNA-
OUT used here matches the size and sequence of RNA-OUT formed in vivo (Lee and 
Schmidt, 1985). Our choice of using an RNA-IN composed of residues 1–75 of native 
RNA-IN was somewhat arbitrary with the exception that the first 36 residues are known 
to participate in pairing with RNA-OUT and residues 21–28 constitute a putative Hfq 
binding site (Lorenz et al., 2010). 
A specific expectation of Hfq producing a rate enhancement in the RNA-
IN:RNA-OUT pairing reaction is that Hfq will bind one or both of the RNA species 
involved. We performed mobility shift assays with 32P-labeled RNA-OUT and RNA-IN 
preparations and purified Hfq to test this. In the binding experiments approximately 
equivalent amounts of RNA-IN and RNA-OUT were used. We show in Figure 2.9A that 
RNA-IN and RNA-OUT both bind Hfq as in both reactions distinct bands with reduced 
mobility were observed upon addition of Hfq (lanes 5–6 and lanes 8–12). We presume 
the supershifted bands designated Hfq:OUT cpx 2 (lane 6) and Hfq:IN cpx 2 (lane 12) 
contain molecules of the respective RNA species with more hexamers of Hfq protein than 
are present in the corresponding cpx 1 species. From these titrations it is also apparent 
that RNA-IN binds Hfq with a higher affinity than does RNA-OUT as about 98% of 
RNA-IN exhibited a reduced mobility at 89 nM Hfq (14.8 nM Hfq6) whereas 
approximately 50% of RNA-OUT had a reduced mobility at an eightfold higher Hfq 
concentration. 
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Figure 2.9. Hfq binds both RNA-IN and RNA-OUT and forms a ternary complex. 
(A) 32P-labeled RNA-IN (75 nt) or RNA-OUT (69 nt) was mixed with varying amounts 
of purified Hfq protein and reactions were subject to EMSA as described in Experimental 
procedures. RNA-IN and RNA-OUT were present at approximately 10 nM in each 
binding reaction. (B) 32P-labeled RNA-OUT (2 nM) was incubated with Hfq (lanes 6–10) 
or Hfq storage buffer (lanes 1–5) for 10 min as in (A). Subsequently, varying 
concentrations of unlabeled RNA-IN were added (where indicated) and incubation was 
continued for an additional 10 min. Reactions were then subjected to EMSA. Positions of 
RNA-OUT (OUT*); RNA-OUT:RNA-IN binary complex (IN:OUT*); Hfq:RNA-OUT 
binary complex (Hfq:OUT*); Hfq:RNA-IN binary complex (Hfq:IN*) and Hfq:RNA-
IN:RNA-OUT ternary complex (Hfq:IN:OUT*) are indicated in (A) and (B). The asterisk 
(*) denotes 32P-label. 
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We also used a mobility shift assay to show that a ternary complex (Hfq:RNA-
IN:RNA-OUT) is formed in reactions containing Hfq, RNA-IN and RNA-OUT. We pre-
incubated Hfq and 32P-labeled RNA-OUT and then added varying amounts of RNA-IN 
(lanes 6–10). In a control set of reactions only 32P-labeled RNA-OUT and unlabeled 
RNA-IN were mixed (lanes 1–5). Addition of unlabeled RNA-IN to a reaction containing 
preformed RNA-OUT:Hfq binary complex resulted in the formation of a super-shifted 
species (relative to RNA-OUT:RNA-IN and RNA-OUT:Hfq binary complexes), the level 
of which increased as a function of increasing RNA-IN concentration (Figure 2.9B). 
Based on this and the requirement for all three species (Hfq, RNA-IN and RNA-OUT) to 
be added to generate the super-shifted complex, we infer that this species is an Hfq:RNA-
IN:RNA-OUT ternary complex. 
2.3 Discussion 
We have shown that disruption of the hfq gene in E. coli markedly increased the 
frequency of IS10 and Tn10 transposition. This is consistent with Hfq being a potent 
negative regulator of Tn10/IS10 transposition. Notably, Hfq has not previously been 
implicated as a regulator of transposition reactions, so this is a new role for this global 
regulator of gene expression that also is central to several stress response pathways 
(Waters and Storz, 2009). Evidence is presented that is consistent with Hfq down-
regulating Tn10/IS10 transposition by acting both as an accessory factor in the mci 
pathway (inhibits initiation of RNA-IN translation) and as a negative regulator of another 
step in Tn10/IS10 transposition. To date the only other host factor shown to negatively 
regulate IS10 transposition to an extent comparable to what we report here for Hfq is 
DNA adenine methylase. In this case inhibition of transposition results from the 
combined effect of DNA adenine methylase down-regulating transposase transcription as 
well as transposase binding to the inside end of IS10 (Roberts et al., 1985). 
2.3.1 Hfq down-regulates IS10 transposase expression 
We observed an increase in β-galactosidase activity in hfq- versus hfq+ in transposase–
lacZ translational fusions, demonstrating that Hfq down-regulates transposase expression. 
Importantly, when we looked at steady-state levels of RNA-IN in hfq- versus hfq+ we saw 
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no significant difference in the two strains. This is consistent with our finding that hfq 
status did not influence RNA-IN expression in a transcriptional fusion. Taken together 
these results are most consistent with Hfq primarily regulating RNA-IN translation. 
However, as we have not directly measured RNA-IN stability in hfq+/- strains we cannot 
rule out an effect of Hfq on RNA-IN turnover. 
The observation that Hfq accelerates the rate of RNA-IN:RNA-OUT pairing in 
vitro is consistent with Hfq acting as an accessory factor in the mci pathway to limit the 
initiation of RNA-IN translation. However, it is difficult to know if this rate enhancement 
is meaningful in a biological context; we presume it would be if the rate of RNA-
IN:RNA-OUT pairing is a limiting factor for a robust mci response. This appears to be 
the case as it has previously been shown that mutations in either RNA-IN or RNA-OUT 
that reduce the rate of pairing in vitro also reduce, in a roughly proportional manner, the 
effectiveness of the mci system (Kittle et al., 1989). We have also shown that disruption 
of the hfq gene resulted in a moderate increase in Tn10/IS10 transposition under 
conditions where mci does not function (Figure 2.3 and Table 2.4). This means that Hfq 
does not function exclusively through the mci pathway to inhibit transposition. In 
agreement with this we observed synergy between mci- and hfq- mutations. Synergy 
between these mutations is not expected in a situation where both mutations act 
exclusively at the same step in transposition. Importantly, this synergy was manifested 
both in transposition and transposase expression assays leading us to speculate that Hfq 
acts at (at least) two different steps in RNA-IN expression to limit transposase synthesis. 
An alternative explanation for the observed synergy might be that neither the mci- nor the 
hfq- mutations fully disrupt the mci pathway, but together the mutations fully block mci. 
To this point we have not carried out any molecular characterization of the mci--
independent pathway for up-regulation of Tn10/IS10 transposition in hfq-. The effect may 
be indirect, resulting from altered regulation of a gene product that is itself a regulator of 
Tn10/IS10 transposition. In this regard, Hfq has been shown to regulate the expression of 
hundreds of genes in Salmonella (Ansong et al., 2009). Alternatively, the absence of Hfq 
might increase the stability of RNA-IN as Hfq is known to influence mRNA stability 
(Aiba, 2007). With regard to the latter possibility, a straightforward scenario that could 
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explain the large difference in the magnitude of the increase in Tn10/IS10 transposition 
in single- versus multi-copy in hfq- would be the following: In multi-copy the absence of 
Hfq would both increase the stability of RNA-IN and the efficiency with which RNA-IN 
is translated (the latter because of the weakening of the mci response). In single-copy 
there would only be the positive effect of stabilizing RNA-IN. 
2.3.2 Hfq interactions with RNA-IN and RNA-OUT 
We have shown that Hfq binds both RNA-IN and RNA-OUT and forms a ternary 
complex when a preformed RNA-OUT:Hfq binary complex is incubated with RNA-IN. 
However, we do not know how Hfq promotes RNA-IN:RNA-OUT pairing. In the case of 
DsrA-directed regulation of rpoS translation, two A-rich sequences present in the rpoS 
leader sequence raise the affinity of Hfq for this RNA (Soper and Woodson, 2008). 
Similarly a U-rich sequence in DsrA is an important Hfq binding determinant for this 
RNA (Brescia et al., 2003). As Hfq is thought to have distinct binding sites for A- and U-
rich RNA sequences (Mikulecky et al., 2004; Sun and Wartell, 2006), it is likely that Hfq 
facilitates rpoS:DsrA complex formation at least in part by bringing binding partners into 
close proximity. Consistent with this, it has been shown that rpoS:DsrA:Hfq complex 
formation is greatly reduced by mutations in one A-rich sequence (5′-AACAA-3′) in rpoS 
RNA (Soper and Woodson, 2008). More recently it has been shown through genomic 
SELEX using Hfq as bait that the above Hfq binding site in rpoS RNA makes up a 
portion of an RNA motif (5′-AAYAAYAA-3′) that can confer low nanomolar binding 
affinity to Hfq (Lorenz et al., 2010). 
At present it is difficult to use a genetic approach to determine if Hfq functions in 
mci because we have already shown that disrupting the hfq gene causes an increase in 
Tn10/IS10 transposition through a mechanism that does not involve the mci pathway. 
However, if we could define specific Hfq binding sites in RNA-IN and/or RNA-OUT that 
are important for RNA-IN:RNA-OUT pairing in vitro, mutagenesis of such sites could 
allow us to disrupt Hfq function in mci without altering its function in other steps in 
transposition. Interestingly, residues 21–28 of RNA-IN (5′-CACAACAA) constitute 
close to a perfect match to the consensus binding-site for Hfq (only the 5′-C does not 
match the consensus sequence). 
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2.3.3 Hfq could link Tn10/IS10 transposition to cellular stress 
response pathways 
Hfq is a mediator of several different cellular stress response pathways, including 
oxidative (Zhang et al., 1998), phosphosugar (Vanderpool and Gottesman, 2004), iron 
(Masse and Gottesman, 2002), osmotic (Vytvytska et al., 1998) and likely cold stress 
(Hankins et al. 2010). Hfq also regulates the expression of the stress response 
transcription factor σs (Sledjeski et al., 2001). In each of the aforementioned pathways 
the stress induces transcription of at least one Hfq-dependent sRNA. Subsequently, Hfq 
interacts with the sRNA to mediate the stress response by promoting the interaction of the 
sRNA with an mRNA that shares partial complementarity with the sRNA (see Figure 
2.10) (Majdalani et al., 2005; Waters and Storz, 2009). In the case of SgrS, for example, 
phosphosugar stress causes up-regulation of this sRNA by at least 10-fold (Vanderpool 
and Gottesman, 2007). As Hfq acts stoichiometrically (not catalytically) with sRNAs to 
promote pairing reactions, the possibility exists that stress induction would significantly 
impact on the number of Hfq molecules in the cell available to interact with other 
substrates. Given the negative regulatory role we have documented here for Hfq in 
Tn10/IS10 transposition, a reduction in the available Hfq concentration could activate 
Tn10/IS10 transposition, thereby linking transposition to a stress response pathway 
(Figure 2.10). One caveat here is that Hfq is a highly expressed protein. It is estimated 
that there are approximately 10,000 Hfq hexamers per cell (Ali Azam et al., 1999). 
However, there are many Hfq binding partners in E. coli including the nucleoid and 
ribosomes, thus it is difficult to predict if the fractional saturation of a given target would 
be low under a specific stress condition. However, this idea is easily testable as one could 
look for changes in the frequency of Tn10/IS10 transposition under conditions where a 
given sRNA is artificially overexpressed. 
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Figure 2.10. Model for linking Tn10/IS10 transposition to Hfq-mediated stress 
response pathways. 
(Left) Growth of E. coli at suboptimal temperatures induces transcription of DsrA RNA 
(sRNA) (Repoila and Gottesman, 2001; Sledjeski et al., 2001); indicated by upward-
pointing arrow. Note that blue is used to indicate a stress or response to a stress condition 
whereas red is used to indicate a non-stress or response to a non-stress condition. DsrA 
RNA basepairs with rpoS mRNA to promote translation in an Hfq-dependent manner 
(Hfq is shown binding to both DsrA and rpoS RNAs) (Soper and Woodson, 2008). 
Additionally, DsrA enhances turnover of hns mRNA leading to reduced levels of H-NS 
protein (downward-pointing arrow) (Lease and Belfort, 2000). (Right) Other cellular 
stresses (see text) also induce expression of Hfq-dependent sRNAs; these inhibit 
translation and/or promote turnover of their respective target mRNAs leading to a stress 
response. (Middle) Hfq is shown binding RNA-IN (mRNA) and RNA-OUT (antisense 
RNA). This leads to reduced expression of Tn10/IS10 transposase protein by mechanisms 
that have not yet been fully defined (this work). Red and blue lines linking the left and 
right panels to the middle panel relate stress/non-stress conditions, cellular levels of 
unbound Hfq protein and the potential of Hfq to function in the Tn10/IS10 system. It is 
hypothesized that under non-stress conditions there would be ample unbound Hfq to bind 
RNA-IN and RNA-OUT and inhibit transposase expression and thus transposition. In 
contrast, under cellular stress conditions Hfq would be titrated by overexpression of one 
or more sRNAs resulting in insufficient levels of unbound Hfq to inhibit transposase 
expression. Accordingly, transposase expression and Tn10/IS10 transposition would 
increase in response to the cellular stress. 
70 
 
2.3.4 Summary 
We have shown that the Hfq protein is a potent negative regulator of Tn10/IS10 
transposition and provided evidence that Hfq inhibits transposition both by participating 
in the mci pathway, which limits ribosome loading onto RNA-IN, and by inhibiting 
another as yet undefined step in transposition. While mci is a phenomenon peculiar to 
Tn10/IS10 (and presumably its close relatives), the observation that Hfq negatively 
regulates a step in Tn10/IS10 transposition that is distinct from the function of mci raises 
the likelihood that Hfq could act as a negative regulator of many different bacterial 
transposition systems. Regulation of Tn10/IS10 and possibly other transposition reactions 
by Hfq could also provide a means of linking transposition reactions with cellular stress 
response pathways if the cellular pool of Hfq available to bind ligands is significantly 
reduced during elicitation of an Hfq-mediated stress response. 
2.4 Experimental procedures 
2.4.1 Strains, bacteriophage and plasmids 
All E. coli strains, plasmids and bacteriophage used in this study are listed in Table 2.6. 
All gene disruption strains were constructed by generalized transduction using phage P1 
as described in Swingle et al. (2004). Integration of transduced DNA into recA- strains 
was made possible by supplying RecA in trans from a temperature-sensitive replicon, 
pET001 (gift of K. Derbyshire). After selection of transductants using appropriate 
antibiotics, growth at 37°C in the absence of selection for pET001 permitted isolation of 
recA- transductants. pDH602 and pDH607 are pACYC184 derivatives encoding IS10-
Kan WT transposase and Nco deletion transposase respectively. They were constructed 
by cloning an SpeI–EcoRV fragment from pNK1219 and pNK2727 (Bender et al., 1991) 
into EcoRV/XbaI cut pACYC184 (CmR; KanR). Single-copy IS10-Kan strains were 
constructed by crossing IS10-Kan WT transposase (pNK1219) and IS10-Kan Nco 
deletion transposase (pNK2727) onto λNK1039 as previously described (Haniford et al., 
1989). KanR phages were isolated and used to lysogenize NK5830 to generate DBH99 
and DBH100, and DBH16 to generate DBH93 and DBH94. For the latter, DBH16 (hfq-) 
was first transformed with pDH633, a derivative of pET001 encoding the hfq gene. This 
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Table 2.6. Strains of E. coli and plasmids used in this study. 
Strain or Plasmid Relevant genotype Source or reference 
 
E.coli 
HB101 
NK5830 
GS081 
DBH17 
DBH16 
DBH23 
DBH93 
DBH94 
DBH99 
DBH100 
NK8044 
DBH15 
DBH90 
DBH92 
DH5α 
BL21Δhns 
 
Plasmids 
pNK1219 
pNK2727 
pDH602 
pDH609 
pWKS30 
pDH614 
pNK2197 
pDH611 
pDH606 
pNK629 
pET001 
 
pDH633 
 
pDH631 
pNK774 
pNK772 
pNK678 
 
 
F- leu- ; StrR (mating out recipient) 
recA- arg-  / F’ pro+ (mating out donor) 
MC4100 hfq-1::Ωcat; CmR  
C600 dsrA::Ωcat; CmR 
NK5830 hfq-1::Ωcat; CmR (mating out donor) 
NK5830 dsrA::Ωcat; CmR (mating out donor) 
DBH16 / λIS10-Kan (WT t’ase); KanR (mating out donor) 
DBH16 / λIS10-Kan (Nco∇ t’ase); KanR (mating out donor) 
NK5830 / λIS10-Kan (WT t’ase); KanR (mating out donor) 
NK5830 / λIS10-Kan (Nco∇ t’ase); KanR (mating out donor) 
recA- lac - / λNK1276 ; KanR (papillation assay)  
NK8044 hfq-1::Ωcat; CmR (papillation assay) 
Chromosomal IS10-lacZ translational fusion; KanR 
DBH90 hfq-1::Ωcat; KanRCmR 
recA- (plasmid propagation) 
recA- hns- / DE3 T7 RNA polymerase; KanR (Hfq over-expression) 
 
 
pBR322-derived; HisG1::IS10-Kan (WT t’ase); ApRKanR 
pNK1219 (Nco∇ t’ase); ApRKanR 
pACYC184-derived; IS10-Kan (WT t’ase); TetSCmRKanR 
pDH602 (R5-mutated t’ase); TetSCmRKanR 
pSC101-derived; low copy-number ori; ApR 
pWKS30-hfq; ApR 
pACYC184 derived; IS10 (bp 1-350); ‘RNA-OUT titrator’; CmSTetR 
pNK2974-derived; IS10-lacZ translational fusion (WT); ApSKanR 
pNK2227-derived; IS10-lacZ translational fusion (R5); ApSKanR 
pACYC184-derived; pTac-t’ase; TetR 
pRR10-ts97-derived; encodes recA; temperature-sensitive ori 
(permissive temp=30°C); ApR 
pRR10-ts97 derived; encodes hfq; temperature-sensitive ori (permissive 
temp=30°C); ApR 
pET3a derived;  Hfq over-expression (IPTG-induced); ApR  
IS10-lacZ transcriptional fusion (WT pIN; WT pOUT); ApR 
IS10-lacZ transcriptional fusion (pIN only); ApR 
Promoterless lacZ (no pIN or pOUT); ‘Background control’; ApR 
 
 
Bolivar (1979) 
Foster (1981) 
Zhang (2002) 
Sledjeski (1996) 
This study 
This study 
This study 
This study 
This study 
This study 
Haniford (1989) 
This study 
Case (1989) 
This study 
Invitrogen 
Zhang (1996) 
 
 
Bender (1991) 
Bender (1991) 
This study 
This study 
Wang (1991) 
This study 
Jain (1995) 
Jain (1995)  
Jain (1995) 
Huisman (1987) 
Coros (2005) 
 
This study 
 
This study 
Simons (1983) 
Simons (1983) 
Simons (1983) 
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was necessary because λ cannot form lysogens on an hfq- host. Subsequently, pDH633 
was segregated out of DBH93 and DBH94 by passage at 37°C. pDH633 was generated in 
the following way. pET001 was cut with Acc561 and BamHI to drop out the recA gene. 
After re-circularizing the plasmid by blunt end ligation of filled-in ends, the resulting 
plasmid (pDH399) was digested with HindIII and XbaI and ligated to HindIII/SpeI-
digested PCR product containing the hfq gene that was generated with primers JR11 and 
JR12. pDH614 is a low-copy-number plasmid containing the hfq gene and was 
constructed by cloning the filled-in HindIII/SpeI-cut PCR product generated with primers 
JR11 and JR12 into SmaI cut pWKS30 (Wang and Kushner, 1991). pDH631 encodes the 
hfq gene fused to the T7 promoter in pET3a and was constructed by cloning the 
BamHI/NdeI digested PCR product formed with primers JR9 and JR10 into NdeI/BamHI 
cut pET3a. pDH606 and pDH611 are pNK2227 and pNK2974 (Jain, 1995), respectively, 
with the KanR gene from IS903 cloned on a filled-in HindIII fragment into the ScaI site 
of the ampicillin resistance gene of a pUC119 derivative (KanR;ApS). 
2.4.2 Mating out assay 
Mating out assays used NK5830 and derivatives as donors and HB101 as recipient. 
Plasmids encoding IS10-Kan were transformed into donor strains and transformants were 
selected on M9-Glucose plates supplemented with arginine, thiamine and kanamycin. 
Donors were grown overnight to saturation in LB Kan and subcultured the following day 
in LB without antibiotic. Subculturing involved an initial 2 h of growth for hfq+ and 4 h 
of growth for hfq- at ‘fast roll’, followed by an additional 2 h of growth for hfq+ and 4 h 
of growth for hfq- at ‘slow roll’. The extra time allotted for growth of Hfq cells ensured 
that donor strains were at roughly the same cell density prior to mixing with the recipient. 
Recipient cells grown in LB to an OD600 of 0.4–0.6 were then mixed with donors and 
cultures were grown at ‘slow roll’ for 1 h. Cultures were then vortexed vigorously, 1 ml 
of mating mix was removed and cells were pelleted and then resuspended in 1 ml of 
0.85% saline. Cells were then plated on M9-Glucose plates supplemented with leucine 
and streptomycin for determining the number of exconjugants and leucine, streptomycin 
and kanamycin for measuring transposition events. The transposition frequency was 
obtained by dividing the number of KanR SmR colonies (hops) by the number of SmR 
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colonies (total exconjugants). We routinely monitored the copy number of IS10-Kan-
containing plasmids to determine if the hfq status of the donor strain influenced plasmid 
copy number. We did this by removing 1 ml of donor culture prior to addition of 
recipient and mixing these cells with 1 ml of DH5α cells containing pBR322. 
Subsequently, we performed plasmid mini-preps and analyzed the samples on a 1% 
agarose gel (Figure 2.2). DH5α/pBR322 was included to provide a control for plasmid 
DNA recovery. For measuring transposition frequency with IS10-Kan lysogens we first 
diluted donors (from independent colonies obtained from glycerol stocks) to 
approximately one cell per culture and then propagated this culture to saturation before 
subculturing (as above) on the day of the mating. This was done to avoid starting with 
mixtures of donor cells that included cells that had already had a transposition event into 
the F plasmid during strain preparation. 
2.4.3 Papillation assay 
Escherichia coli NK8044 and DBH15 (NK8044 transduced to hfq-), which contain mini-
Tn10LK, were transformed with either pNK629 (pTac-transposase) or pACYC184 (no 
transposase control). Both NK8044 and pNK629 are described in (Haniford et al., 1989). 
Transformants were selected on MacConkey lactose plates supplemented with 
tetracycline (15 µg ml-1). After three days of growth individual colonies were imaged on 
an hp scanjet 3670 scanner and the number of LacZ+ papillae was counted by visual 
inspection of images. 
2.4.4 Semi-quantitative RT-PCR 
Steady-state transposase mRNA levels were determined by extracting RNA from hfq+ 
and hfq- donor strains harboring pNK1219 (Table 2.1) and performing RT-PCR. RNA 
was isolated using the RNeasy minikit (Qiagen) and treated with RQ1 RNase-free DNase 
(Promega) as per the manufacturer’s instructions. RNA was quantified spectroscopically 
and RNA purity and quality were assessed by determining the OD260/280 ratio and by 
visualizing small and large ribosomal RNA subunits on a 1% agarose gel respectively. 
RT-PCR was carried out as described in Gibb and Edgell (2007) using M-MuLV reverse 
transcriptase (NEB), Taq DNA polymerase (Promega), 3 µg of cellular RNA and primer 
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pairs JR5 and JR6 for RNA-IN and JR7 and JR8 for 16S rRNA. The PCR cycle for RNA-
IN was: 98°C, 30 s; 65.8°C, 45 s; 72°C, 60 s and 22 cycles were run. The PCR cycle for 
16S rRNA was as above except that the annealing temperature was 61.5°C and eight 
cycles were run. We checked that we were within the linear range of amplification for 
both sets of RT-PCR reactions by repeating the analysis using two- and fourfold dilutions 
of the input RNA and found that the band intensities of the PCR products decreased 
linearly (Figure 2.11). 
2.4.5 β-Galactosidase assay 
Isogenic hfq+/- strains of E. coli containing transposase-β-galactosidase transcriptional or 
translational fusions were grown as described for the mating out assay. After reaching 
mid-log-phase cells were placed on ice for 20 min, pelleted and resuspended in minA 
medium. β-Galactosidase activity in cell extracts was determined as described in Jain and 
Kleckner (1993). At least four different transformants of each strain was tested and mean 
values plus standard deviation on the mean were calculated. 
2.4.6 Protein purification 
Hfq protein was purified from E. coli BL21(DE3) cells transformed with pDH631. 
Briefly, cultures were grown to an OD600 = 0.6 at 37°C. Hfq expression was induced by 
addition of 1 mM IPTG. After 2 additional hours of growth at 37°C cells were harvested 
by centrifugation and resuspended in lysis buffer (50 mM Tris-HCl pH 7.5, 1 mM EDTA, 
50 mM NH4Cl, 5% glycerol). Cells were lysed by passage through a French press and 
cellular debris was removed by centrifugation. All subsequent steps in the purification 
were carried out as described in Brescia et al. (2003). Hfq protein purity was assessed by 
SDS-PAGE and found to be > 99% pure. Hfq protein concentration was determined 
spectroscopically using a molar extinction coefficient of 3840 M-1 cm-1 (Lease and 
Woodson, 2004). 
2.4.7 In vitro transcription and RNA labeling 
Linear DNA templates for run-off transcription of RNA-IN (nucleotides 1–75) and RNA-
OUT (nucleotides 1–69) were synthesized by PCR using primers JR1/JR2 and JR3/JR4  
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Figure 2.11. Linear dependence of RT-PCR signal intensity on the concentration of 
input RNA. 
RNA extracted from 3 independent isolates (either hfq+ or hfq-) was subjected to 2- and 
4-fold dilutions prior to RT-PCR amplification of RNA-IN or 16S rRNA (rrsB) as in 
Figure 2.4, and the resulting amplicons quantified by densitometry on an AlphaImager. 
The amount of input RNA (0.75, 1.50 or 3.00 µg) was plotted on the x-axis and the 
average area of each amplicon (in AlphaImager units) was plotted on the y-axis. (A) and 
(B): average area of the RNA-IN or 16S rRNA amplicons (respectively) from hfq+ 
isolates; (C) and (D): average area of the RNA-IN or 16S rRNA amplicons (respectively) 
from hfq- isolates. Error bars represent the standard deviation on the mean. Lines were 
obtained by linear regression (Prism). 
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respectively; note that in each primer pair the ‘forward’ primer included a T7 promoter. 
The amplicons were gel purified and used as templates for in vitro transcription using T7 
RNA polymerase (NEB). For in vitro transcription approximately 1 µg of template DNA 
was mixed with 0.5 mM of each rNTP, 50 mM DTT, 0.5 ml of RNasin (Promega), 50 
units of T7 RNA polymerase in supplied reaction buffer (NEB) in a total volume of 20 
ml. The mixture was incubated at 37°C for 2 h before adding 1 unit of RQ1 RNase free 
DNase (Promega) and continuing incubation for 0.5 h. The mixture was then ethanol 
precipitated and resuspended in 20 ml of Hfq binding buffer; 50 mM Tris-HCl (pH7.5), 1 
mM EDTA, 250 mM NH4Cl, 10% glycerol. In vitro transcribed RNA was 32P-labeled 
either by including [α-32P]-CTP in the transcription reaction (RNA-IN) or by treating 
phosphatased transcript with T4 polynucleotide kinase and [γ-32P]-ATP (RNA-OUT). 
RNAs were subject to denaturing PAGE and purified from gel slices. Eluates containing 
RNA were run through a Biospin 6 column (Bio-Rad) and then concentrated by ethanol 
precipitation. RNA was resuspended in Hfq binding buffer and the concentration was 
determined spectroscopically using a NanoSpectrophotometer (IMPLEN). 
2.4.8 Gel retardation assay 
32P-labeled RNA-IN or RNA-OUT was incubated at 95°C for 2 min and then placed on 
ice before being mixed with Hfq protein in Hfq binding buffer. The final concentration of 
RNA-IN or RNA-OUT per binding reaction was 10 nM. Hfq concentrations ranged from 
0.089 mM to 1.43 mM and the total volume per binding reaction was 10 ml. Binding 
reactions were incubated at 25°C for 10 min before being mixed with load dye (20 mM 
Tris-HCl pH 7.5, 10 mM DTT, 100 mM KCl, 30% glycerol; 0.05% w/v bromophenol 
blue) and loaded onto a 6% native polyacrylamide gel. Electrophoresis took place in 1x 
TAE buffer and was carried out at 200 V for 1 h. Following electrophoresis the gel was 
dried and analyzed using a Phosphorimager. For detection of the ternary complex, Hfq 
protein and 32P-labeled RNA-OUT were first incubated together for 10 min and then 
varying concentrations of RNA-IN were added. Reactions were subjected to PAGE and 
analyzed as described above. 
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2.4.9 Kinetic analysis of RNA-IN:RNA-OUT pairing 
Ternary or binary complexes were formed as described above with 32P-labeled RNA-
OUT in a total reaction volume of 80 ml. At the indicated time intervals 10 µl aliquots 
were removed from the reaction and added to tubes containing 50 µl of phenol and 40 µl 
of water. After vortexing and centrifugation, 16 µl of aqueous phase was removed, mixed 
with 4 µl of load dye mix and subject to electrophoresis on a 6% PAGE as previously 
described. Observed rate constants for RNA-IN:RNA-OUT pairing were calculated by 
plotting the number of counts in the RNA-IN:RNA-OUT band on the y-axis and time on 
the x-axis. The resulting curves were fit by non-linear regression to the equation: 
RNA-IN:RNA-OUTt = RNA-IN:RNA-OUTmax (1 – e-
kobs) , 
where RNA-IN:RNA-OUTt is the amount of binary complex at time t. t1/2 values were 
calculated using the equation: 
t1/2 = ln2 / kobs 
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Chapter 3 2 
3 Hfq restructures RNA-IN and RNA-OUT and facilitates 
antisense pairing in the Tn10/IS10 system 
3.1 Introduction 
Small RNAs (sRNAs) have emerged as important components of gene expression 
regulatory networks in bacteria. sRNAs generally function by base-pairing to mRNAs 
with which they share at least partial sequence complementarity. Base-pairing between 
sRNAs and mRNAs typically influences translation and/or stability of the mRNA (for 
reviews, see Gottesman and Storz 2011; Vogel and Luisi 2011). sRNAs are categorized 
as either trans- or cis-encoded. Trans-encoded sRNAs are expressed from distinct loci 
relative to the transcripts they regulate, whereas cis-encoded sRNAs are expressed from 
the strand opposite their target mRNA and, consequently, are perfectly complementary to 
at least a portion of their target RNA (Figure 3.1A). Cis-encoded sRNAs are also referred 
to as antisense RNAs (or asRNA). The regulation imposed by many trans-encoded 
sRNAs is dependent on the protein Hfq, an Sm-family protein that is present in many 
bacterial species. With regard to sRNA-based regulation, Hfq functions by promoting the 
pairing of sRNAs to their target mRNAs (Moller et al. 2002; Zhang et al. 2002; Vogel 
and Luisi 2011). The expression of many trans-encoded sRNAs is up-regulated by 
environmental stress, and typically this imposes a biological response to stress through 
Hfq-mediated pairing of sRNAs and their target mRNAs (Altuvia et al. 1997; Vogel and 
Papenfort 2006). 
asRNAs were originally found on extra-chromosomal DNAs, such as plasmids 
and transposons. Chromosomally encoded asRNAs have since been identified, although a 
subset of these is imbedded within mobile DNA elements that have recently been  
                                                
2
 A version of this chapter has been published: Ross,J.A., Ellis,M.J., Hossain,S and Haniford,D.B. (2013) 
Hfq restructures RNA-IN and RNA-OUT and facilitates antisense pairing in the Tn10/IS10 system. RNA, 
19(5), 670-684. 
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Figure 3.1. Small regulatory RNAs (sRNAs) and the Tn10/IS10 antisense system. 
(A) Cis- vs. trans-encoded sRNAs. Transcribed strands of three different genes and their 
corresponding RNAs (color coded) are shown. Pairing of a trans-sRNA (gold) and an 
mRNA (green) and of a cis-sRNA (pink) and an mRNA (cyan) is shown. Hfq (blue 
hexamer) catalyzes pairing in the former case where there is partial sequence 
complementarity between partners, but it is unclear if it also catalyzes pairing in the latter 
case where there is perfect sequence complementarity between partners. Asterisks (*) 
define the translation initiation region (TIR) of the mRNAs. (B) Structure of Tn10 and 
IS10-Kan. Tn10 is a 9147-bp composite transposon that confers tetracycline resistance 
(TetR). Tn10 is comprised of IS10-Left and IS10-Right, the latter of which encodes a 
functional transposase protein that catalyzes DNA cleavage and joining events involving 
the “outside” (OE) and “inside” (IE) ends. The transposase mRNA (RNA-IN) is encoded 
from the promoter pIN (blue squares). A second promoter (pOUT–black squares) within 
IS10-Right encodes a cis-sRNA (also referred to as an antisense RNA), RNA-OUT. To 
follow transposition of IS10-Right in E. coli, a KanR gene cassette was cloned into IS10-
Right, creating IS10-Kan. RNA-OUT is depicted as a stable stem–loop structure (black) 
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and RNA-IN is depicted as a blue line with asterisks defining the TIR. RNA-OUT is 
known to pair with RNA-IN, and this inhibits translation of RNA-IN, thereby down-
regulating transposition. Hfq can enhance the rate of RNA-IN:OUT pairing in vitro, but it 
is not known if Hfq plays a role in this antisense system in vivo. 
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acquired (e.g., pathogenicity islands). The general perception is that, due to the perfect 
complementarity between asRNAs and their targets, the regulatory function of asRNAs 
will not be dependent on Hfq (Waters and Storz 2009). 
Tn10/IS10 (Figure 3.1B) encodes a 69-nt asRNA (RNA-OUT) that regulates 
transposase expression by pairing with the transposase mRNA (RNA-IN). This pairing 
down-regulates transposase translation by sequestering the 5′ translational initiation 
region (TIR) from the ribosome, thereby limiting transposase translation (Simons and 
Kleckner 1983; Ma and Simons 1990). We recently demonstrated that the frequency of 
Tn10/IS10 transposition from a multi-copy plasmid is greatly increased in an hfq- strain 
of Escherichia coli, thereby implicating Hfq as a potent negative regulator of Tn10/IS10 
transposition (Ross et al. 2010). The Hfq-effect was much less robust in a system with 
reduced RNA-OUT levels, suggesting that Hfq functions, in part, through antisense 
regulation. Transposase expression from a translational fusion was also found to increase 
in the hfq- background, consistent with a post-transcriptional role for Hfq in transposase 
regulation. Furthermore, studies in vitro demonstrated that Hfq bound both RNA-IN and 
RNA-OUT and increased the rate at which these molecules pair. Taken together, these 
results are consistent with Hfq playing an important role in translational regulation 
mediated by an asRNA (Ross et al. 2010). 
The finding that Hfq participates in a regulatory system involving an asRNA 
raises questions regarding the mechanism through which Hfq acts in this system and 
invites comparisons to its mechanism of action in trans-sRNA regulated systems. Hfq 
readily forms a hexamer, and the hexameric unit possesses at least two RNA binding 
sites. These sites, referred to as the proximal and distal binding sites, are located on 
opposing surfaces of the toroidal structure of the hexamer. Structure-based design of 
mutations in the proximal and distal binding sites has been important in defining the 
RNA binding specificities of these sites. The proximal site mutation K56A blocks Hfq 
binding to U-rich trans-sRNAs, thereby implicating the proximal site as the trans-sRNA 
binding site. In contrast, the Y25A mutation impairs Hfq binding to A-rich RNAs as well 
as mRNAs, thereby implicating the distal site in mRNA binding	  (Mikulecky et al. 2004; 
Brennan and Link 2007; Olejniczak 2011). 
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In the current work, we have further evaluated the interactions between E.coli Hfq 
and Tn10/IS10-encoded RNA-IN and RNA-OUT and have begun to evaluate the 
importance of these interactions with respect to the function of the asRNA system of this 
transposon. 
3.2 Results 
3.2.1 Hfq binds RNA-IN approximately 80-fold more tightly than 
RNA-OUT 
In previous work, we demonstrated using EMSA that E.coli Hfq binds RNA-IN and 
RNA-OUT (Ross et al. 2010). Our initial objective in the current work was to quantify 
the binding strength of these interactions to facilitate comparison with previously defined 
trans-sRNA/mRNA partners whose pairing is catalyzed by Hfq. Toward this end, we 
prepared 32P-labeled RNA-OUT (69 nt + 2 extra nucleotides encoded by the expression 
construct) and a truncated form of RNA-IN (the first 160 nt) by in vitro transcription and 
individually mixed each of these RNAs (∼ 0.1 nM) with purified Hfq over a broad range 
of Hfq concentrations. Binding reactions were then analyzed on a 6% polyacrylamide gel. 
We show in Figure 3.2A that two distinct Hfq-bound RNA-OUT complexes were 
generated in our “Hfq titration.” Just under 50% of the input RNA was shifted to a 
reduced mobility (Hfq:OUT-1) at an Hfq concentration of 14 nM (lane 3). At 38 nM Hfq 
(lane 9), a second complex (Hfq:OUT-2) was detected, and at 48 nM, Hfq:OUT-2 and 
Hfq:OUT-1 were present at close to a 1:1 ratio. Apparent dissociation constants KD1 and 
KD2, for Hfq:OUT-1 and Hfq:OUT-2, respectively, are 19.6 and 44.8 nM, calculated per 
Hfq hexamer (Figure 3.2B; Table 3.1). 
We show in Figure 3.2C that Hfq also formed multiple complexes (four distinct 
species) with RNA-IN-160. Hfq:IN-1 formed at the lowest Hfq concentration in the 
titration. The apparent KD for this complex is ~0.24 nM per hexamer (Figure 3.2D; Table 
3.1). This represents an 81-fold higher affinity relative to Hfq binding to RNA-OUT. At 
higher Hfq concentrations, additional Hfq:IN complexes were formed (Hfq:IN-2; Hfq:IN-
3 and Hfq:IN-4). It appears as though Hfq:IN-2 was generated from Hfq:IN-1, Hfq:IN-3  
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Figure 3.2. Hfq binds with high and moderate affinities to RNA-IN and RNA-OUT 
in vitro. 
32P-labeled RNA-OUT (A) or RNA-IN (C) was mixed with varying concentrations 
(reported per hexamer) of purified Hfq protein, and reactions were subject to EMSA as 
described in Materials and Methods. Band intensities were quantified (ImageQuant), and 
the percent of each shifted species (relative to total labeled RNA) was plotted vs. Hfq6 
concentration (B, D). RNA-OUT formed two complexes with Hfq, Hfq:OUT*1, and 
Hfq:OUT*2. RNA-IN formed four complexes with Hfq, Hfq:IN*1, Hfq:IN*2, Hfq:IN*3, 
and Hfq:IN*4. Apparent dissociation constants (KD) are indicated; see Table 3.1 for a 
summary of KD values and Hill coefficients determined in this study. RNA-OUT and 
RNA-IN were present at a final concentration of ~0.1 nM. Error bars represent standard 
error from two experiments. KD is reported ± standard error. 
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Table 3.1. In vitro bindinga of RNA-OUT or RNA-IN to WT, distal- or proximal-
impaired Hfq mutants. 
RNA Species Hfq variant KD1 (nM) KD2 (nM) h 
 
RNA-OUT 
 
 
 
 
RNA-IN 
 
 
HfqWT 
his6-HfqWT 
his6-HfqY25A 
his6-HfqK56A 
 
HfqWT 
his6-HfqWT 
his6-HfqY25A 
his6-HfqK56A 
 
19.6 ± 0.94 
75.6 ± 6.98 
94.3 ± 6.50 
-- 
 
0.24 ± 0.01 
0.99 ± 0.13 
1.69 ± 0.23 
3.10 ± 0.40 
 
44.8 ± 2.57 
179 ± 18.5 
202 ± 2.50 
389 ± 14.1 
 
1.18 ± 0.12 
2.29 ± 0.31 
11.1 ± 2.92 
15.1 ± 1.01 
 
3.45 ± 0.49 
2.20 ± 0.36 
2.42 ± 0.32 
-- 
 
2.44 ± 0.27 
2.09 ± 0.55 
1.32 ± 0.20 
1.00 ± 0.10 
 
a Binding oberved by EMSA. The percentages of RNA bound by Hfq were  
plotted versus Hfq6 concentration (in nM) and the data were fit to a binding  
curve to determine apparent KD values and Hill Slopes (h), expressed ±  
Standard Error. Binding assays were performed twice.   
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was generated from Hfq:IN-2, and Hfq:IN-4 was generated from Hfq:IN-3, as the 
appearance of each of these species coincided with the reduction in the amount of the 
species with the next highest gel mobility. The apparent KD and Hill coefficient for each 
Hfq:RNA complex is summarized in Table 3.1. 
Supershifting in the above experiments can most easily be explained by each of 
the RNAs having multiple Hfq binding sites with different affinities. Detection of 
supershifting over a narrower Hfq concentration range for RNA-OUT vs. RNA-IN 
(reflected in the higher Hill coefficient) is consistent with a higher degree of 
cooperativity in the former. 
3.2.2 RNase and hydroxyl radical footprinting of RNA-IN, RNA-
OUT, and Hfq:RNA complexes 
To further characterize Hfq:RNA-IN and Hfq:RNA-OUT interactions in vitro, we used a 
combination of hydroxyl radical and ribonuclease (RNase) footprinting. Hydroxyl radical 
and RNase footprinting have both been used to identify Hfq binding sites within target 
mRNA and sRNAs (Brescia et al. 2003; Lease and Woodson 2004; Vecerek et al. 2005; 
Rolle et al. 2006). RNase footprinting also provides insight into the structure of the RNA 
as well as structural changes in the RNA upon protein binding. Structure-probing 
techniques have not previously been applied to RNA-IN and RNA-OUT, although a 
model for RNA-OUT (Model I) was proposed based on predictions from in silico RNA 
folding programs and genetic data (see Figure 3.3B; Case et al. 1989; Kittle et al. 1989). 
For RNase structure probing/footprinting, 5′ end-labeled RNA-OUT was treated 
with either RNase A, T1, or V1 in the presence or absence of purified Hfq protein. RNase 
A and T1 cleave RNA following single-stranded C/U and G, respectively, while RNase 
V1 cleaves 3′ of paired nucleotides. 
RNase probing of RNA-OUT yielded a predicted structure similar to what has 
been previously proposed (Figure 3.3B). However, our data support some modifications 
to this model (see Figure 3.3A,B; note that ribonuclease-sensitive residues in Model II 
are colored red for A or T1 and blue for V1). U33, which was previously predicted to be 
in the unpaired loop, exhibited moderate sensitivity to V1 and relatively low sensitivity to 
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Figure 3.3. Structure-probe analysis of RNA-OUT and Hfq:RNA-OUT complex. 
(A) 32P-labeled RNA-OUT (65 nM) was incubated with or without Hfq as indicated 
before hydroxyl radical (lanes 4–7) or ribonuclease (A, T1, or V1; lanes 8–19) 
treatments. Reactions, including untreated RNA (lanes 2,3) and a G-ladder (lane 1), were 
analyzed on a 10% denaturing polyacrylamide gel. Nucleotide labeling is relative to the 
RNA-OUT in vitro transcriptional start site, which includes two extra nucleotides 
introduced by T7 RNA polymerase at the 5′ end of the RNA. Where Hfq was included, it 
was present at 1460, 2190, and 4380 nM. (B) A previous model of RNA-OUT (Model I) 
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is compared to the model derived from the current work (Model II). Colored letters 
represent RNase-sensitive positions in RNA-OUT observed in the absence of Hfq. Red 
indicates cleavage by either RNase A or T1, while blue indicates cleavage by RNase V1. 
Symbols (triangles and asterisks) are defined in the text. [This Figure and the work it 
represents was contributed by M. Ellis.] 
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A, suggesting that this residue is base-paired, presumably to A39. C42 and C43 were 
both strongly sensitive to A, and this is consistent with a 2-nt bulge (bulge 1) in the 3′ 
side of the stem, immediately adjacent to the loop. Also, in Model II, bulge 2 is larger 
than in Model I, consisting of six as opposed to three unpaired residues. This is supported 
by sensitivity of U24, A25, U26, and U27 to A and low sensitivity	  of G48 to T1. 
Additionally, for 14 of the 23 bp in the predicted stem, at least 1 nt in the pair showed 
sensitivity to V1, and only 2 bp had 1 nt that was sensitive to A. The V1-sensitive 
residues appeared in all four segments of the stem that are separated by bulges. In 
contrast, no residues in the loop or bulges exhibited V1 sensitivity. 
Addition of Hfq to RNA-OUT caused some significant changes in the RNase 
cleavage profile (indicated by upward and downward pointing triangles in Figure 3.3A, 
B). In this experiment, Hfq was added to RNA-OUT at concentrations sufficient (based 
on EMSA data) (Figure 3.4A) to give >90% Hfq:OUT-1 (1460 nM) and >90% 
Hfq:OUT-2 (2190 and 4380 nM). Based on similarities of sample loading and total 
reactivity relative to the “no Hfq” control, results for the “intermediate” Hfq 
concentration (2190 nM—lanes 10, 14, and 18) were the easiest to analyze and are 
discussed in detail below. 
Hfq binding appears to destabilize the base-paired stem of RNA-OUT. All four of 
the stem regions contained residues that increased in sensitivity to single-strand-specific 
ribonuclease (upward facing red triangles), and the lower stem also contained residues 
that exhibited reduced sensitivity to double-strand-specific ribonuclease (downward 
facing blue triangles). Destabilization of the stem by Hfq could be functionally 
significant because the 5′ portion of the stem, including residues 6–33, is expected to pair 
with RNA-IN in the antisense response. 
Interestingly, of the predicted 15 unpaired residues in RNA-OUT, eight exhibited 
increased reactivity to single-strand-specific ribonucleases. While it is not obvious how to 
interpret this result, perhaps the simplest explanation is that Hfq binding to RNA-OUT 
prevents conversion of loops and/or bulges to structures that include base-paired regions. 
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Figure 3.4. RNA footprinting EMSAs.  
Following binding reactions (see Materials and Methods) for RNA-OUT (A) and RNA-
IN (B) footprinting experiments (shown in Figures 3.3 and 3.5 respectively), a sample 
was run on a 6% polyacrylamide gel to monitor RNA:Hfq complex formation. The final 
concentration of RNA-OUT was 65 nM, RNA-IN was 45 nM, and Hfq concentrations are 
reported per hexamer. [This Figure and the work it represents was contributed by M. 
Ellis.] 
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Figure S1. RNA fooprinting EMSAs. Following binding reactions (see Materials and Methods) for 
RNA-OUT (A) and RNA-IN (B) footprinting experiments (shown in Figures 3 and 4 respectively), a 
sample was run on a 6% polyacrylamide gel to monitor RNA:Hfq complex formation. The final 
concentration of RNA-OUT was 65 nM, RNA-IN was 45 nM, and Hfq concentrations are reported 
per hexamer.
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Finally, a stretch of five consecutive residues in bulge 2 (nucleotides 23–27) 
exhibited a decrease in sensitivity to all three RNases (green asterisks). This suppression 
could result from Hfq binding to this segment. Notably, this is a very U-rich sequence (5′ 
UUAUUG 3′) that is predicted to be in single-stranded form. E. coli Hfq has been shown 
to preferentially bind U-rich single-stranded sequences in sRNAs through its proximal 
binding site (Ishikawa et al. 2012), and we provide evidence below that Hfq engages 
RNA-OUT exclusively through its proximal binding site (Figure 3.8). Using data from 
our RNase probing of RNA-OUT in the presence of Hfq, we determined a single 
structure of an RNA-OUT:Hfq complex (Figure 3.6). This predicted structure is largely 
single stranded, with the exception of 5 bp forming between nucleotides 29–33 and 59–
63. Of the 35 nt that are predicted to base-pair with RNA-IN, 30 are in single-stranded 
regions after Hfq addition. 
We also performed hydroxyl radical footprinting on Hfq:RNA-OUT complexes to 
further investigate the position(s) of Hfq binding (Figure 3.3A, lanes 4–7) but were 
unable to see clear and reproducible patterns of protection. The hydroxyl radical cleavage 
pattern was, however, useful in assigning cleavage products produced in the RNase 
structure-probe experiments. 
We next probed the structure of the first 160 nt of RNA-IN with RNases as 
described for RNA-OUT. In the absence of Hfq, there was a significant amount of 
reactivity to V1 nuclease (lanes 2 and 11 in Figure 3.5A), which is indicative of this RNA 
forming base-paired segments. Two regions in which V1-reactive residues clustered 
(residues 17–35 and 45–60) (indicated by a solid blue line in Figure 3.5A) also showed 
minimal reactivity to single-strand-specific ribonucleases. Hard constraints from the 
nuclease data (circled letters in Figure 3.5B) were input into the Mfold program to 
generate a model of RNA-IN-160 structure. Notably, addition of these hard constraints 
resulted in the output of a single structure. The model predicts one substantial stem that 
includes 11 bp and two bulges. The stem includes residues 25–36 on one strand and 
residues 45–60 on the other strand. At least 1 nt in each of the 11 predicted base pairs 
showed reactivity to V1. We note that our model for RNA-IN-160 includes some 
secondary structure involving the first 20 nt. However, the single base pair between  
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Figure 3.5. RNase footprinting of RNA-IN. 
(A) 32P-labeled RNA-IN-160 (45 nM) was incubated with or without Hfq as indicated 
before treatment with ribonuclease A, T1, or V1 (lanes 5–13). Reactions, including RNA 
not treated with RNase (lanes 2–4) and a G-ladder (lane 1), were analyzed on a 10% 
denaturing polyacrylamide gel. Nucleotide labeling is relative to the RNA-IN in vitro 
transcriptional start site, which is nucleotide 1. Blue bars highlight clusters of V1 
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sensitivity observed in the absence of Hfq. (B) A model is shown for the secondary 
structure of RNA-IN-160. The model was produced using Mfold with hard constraints 
(circled positions) obtained from two independent RNase structure-probe experiments 
(part A and Appendix A). RNase A/T1 cleavage is indicated with red letters, while V1 
cleavage is indicated with blue letters. Symbols (triangles and asterisks) are defined in the 
text. [This Figure and the work it represents was contributed by M. Ellis.] 
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Figure 3.6. Structure of RNA-OUT and RNA-IN in the presence of Hfq.  
5’ end-labeled RNA-OUT (A) and RNA-IN (B) was probed with RNase A/T1/V1 in the 
presence of Hfq (see Figures 3.3 and 3.5). Nucleotides indicated in red and blue represent 
mFold constraints for ssRNA and dsRNA, respectively. These structures formed at 37°C 
in the presence of 10 mM MgCl2. Putative Hfq-binding sites were entered as single-
stranded constraints. [This Figure was contributed by M. Ellis.] 
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Figure S3. Structure of RNA-OUT and RNA-IN in the presence of Hfq. 5’ end-labeled RNA-OUT (A) and 
RNA-IN (B) was probed with RNase A/T1/V1 in the presence of Hfq (see Figures 3 and 4). Nucleotides 
indicated in red and blue represent mFold constraints for ssRNA and dsRNA, respectively. These structures 
formed at 37oC in the presence of 10 mM MgCl2. Putative Hfq-binding sites were entered as single-stranded
constraints.
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position 6 and 149 is unlikely to maintain the most 5′ and 3′ portions of the RNA in a 
stable secondary structure. The absence of stable secondary structure within the first 8 nt 
of RNA-IN suggests that there is no structural impediment to initiating pairing with 
RNA-OUT. Of the first 35 nt of RNA-IN-160 that are complementary to RNA-OUT, 
residues 25–35 are sequestered in a stem that may interfere with the antisense response. 
Addition of Hfq to RNA-IN-160 had substantial effects on RNA structure. Much 
of the V1 sensitivity in the predicted stem was lost (indicated by downward pointing blue 
triangles in Figure 3.5A,B). Strikingly, starting at position 104 and continuing to position 
149, there was a large increase in V1 sensitivity with the addition of Hfq. As there were 
few residues within the 104–149 segment that showed substantial increases in either A or 
T1 sensitivity upon Hfq addition, it appears likely that some intra-molecular base-pairing 
is occurring in this region. There were also a few regions that showed a decrease in 
reactivity to both single- and double-strand-specific ribonucleases. This includes 
segments 3–13, 17–25, 38–40, and 71–92 (denoted by green asterisks). These regions 
could define Hfq binding sites. Notably, at the highest concentration of Hfq used in this 
experiment, we anticipate, based on EMSA data (Figure 3.4), that there could be as many 
as three distinct Hfq binding sites in RNA-IN-160. A predicted structure of RNA-IN-160 
in the presence of Hfq is presented in Figure 3.6. Consistent with the RNase footprinting 
data, the first 98 nt of RNA-IN are mostly single-stranded, with two small hairpins 
formed at nucleotides 34–56 and 66–79. An extensive stem–loop structure is predicted to 
form from nucleotides 99–160. We note that 33 out of 35 nt of RNA-IN that are expected 
to base-pair with RNA-OUT are single-stranded in the presence of Hfq. 
Note that RNase data for RNA-IN-160 footprinting comes from two independent 
experiments (Figure 3.5A; Appendix A). All reactivities were reproducible except at 
positions C72–C75, where we saw Hfq-dependent protection of these residues only in the 
experiment shown in Appendix A. 
To further probe the location of Hfq binding sites in RNA-IN-160, we performed 
hydroxyl radical footprinting on 5′ end-labeled RNA-IN-160 using multiple Hfq 
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Figure 3.7. Hydroxyl radical footprinting of RNA-IN. 
(A) 32P-labeled RNA-IN-160 (45 nM) was incubated with increasing concentrations of 
Hfq (lanes 3–10) and then subject to hydroxyl radical treatment (lanes 2–10). Lane 1 
contains RNA not treated with hydroxyl radicals. Samples were analyzed as in Figure 
3.5. Nucleotides are numbered as in Figure 3.5. Green asterisks identify positions 
protected from hydroxyl radical cleavage in the presence of Hfq, while purple asterisks 
identify positions where Hfq induced hypersensitivity to hydroxyl radical cleavage. (B) 
Quantification of band intensities from selected lanes of the gel image in part A is shown. 
Reactivity is presented in arbitrary units (AU). [This Figure and the work it represents 
was contributed by M. Ellis.] 
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concentrations (Figure 3.7). Quantitation of portions of the gel image showing the 
greatest differences in band intensity for “no Hfq” (lane 2) and selected “plus Hfq” 
samples (lanes 3, 6, and 10) is also presented. A region spanning residues 29 to 46 
showed protection against hydroxyl radical cleavage at both 149 nM and 347 nM Hfq. At 
the higher Hfq concentration, additional zones of protection were observed as indicated 
beside the gel image (green asterisks). Due to discontinuities in the patterns of protection 
it is difficult to infer the boundaries of individual binding sites and, therefore, the total 
number of sites. However, based on the density of protected residues in the 29–46 
segment and the fact that there was uniform protection in this cluster at an intermediate 
Hfq concentration, we suggest that this cluster defines a single Hfq binding site. The 
region spanning residues 84 to 94 includes the second highest density of protected 
residues and could represent a second Hfq binding site. This second site would be a lower 
affinity site relative to the site within the nucleotide 29–46 segment, as protections in this 
site were only observed at the highest Hfq concentrations. Unfortunately, we were not 
able to obtain high-quality hydroxyl radical footprinting data for the most 5′ portion of 
RNA-IN-160 to further test the possibility raised by RNase footprinting that this segment 
also contains an Hfq binding site. We do note that five residues (38, 39, 40, 45, and 46) 
within segment 29–46 showed a general suppression of cleavage by RNases (Figure 
3.5A), as did residues 80, 82, and 86, which are close to or within segment 84–94, 
supporting the possibility that these segments include Hfq binding sites. 
3.2.3 RNA-binding sites in Hfq that interact with RNA-IN and RNA-
OUT 
Hfq has at least two distinct RNA-binding surfaces, enabling it to simultaneously bind 
multiple RNAs and catalyze trans-sRNA/mRNA pairing reactions. To gain insight into 
how Hfq interacts with RNA-IN and RNA-OUT, we performed experiments designed to 
define the surfaces in Hfq that interact with these RNAs. It should be recognized that Hfq 
binding determinants for an asRNA have not previously been reported. Two 
complementary approaches were used. In one approach, we performed binding assays 
with RNA-IN-160 or RNA-OUT and Hfq mutants that are defective in either proximal 
site (HfqK56A) or distal site (HfqY25A) RNA binding. In the second approach, we 
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performed binding assays with HfqWT and RNA-IN-160 or RNA-OUT in the presence of 
competitor RNAs that exhibit high affinities for either the proximal (DsrA) or distal (A18) 
RNA-binding surfaces of Hfq. 
For binding experiments with Y25A and K56A mutant forms of Hfq, it was 
necessary to use Hfq bearing a C-terminal his6 epitope tag (hereafter referred to as “his6-
Hfq”). This is because, unlike HfqWT, the two mutant forms of Hfq are not heat-stable 
and therefore cannot be purified in the same way as untagged HfqWT (Mikulecky et al. 
2004). However, all three forms of the his6-tagged Hfq can be purified using nickel 
affinity chromatography. We show in Figure 3.8A and Table 3.1 that WT and Y25A 
forms of his6-Hfq bound RNA-OUT with similar affinities (KD1 ~76 nM and 94 nM, 
respectively). In contrast, his6-HfqK56A bound very poorly to RNA-OUT at Hfq 
concentrations up to 309 nM. At the high end of the HfqK56A titration (upwards of 464 
nM Hfq6), essentially all of RNA-OUT was bound by HfqK56A, forming Hfq:OUT- 2 with 
an apparent KD ~389 nM. This represents a fivefold reduction in the affinity of his6-
HfqK56A vs. his6-HfqWT for RNA-OUT. 
The above results are consistent with Hfq binding RNA-OUT through its 
proximal site, which is typical of how Hfq binds trans-sRNAs. If this is correct, then it is 
expected that an sRNA, but not a distal-specific RNA, would act as a competitor for 
RNA-OUT binding to untagged HfqWT. We show in Figure 3.8B that this is the case. 
When we pre-incubated Hfq with DsrA (an sRNA) or A18 (a distal-specific RNA) and 
then added 32P-labeled RNA-OUT, only DsrA inhibited Hfq:OUT-1 complex formation; 
IC50 values (Table 3.2; Figure 3.9) are ~7 nM and >4000 nM for DsrA and A18, 
respectively. In fact, there was evidence of ternary complex formation at A18 
concentrations above 31 nM (see lanes 18–24 in Figure 3.8B). Overall, we conclude that 
RNA-OUT behaves like a trans-sRNA in its interaction with Hfq.  
In titrations with RNA-IN-160 and his6-tagged Hfq proteins (WT, K56A, and 
Y25A), there was a moderate reduction in binding affinity. This is reflected by changes in 
KD1 of 1.7- and 3-fold, respectively, for HfqY25A and HfqK56A vs. HfqWT (see Figure  
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Figure 3.8. RNA-OUT interacts specifically with the proximal RNA-binding surface 
of Hfq. 
(A) EMSAs with 32P-labeled RNA-OUT (~0.4 nM) and either WT or mutant forms of 
Hfq. HfqY25A is defective in RNA-binding at the distal site, and HfqK56A is defective in 
RNA-binding at the proximal site. The corresponding binding curves are presented below 
each gel image. Error bars represent standard error from two experiments. Note that all 
forms of Hfq used in this experiment possess a his6 epitope tag at their C termini. Species 
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are labeled as in Figure 3.2. (B) EMSAs performed in the presence of competitor RNAs. 
HfqWT (untagged) was first mixed with various concentrations of DsrA or A18 RNA for 5 
min, and 32P-labeled RNA-OUT (0.4 nM) was added. After an additional 15 min, 
reactions were subjected to polyacrylamide gel electrophoresis. A species expected to 
represent a ternary complex is labeled A18:Hfq:OUT*. IC50 values were calculated from 
curves shown in Figure 3.9 and are reported in Table 3.2. 
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Figure 3.9. IC50 determinations for A18 and/or DsrA competition experiments. 
The percentage inhibition of Hfq:IN-1 (A-C) and Hfq:OUT-1 (D-E) complex formation 
by competitor RNAs (DsrA, A18 or DsrA+A18) is plotted as a function of competitor 
concentration. The data is derived from experiments in Figures 3.8 and 3.10 plus 
additional experiments not shown. Data were fit to sigmoidal curves to obtain the IC50 
values (reported in Table 3.2).  
 
 
 
A B 
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Table 3.2. In vitro competitiona by DsrA or A18 for binding of HfqWT to RNA-IN or 
RNA-OUT. 
RNA Species DsrA IC50 (nM) A18 IC50 (nM) DsrA+A18 IC50 (nM)c 
 
RNA-OUT 
 
RNA-IN 
 
6.77 ± 0.317 
 
52.7 ± 14.1 
 
> 4000b 
 
10.6 ± 1.18 
 
N.D. 
 
8.93 ± 2.12 
 
a IC50 values (± Standard Error) were measured by EMSA. Percentage of  
competition was plotted versus competitor concentration and IC50 values were  
obtained from the resulting curves (shown in Figure 3.9). Competition assays were 
performed twice. 
b Instead of competition, a ternary complex was formed. 
c Reported for each competitor in the mix. 
N.D., not determined. 
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3.10A; Table 3.1). These results are consistent with RNA-IN-160 binding to both the 
proximal and distal sites. Competition experiments support this inference, as both DsrA 
and A18 gave some inhibition of Hfq:IN-1 formation when each of these RNAs was pre-
incubated with Hfq prior to addition of RNA-IN-160. More specifically, we observed 
strong inhibition of Hfq:IN-1 formation at concentrations above the KD for A18:Hfq 
complex formation, which is ~10 nM (Figure 3.10B, lanes 11–15; IC50 ~11 nM, Table 
3.2; Figure 3.9; Sun and Wartell 2006). In contrast, we observed weak inhibition of 
Hfq:IN-1 formation at DsrA concentrations above the KD for DsrA:Hfq complex 
formation, which is ~21 nM (Figure 3.10B, lanes 6–8; IC50 ~53 nM, Table 3.2; Figure 
3.9; Mikulecky et al. 2004). At A18 concentrations above its KD for Hfq (lanes 11–15), 
primarily the proximal site is expected to be available for RNA-IN-160 binding, and at 
DsrA concentrations above its KD for Hfq (lanes 5–7), primarily the distal site is expected 
to be available for RNA-IN-160 binding. Accordingly, the stronger inhibition observed 
for A18 is consistent with the distal site of Hfq being the higher affinity site for RNA-IN-
160 binding. This is typical of Hfq binding to mRNAs (Mikulecky et al. 2004; Soper et 
al. 2011). 
We also performed a competition experiment where both competitors were mixed 
with Hfq simultaneously and then RNA-IN-160 was added (Figure 3.10B, lanes 16–26). 
Very strong inhibition of Hfq:IN-1 formation was only observed when the concentrations 
of both A18 and DsrA were close to or above their respective KD values for Hfq complex 
formation (lanes 23–26). These results suggest that an additional RNA-binding site in 
Hfq does not contribute significantly to the formation of a stable Hfq:RNA-IN-160 
complex. 
3.2.4 HfqK56A exhibits a reduced rate of RNA-IN:OUT pairing in 
vitro 
The results in the previous section show that RNA-IN can contact both the distal and 
proximal sites in Hfq and that RNA-OUT binds only to the proximal site. One or more of 
these interactions is likely important for the acceleration in the rate of RNA-IN:OUT 
pairing directed by Hfq that we previously documented (Ross et al. 2010). The proximal 
site is likely of particular importance, as both RNA species could conceivably bind here 
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Figure 3.10. RNA-IN interacts with the distal and proximal RNA-binding surfaces 
of Hfq. 
(A) EMSAs with 32P-labeled RNA-IN (0.17 nM) and either WT or mutant forms of his6-
tagged Hfq. Species are labeled as in Figure 3.2. Binding curves are shown below the 
corresponding EMSA, and apparent KD values are reported in Table 3.1. Error bars 
represent standard error from two experiments. (B) EMSAs performed in the presence of 
competitor RNAs. Competitor experiments were performed as described in Figure 3.8B 
except that RNA-IN was present at a concentration of 0.17 nM. For lanes 18–26, a 1:1 
mix of DsrA and A18 was serially diluted to the indicated concentrations before 
competition. IC50 values were calculated from curves shown in Figure 3.9 and are 
reported in Table 3.2. 
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and begin to pair. Accordingly, we asked if an intact proximal RNA-binding site is 
necessary for Hfq to accelerate the rate of RNA-IN:OUT pairing. Note that we developed 
an alternative means to purify untagged HfqWT and HfqK56A (see Materials and Methods), 
as the his6-tagged forms gave inconsistent pairing results. We mixed Hfq (WT or K56A), 
32P-labeled RNA-OUT, and 32P-labeled RNA-IN-160 and incubated them for the 
indicated times before processing and analysis on a native polyacrylamide gel. Processing 
involved phenol extraction (mixing, centrifugation, and recovery took ~15 sec) and then 
immediately loading the samples on a native polyacrylamide gel. This step was included 
to remove Hfq from the paired product so that identification of this species was 
unambiguous. The ratio of RNA-OUT to RNA-IN was fixed (10:1) to roughly reflect the 
ratio of these RNAs in vivo. The Hfq concentration used (45 nM) was set from a 
preliminary experiment where we determined the minimum concentration of Hfq that 
yielded an enhancement in RNA-IN:OUT pairing (relative to the absence of Hfq) at the 
above ratio of RNA-OUT to RNA-IN (see Figure 3.11). 
We show in Figure 3.12 that addition of 45 nM HfqWT increased the rate (kobs) of 
RNA-IN:OUT pairing approximately 19-fold relative to no Hfq addition (kobs = 1.51   
min-1 for HfqWT vs. 0.080 min-1 in the absence of Hfq). By comparison, the rate 
enhancement was less than twofold when HfqK56A was used (kobs = 0.14 min-1). These 
results indicate that the K56A mutation negatively impacts RNA-IN:OUT pairing under 
these specific conditions, consistent with the proximal surface playing an important role 
in the enhancement of antisense pairing in vitro. 
3.2.5 IS10-Kan transposition is derepressed in strains expressing 
Y25A and K56A forms of Hfq 
While Hfq increases the rate of RNA-IN:OUT pairing substantially in vitro, it is difficult 
to know if effective antisense inhibition of transposase expression requires this 
enhancement in the RNA pairing rate in vivo. To address this issue, we asked if untagged 
HfqK56A (which is impaired in its ability to promote IN:OUT pairing in vitro) is also less 
effective than wild-type Hfq at repressing IS10 transposition. We also assessed the ability 
of the distal-impaired HfqY25A to repress transposition of IS10. We used a “mating out”  
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Figure 3.11. Measurement of RNA-OUT:RNA-IN pairing as a function of Hfq 
concentration.  
RNA-IN:RNA-OUT pairing reactions were performed in the presence of the indicated 
concentrations of Hfq (WT or K56A) as described in Figure 3.12 for a 2 minute reaction. 
As 45 nM gave an enhancement in RNA-IN:OUT pairing, this concentration of Hfq was 
used in the experiments summarized in Figure 3.12.     
HfqWT HfqK56A
OUT:IN*
IN*
OUT*
45- -- 11 22 11 2245Hfq6 (nM)
++ +- + + + ++
+- ++ + + + ++0.85 nM IN*
8.5 nM OUT*
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Figure 3.12. RNA-IN:RNA-OUT pairing reactions. 
(A) 32P-labeled RNA-IN-160 (0.85 nM) was mixed with excess 32P-labeled RNA-OUT 
(8.5 nM) and, where indicated, untagged WT or K56A Hfq (45 nM). Note that RNA-
OUT had a lower specific activity than RNA-IN. At the indicated time points, pairing 
reactions were stopped by treatment with a phenol/water mix and immediately loaded 
onto a 6% native polyacrylamide gel. (B) The amount of RNA-OUT:RNA-IN* complex 
(OUT:IN*) was determined as a percentage of total RNA-IN* for each time point and 
plotted as a function of time. Error bars represent the standard error from three 
experiments. The observed rate constant (kobs) is indicated for each reaction. These values 
were derived from curves corresponding to the equation describing the rate of 
exponential association, presented in Materials and Methods. 
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assay to measure the frequency of IS10-Kan transposition from a multi-copy plasmid in 
different genetic backgrounds. In this assay, the frequency of transposition of IS10-Kan 
from a multi-copy plasmid to the F plasmid in the donor strain is measured (see Materials 
and Methods). For the mating out experiments, the Hfq status was manipulated by 
transforming the donor strain (DBH16; hfq-) with a plasmid expressing untagged WT, 
Y25A, or K56A forms of Hfq from a native hfq promoter. As controls, we also measured 
the frequency of IS10-Kan transposition in hfq+ (DBH33; full repression) and hfq- (no 
repression) strains. 
The results of the mating out analysis are presented in Figure 3.13, where we 
report the fold change in transposition frequency relative to the average transposition 
frequency calculated for hfq+. In both the hfqK56A and hfqY25A strains, IS10-Kan 
transposition was derepressed to about the same level as in hfq-. Importantly, these 
deficiencies cannot be attributed to differential levels of Hfq expression in the different 
strains, as Western blotting confirmed that plasmid-encoded WT, Y25A, and K56A 
forms of Hfq were present at comparable levels in the respective donor strains (Appendix 
B). These results show that Hfq mutants that are partially defective in binding RNA at 
specific surfaces, one of which (K56A) is impaired in its ability to catalyze RNA-
IN:OUT pairing in vitro, are unable to repress IS10 transposition in vivo. 
Hfq is also known to stabilize trans-encoded sRNAs (for review, see Vogel and 
Luisi 2011), and such an activity could influence the effectiveness of RNA-OUT in the 
Tn10/IS10 antisense system. We performed a rifampicin time-course experiment to look 
at this possibility. We show in Figure 3.14 that the half-life of RNA-OUT actually 
decreased by about 2.5-fold in an hfq+ relative to an hfq- strain. Accordingly, we can rule 
out the possibility that Hfq contributes to the antisense system by stabilizing RNA-OUT. 
3.3 Discussion 
Tn10/IS10 transposition is negatively regulated by an asRNA (RNA-OUT) that pairs 
with the 5′ TIR of the transposase mRNA (RNA-IN) to inhibit transposase expression.  
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Figure 3.13. IS10-Kan transposition is derepressed in E. coli encoding Y25A and 
K56A forms of Hfq. 
E. coli cells (hfq+ or hfq-) were co-transformed with pDH602 (encodes IS10-Kan) and a 
compatible plasmid encoding untagged Hfq (WT, K56A, or Y25A) or the corresponding 
“empty vector” control. Relative transposition frequencies were measured using the 
conjugal mating out assay (see Materials and Methods for details). An average 
transposition frequency (4.03 x 10-4 events per mL of mating mixture) was calculated for 
the hfq+ strain (hfq+/emp.vect.) from 15 independent “donor” colonies across four 
independent experiments, and this value was set at 1. All other transposition values are 
expressed relative to this value where Hfq-directed repression of transposition is at its 
maximal level. Bars indicate the mean; the error bars indicate standard error on the mean. 
From left to right, the n value for each treatment group is 15, 15, 14, 16, and 11—these 
were compiled from at least two (and up to four) independent experiments. An asterisk 
(*) indicates that means were significantly different from the hfq+ control group; P values 
are indicated above the corresponding bars. 
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Figure 3.14. RNA-OUT half-life analysis in isogenic hfq+/- backgrounds.   
Rifampicin-sensitive strains DBH116 (hfq+) and DBH117 (hfq-) were transformed with 
plasmid pDH502 (ApRKanR, source of IS10-Kan; Ross et al., 2010). Cells were grown to 
mid-log phase in 20 mL LB supplemented with 25 µg/mL kanamycin. (A) Two ‘time 0’ 
samples (600 µL) were removed to tubes containing 300 µL ‘Stop solution’ (1.5% [w/v] 
SDS, 300 mM Sodium Acetate, 30 mM EDTA), boiled for 1 minute and stored on ice. 
Rifampicin was immediately added to the remaining cells (final concentration: 200 
µg/mL), and 600 µL samples were removed at the indicated time and processed as above. 
After all samples were collected on ice, total RNA was extracted by the ‘hot phenol’ 
method, treated with Turbo DNase (Ambion) and ethanol precipitated. Samples were 
resuspended in nuclease-free water and quantified by spectroscopy. RNA-OUT levels 
were assessed by primer extension with 32P-labeled JR4; cDNA was fractionated by 
denaturing PAGE. OUT (+69)* indicates full-length primer extension product; OUT 
(primer)* indicates unextended primer. Note that the top panel is an over-exposure of the 
region of the gel where +69* migrated. (B) The area of the bands corresponding to full-
length RNA-OUT and unextended primer were quantified (ImageQuant) and RNA-OUT 
A     
B
hfq-
10 30 4020 50 60
hfq+
0010 30 4020 50 6000
OUT (+69)*
OUT (primer)*
Time (min)
t1/2 = 21 min
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(+69) was divided by unextended primer for each lane; these values were normalized to 
time 0 in the hfq+ strain and plotted on the y-axis, with Time (after rifampicin addition) 
on the x-axis. To obtain half-lives, the resulting curves were fit by non-linear regression 
to the equation describing exponential decay (Prism); note that the plateau was set to zero 
RNA-OUT remaining: 
P = Span•e-k•t 
Where P is the proportion of RNA-OUT remaining, Span is 1.0, t is time (in minutes) and 
k is the rate of decay in units of min-1. The half-life (t1/2) is equal to 0.6932/k.  
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Hfq is also a negative regulator of Tn10/IS10 transposition that down-regulates 
transposase expression in vivo. The effect of disrupting hfq on Tn10/IS10 transposition is 
diminished in a system with reduced RNA-OUT expression. In vitro, Hfq binds RNA-IN 
and RNA-OUT, forms a ternary complex with these RNAs, and increases the rate of 
RNA-IN:OUT pairing. Taken together, these observations are consistent with Hfq 
regulating Tn10/IS10 by operating on the antisense mechanism. In the current work, we 
have further characterized the interactions between Hfq, RNA-IN, and RNA-OUT with 
regard to binding affinity, binding sites within Hfq that govern these RNA contacts, and 
the impact mutating one of these binding sites has on RNA-IN:OUT pairing. We have 
also begun to define Hfq binding sites within each RNA, as well as the impact Hfq 
binding has on the structure of these RNAs. 
3.3.1 RNA-IN and RNA-OUT bind Hfq like a prototypical sRNA-
mRNA pair 
The Hfq binding affinities we have measured for RNA-IN and RNA-OUT are consistent 
with what is typically seen for canonical trans-encoded sRNA-mRNA pairs. For 
example, KD1 for RNA-OUT is 19.6 nM and KD1 for Hfq binding to DsrA is 21 nM 
(Mikulecky et al. 2004). Hfq binds RNA-IN with sub-nanomolar affinity (apparent KD1 
0.24 nM), which is comparable to the tightest Hfq-mRNA interactions described to date 
(OmpC 0.9 nM, Fender et al. 2010; SodB 0.3 nM, Geissmann and Touati 2004; RpsO 90 
pM, Folichon et al. 2003). 
We also investigated determinants in Hfq responsible for RNA-IN and RNA-OUT 
binding. Hfq possesses at least two distinct RNA-binding surfaces; the distal site 
generally binds A-rich RNA/mRNA while the proximal site binds U-rich sRNAs 
(Mikulecky et al. 2004; Soper et al. 2011; Ishikawa et al. 2012). Both competition and 
binding experiments (with Hfq variants) revealed that Hfq binds RNA-OUT exclusively 
through its proximal RNA-binding surface. For RNA-IN, both the distal and proximal 
binding sites in Hfq contribute to RNA-IN binding, although the distal site is the higher 
affinity site. In canonical sRNA-mRNA systems, there is competition between sRNA and 
mRNA binding at the proximal site, and this appears to be required for the formation of 
the paired species (Hwang et al. 2011). Competition is ensured by the individual RNAs 
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having similar binding affinities for the proximal site, and in general, these affinities are 
much weaker than those for the distal site. The high affinity interaction for the mRNA 
with the distal site effectively tethers the mRNA to Hfq, allowing other parts of the 
mRNA to interact relatively weakly with the proximal site, and this increases the 
probability that the mRNA and sRNA can occupy the proximal site at the same time 
(Hopkins et al. 2011). As discussed above, the Hfq:RNA interactions in the IS10 system 
are consistent with this general model. A recent study defined a third RNA-binding site in 
Hfq (the lateral surface) that may be important in allowing the mRNA to simultaneously 
bind distal and proximal sites (Sauer et al. 2012). Our competition studies indicate that 
the lateral surface alone is not sufficient for binding RNA-IN or RNA-OUT. 
We have not defined the number of Hfq hexamers present in any of the Hfq:RNA-
IN or Hfq:RNA-OUT complexes. The KD values discussed above relate only to the 
complexes formed at the lowest Hfq concentrations in each titration. For RNA-IN, at 
least four distinct Hfq complexes were detected, raising the possibility that at least four 
Hfq hexamers may be accommodated within the first 160 nt of RNA-IN. Results from 
hydroxyl radical footprinting support the existence of multiple Hfq binding sites in RNA-
IN. One such site may extend from position 29 to 46 and appears to be the highest 
affinity site identified by hydroxyl radical footprinting, as it was occupied at a lower Hfq 
concentration relative to the other sites. For RNA-OUT, two distinct Hfq-bound species 
were detected. Results from RNase footprinting revealed only one strong candidate for an 
Hfq binding site within RNA-OUT. This site is located within the U-rich segment of 
bulge 2. We don’t yet know which Hfq binding site(s) in RNA-IN or OUT are 
biologically relevant. Work in other systems is consistent with the idea that maximal 
pairing of an mRNA:sRNA pair can require the mRNA to bind multiple Hfq hexamers 
(Soper and Woodson 2008; Salim and Feig 2010). Mutagenesis of potential Hfq binding 
sites in RNA-IN and RNA-OUT is currently under way to test the importance of 
individual sites in IS10 transposition. 
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3.3.2 A proximal site mutation impacts on RNA-IN:OUT pairing 
and IS10 transposition 
The rate of RNA-IN:OUT pairing was substantially enhanced by HfqWT but not HfqK56A. 
A limitation of this analysis was that we measured kobs under one specific set of 
parameters as opposed to measuring a second-order rate constant. We used excess RNA-
OUT relative to RNA-IN (10:1) and a small excess of Hfq relative to both (less than 
fivefold). As “available” Hfq is thought to be limiting in the cell (Hussein and Lim 2011; 
Moon and Gottesman 2011), we feel this is a reasonable approximation of in vivo 
conditions. Under these conditions, the kobs value was 10.6-fold lower for HfqK56A vs. 
HfqWT. 
We also measured the impact of the Hfq proximal and distal site mutations on 
IS10 transposition. IS10 transposition was derepressed in both hfqK56A and hfqY25A strains 
relative to hfqWT. RNA-IN:OUT pairing in vitro was enhanced ~19-fold by HfqWT relative 
to no Hfq, and the magnitude of derepression of IS10 transposition in hfq- relative to hfq+ 
was ~10–15-fold. Furthermore, in vitro pairing was ~10-fold faster in the presence of 
HfqWT relative to HfqK56A, and in vivo transposition was derepressed ~12-fold for hfqK56A 
relative to plasmid-borne hfq+. Taken together, these results are consistent with Hfq 
playing a significant role in the pairing component of the IS10 antisense system. Another 
way in which Hfq might facilitate the IS10 antisense system is through the stabilization 
of RNA-OUT. However, this possibility is not supported by our observation that RNA-
OUT stability is actually reduced in an hfq+ compared to an hfq- strain. Finally, Hfq 
might directly interfere with IS10 transposase translation. We think this is unlikely 
because, as previously noted, the large increase in Tn10/IS10 transposition from a multi-
copy plasmid in hfq- is tightly linked to the expression of RNA-OUT. 
3.3.3 How might Hfq promote pairing in the IS10 antisense 
system? 
The simplest scenario for how Hfq promotes RNA pairing in the IS10 antisense system is 
that, through simultaneous binding of RNA-IN and RNA-OUT, Hfq acts as a pairing 
catalyst by increasing the local concentration of these two RNAs. In addition to providing 
a single surface to which both RNAs bind, Hfq might actively alter the structure of RNA-  
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Figure 3.15. Model for RNA-IN:OUT antisense pairing in the presence vs. absence 
of Hfq. 
The Hfq-independent pairing pathway is shown on the left-hand side (structures i, iv, and 
vii) and the Hfq-dependent pathway is shown on the right-hand side (structures iii, vi, and 
viii). In structures (ii) and (v) Hfq is shown bound to RNA-OUT and RNA-IN, 
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respectively, but conformational changes in the RNAs have not yet taken place. Other 
structures are described in the text. Hfq hexamers are indicated by green circles. The start 
codon (AUG) and Shine-Dalgarno sequence (SD) of RNA-IN are indicated by asterisks 
(*) at the first nucleotide of each sequence. Intramolecular base pairs in RNA-OUT/IN 
are indicated by blue and red, respectively. Intermolecular base pairs between RNA-OUT 
and RNA-IN are in gray. [This Figure was prepared primarily by M. Ellis, with input 
from J. Ross.] 
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IN and RNA-OUT to promote pairing. In fact, our structure-probing data support an Hfq-
dependent restructuring model (Figure 3.15). On the left-hand side of Figure 3.15, we 
show how RNA-IN and RNA-OUT might interact in the absence of Hfq. Structure-
probing experiments with RNA-IN and RNA-OUT revealed that the pairing region of 
both RNAs is at least partly sequestered in secondary structure. In this pathway, a total of 
8 bp between RNA-IN and RNA-OUT could readily form without any RNA restructuring 
(structure vii). In the right-hand panel, we show how pairing could occur with RNAs 
(structures iii and vi) that have been restructured by Hfq. In the presence of Hfq, the 
pairing region of both RNAs is largely single-stranded, leading to the formation of a 
paired species (structure viii) that contains 30 bp between RNA-IN and OUT. Notably, 
only in structure viii is the TIR sequestered through base-pairing with RNA-OUT. We 
anticipate that upon Hfq dissociation, RNA-OUT will adopt its native structure (transition 
from structure iii to structure i). However, the capacity of the 3′ end of RNA-IN to form a 
stable secondary structure in the presence of Hfq may prevent Hfq-bound RNA-IN 
(structure vi) from converting back to structure iv upon Hfq release. As Hfq rapidly 
cycles on and off of RNAs (Fender et al. 2010), the formation of the 3′ stem-loop 
structure could maintain RNA-IN in a “pairing competent” state after Hfq release. 
Consistent with genetic data, the “Hfq pairing pathway” includes pairing of the 5′ 
terminus of RNA-IN with the hairpin loop of RNA-OUT. Also, the internal loop of RNA-
OUT has been shown to be important for the antisense response (Case et al. 1989; Kittle 
et al. 1989; Jain 1995). In the Hfq-independent pathway, nucleotides within this loop can 
directly pair with RNA-IN, facilitating further propagation of pairing. In the Hfq 
pathway, we suggest that internal loop residues directly participate in Hfq binding and 
are, therefore, important in the restructuring of RNA-OUT. 
An active remodeling role for Hfq has been well documented in other systems. 
Hfq alters the structure of RpoS mRNA such that the sequence that base-pairs with DsrA 
becomes single stranded (Soper et al. 2011). The pairing region within SodB mRNA is 
also sequestered in a stem-loop structure; Hfq binding is required to disrupt this stem-
loop, resulting in formation of a large loop that is then competent to pair with the sRNA, 
RyhB (Geissmann and Touati 2004). 
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In other systems, the presence of base-pairing discontinuities in structured regions 
of asRNAs has also been shown to be critical for antisense regulation (see Wagner et al. 
2002). At this point, it is unclear if these discontinuities are sufficient for a robust 
antisense response in vivo, and in this regard, it will be interesting to see if the 
effectiveness of other antisense systems shows any reliance on Hfq. 
In the current work, we have provided additional insight into how Hfq interacts 
with the RNA components of the IS10 antisense system and provided further evidence 
that these interactions ultimately influence this system. To date, only one other antisense 
system is known to be Hfq-regulated. Hfq regulates the expression of the chromosomally 
encoded gadX gene, which is involved in acid tolerance in E. coli. An sRNA called GadY 
is antisense to the 3′ UTR of GadX, and it has been shown that GadY expression 
increases the stability of the GadX transcript. Importantly, Hfq binds to the GadY 
transcript and stabilizes it (Opdyke et al. 2004). However, it has not been established if 
Hfq plays a direct role in promoting pairing of GadY and GadX RNAs. With regard to 
other transposons, it should be noted that antisense RNAs to the transposase have been 
identified, including IS30 (Arini et al. 1997) and IS200 (Sittka et al. 2008). Additionally, 
a recent study identified five transcripts in Mycobacterium smegmatus that bind Hfq and 
are antisense to transposase mRNAs (Li et al. 2012). It will be interesting to see if any of 
these transposons are regulated by Hfq. Notably, Hfq regulation of other transposons 
might not be limited to systems encoding asRNAs. Trans-encoded sRNAs frequently 
target more than just one mRNA (for review, see Repoila et al. 2003), and as such, there 
is the potential for “off-target” effects wherein a trans-encoded sRNA might fortuitously 
target a transposase mRNA. This could provide the host with a previously unrecognized 
pathway to either down- or up-regulate transposon mobilization. Furthermore, as the 
induction of the transcription of sRNA genes is often linked to various cellular stresses 
(Repoila et al. 2003), and this induction can temporarily limit the availability of Hfq in 
the cell (Hussein and Lim 2011; Moon and Gottesman 2011), there is the potential to 
indirectly regulate transposition reactions through stress response pathways. 
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Table 3.3. List of E.coli strains and plasmids used in this study. 
Strain or 
Plasmid 
Relevant genotype Use Source or 
reference 
 
E.coli 
HB101 
DBH33 
DBH16 
DH5α 
BL21 
 
Plasmids 
pDH602 
pDH631 
pWKS30 
 
pDH700 
pDH701 
pDH713 
pDH686 
 
pDH688 
 
pDH697 
 
 
F- leu- ; StrR 
NK5830; recA- arg-  / F’ pro+  
NK5830 hfq-1::Ωcat; CmR  
recA-  
recA- / DE3 T7 RNA polymerase 
 
 
pACYC184-derived; IS10-Kan ; CmRKanR 
pET3a derived;  T7-hfq ; ApR  
pSC101-derived; low copy-number ori ; ApR 
 
pWKS30-P3-hfqWT ; ApR 
pWKS30-P3-hfqK56A ; ApR 
pWKS30-P3-hfqY25A ; ApR 
pET28a-derived; C-terminal his6-tagged 
HfqWT; kanR 
pET28a-derived; C-terminal his6-tagged 
HfqK56A; kanR 
pET28a-derived; C-terminal his6-tagged 
HfqY25A; kanR 
 
 
Mating out recipient 
Mating out donor 
Mating out donor 
Plasmid propagation 
Hfq over-expression 
 
 
Mating out assays 
Hfq over-expression  
‘Empty vector’ for 
Hfq expression 
HfqWT expression 
HfqK56A expression 
HfqY25A expression 
HfqWT over-
expression 
HfqK56A over-
expression 
HfqY25A over-
expression 
 
 
Bolivar (1979) 
Ross (2010) 
Ross (2010) 
Invitrogen 
Studier (1986) 
 
 
Ross (2010) 
Ross (2010) 
Wang (1991) 
 
This study 
This study 
This study 
Mikulecky 
(2004) 
Mikulecky 
(2004) 
Mikulecky 
(2004) 
 
 
 
 
 
 
 
 
 
125 
 
Table 3.4. List of oligonucleotides used in this study. 
Name Sequence (5’ to 3’) Use 
 
JR1 
 
JR2-2 
JR3 
 
JR4 
JR15 
JR16 
JR17 
 
JR18 
 
JR19 
 
JR20 
 
JR21 
 
JR22 
 
TAATACGACTCACTATAGGCGAAAAAT
CAATAATCAGACAACAAG 
CAAGTTCGGTAAGAGTGAGAG 
GAATTGTAATACGACTCACTATAGGGCT
CGCACATCTTGTTGTC 
GGATACACATCTTGTCATATGATCA 
NNTCTAGANNCAGGTTGTTGGTGCTATC 
NNAAGCTTNNTTATTCGGTTTCTTCGCT  
AGCCAGATGGTTTACGCGCACGCGATTT
CTACT  
AGTAGAAATCGCGTGCGCGTAAACCAT
CTGGCT  
GTTCCAGTTTCTATTGCTTTGGTGAATG
GTATTAAG  
CTTAATACCATTCACCAAAGCAATAGAA
ACTGGAAC 
TAATACGACTCACTATAGGCAACACATC
AGATTTCCTGGTGTAACGAATT 
AAATCCCGACCCTGAGGGGGTCGGGAT 
 
Forward primer (includes T7 promoter) for in 
vitro transcription template (RNA-IN) 
Reverse primer for above (RNA-IN-160) 
Forward primer (includes T7 promoter) for in 
vitro transcription template (RNA-OUT) 
Reverse primer for above 
Forward primer for pDH700 construction 
Reverse primer for above 
Forward primer for K56A quikchange 
mutagenesis 
Reverse primer for above 
 
Forward primer for Y25A quikchange 
mutagenesis 
Reverse primer for above 
 
Forward primer (includes T7 promoter) for in 
vitro transcription template (DsrA) 
Reverse primer for above 
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3.4 Materials and Methods 
3.4.1 Strains, plasmids, and primers 
All E. coli strains and plasmids used in this study are listed in Table 3.3. Oligonucleotides 
used are listed in Table 3.4. To express Hfq in vivo, we cloned a fragment that included 
the hfq gene with its P3 promoter into the low-copy cloning vector pWKS30 (Wang and 
Kushner 1991). The aforementioned fragment was generated by PCR using genomic 
DNA from DBH33 and primers JR15 and JR16, which include XbaI and HindIII sites, 
respectively. After digestion of the PCR product with XbaI-HindIII, the “hfq” fragment 
was ligated into XbaI-HindIII-digested pWKS30, creating pDH700. We then used 
pDH700 as a template for site-directed mutagenesis to create pDH701 and pDH713, 
which encode HfqK56A and HfqY25A, respectively. For purification of C-terminal his6-
tagged Hfq (WT, HfqY25A, and HfqK56A), the hfq gene was cloned into pET28a as 
described in Mikulecky et al. (2004). 
3.4.2 Hfq purification and quantitation 
Untagged Hfq was purified as described in Ross et al. (2010) but included a treatment of 
the lysate with DNase I (100 units) and RNase A (100 µg) for 1 h on ice before heat 
treatment of the lysate at 85°C. His6-Hfq proteins were purified as described in 
Mikulecky et al. (2004). Untagged HfqWT and HfqK56A for the experiments presented in 
Figure 3.12 were expressed from pDH700 and pDH701 and purified on a TALON Cobalt 
column as described in Soper et al. (2010), followed by further purification on a polyA 
column as described in Ross et al. (2010). Purified Hfq was dialyzed against Hfq 
storage/binding buffer (50 mM Tris, pH 7.5, 1 mM EDTA, 250 mM NH4Cl, 10% (v/v) 
glycerol). SDS-PAGE revealed that the Hfq was ~95% pure (Appendix B). Hfq 
concentration was determined by Bradford assay. 
3.4.3 In vitro transcription and RNA purification 
Linear DNA templates for run-off transcription of RNA-IN (nucleotides 1–160) or RNA-
OUT (nucleotides 1–69) were amplified from pDH602 (Ross et al. 2010) by PCR with 
primers JR1/JR2-2 or JR3/JR4, respectively; note that, for each primer pair, the forward 
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primer includes the T7 core promoter. The same approach was used to make templates 
for in vitro transcription of DsrA (primers JR21/JR22). Our standard in vitro transcription 
reaction for generating unlabeled RNA was performed in a 30-µL volume with 200 ng 
DNA template, 2.5 mM rNTPs, 10 mM DTT, 1x T7 RNA polymerase reaction buffer 
(NEB), 100 units RNasin (Promega), 2.5 units yeast inorganic pyrophosphatase (NEB), 
and 100 units T7 RNA polymerase (NEB). For preparing 32P-labeled RNA, in vitro 
transcription was performed in a 20-µL volume as above except that UTP was added to 
only 50 nM, and 2.5 µCi [α-32P]UTP was added. Reaction mixtures were incubated at 
37°C for 1 h before adding 0.1 units of Turbo DNase (Ambion) per µL of reaction and 
continuing incubation for 20 min. RNAs were purified using denaturing PAGE and, after 
elution from gel slices, were concentrated by ethanol precipitation and finally 
resuspended in Hfq storage/binding buffer. RNA concentrations were determined using a 
NanoSpectrophotometer (IMPLEN). Purity of in vitro transcribed RNA was assessed by 
high-resolution denaturing PAGE. A18 was purchased from Sigma-Aldrich and dissolved 
in Hfq storage/binding buffer. 
3.4.4 Hfq-RNA binding assays 
In our standard Hfq-RNA binding reaction, we mixed 32P-labeled RNA (0.1–0.4 nM) 
with Hfq (0.05–1856 nM) in Hfq storage/binding buffer (total reaction volume 10 µL) for 
15 min at 37°C. In the case of “competitor” experiments, unlabeled competitor RNAs 
(0.5–4000 nM) were mixed with Hfq for 5 min as described above, and then either 32P-
labeled RNA-IN (0.17 nM) or RNA-OUT (0.4 nM) was added. Incubation was continued 
at 37°C for an additional 15 min. Prior to mixing RNA with Hfq, the various RNA 
species were incubated at 95°C for 2 min, placed on ice for 2 min, and equilibrated to 
37°C. At the reaction end points, samples were mixed with 0.3 volumes of gel load dye 
(21 mM Tris-HCl pH 7.5, 10 mM DTT, 100 mM KCl, 30% (v/v) glycerol, 0.05% (w/v) 
bromophenol blue) and applied to a 6% native polyacrylamide gel. Electrophoresis was 
carried out at 14 V/cm for 70 min, whereupon the gel was dried and exposed to a 
phosphorimager screen. Gel images were obtained using the STORM phosphorimager. 
For measuring the equilibrium dissociation constant (KD) in binding reactions, 
bands representing shifted and unshifted RNA species were quantified (ImageQuant 
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software), and the percentage of counts for a given shifted species (relative to total counts 
for all bands in the lane) was plotted on the y-axis and Hfq concentration on the x-axis 
(Prism software). The resulting curve was fit by nonlinear regression to the equation: 
P: L = P: L!"# ∙ [P]!K!! + [P]!  
 
where P and L are Hfq and RNA, respectively, P:L is the percentage of RNA shifted by 
Hfq, [P] is the concentration of Hfq6 in nM, KD is the equilibrium dissociation constant, 
and h is the Hill coefficient. To calculate KD1, the percentages of all shifted species were 
summed to yield the appropriate curve (e.g., the curve marked “total” in Figure 3.2B or 
D). To calculate KD2 for RNA-OUT, the percentages of all species representing complex 
2 were plotted (e.g., the curve marked “Hfq:OUT*2” in Figure 3.2B). To calculate KD2 
for RNA-IN-160, the total percentages of all species other than free RNA-IN-160 or 
Hfq:IN*1 were plotted (i.e., the curve marked “Hfq:IN*2” in Figure 3.2D). To calculate 
KD3 for RNA-IN-160, the total percentages of all species other than free RNA-IN-160, 
Hfq:IN*1 or Hfq:IN*2 were plotted (i.e., the curve marked “Hfq:IN*3” in Figure 3.2D). 
For calculating IC50 values (i.e., the concentration of competitor RNA that 
inhibited Hfq:RNA-IN or Hfq:RNA-OUT complex formation by 50%), bands 
representing Hfq:RNA* complexes (* denotes radiolabeled RNA-IN or RNA-OUT) and 
unshifted RNA* were quantified, and the percentage of Hfq-shifted RNA* at 0 nM 
competitor was set at 0% competition. The percentage of Hfq-shifted RNA* remaining at 
increasing concentrations of competitor was subtracted from 100% to give the percent 
competition (0% shifted complex = 100% competition). Percent competition was plotted 
on the y-axis and competitor concentration on the x-axis (Prism). The resulting curve was 
fit by nonlinear regression to the equation: 
 
PC = PC!"# ∙ [C]IC!" + [C]  
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where PC is percent competition, [C] is the concentration of competitor RNA in nM, and 
IC50 is the concentration of competitor RNA giving 50% competition. 
3.4.5 RNA structure-probing and footprinting 
In vitro-transcribed RNA-IN and RNA-OUT were gel-purified, treated with Antarctic 
Phosphatase (NEB) and 5′ end-labeled with [γ-32P]ATP (Perkin Elmer) and OptiKinase 
(USB). 5′-labeled RNA was gel-purified, ethanol-precipitated, and finally resuspended in 
RNA Storage Buffer (20 mM MES pH 7.0, 150 mM NaCl, 1 mM EDTA). RNA 
concentrations were determined using a NanoSpectrophotometer (IMPLEN). RNA and 
Hfq were mixed in RNA Structure Buffer (20 mM MES pH 7.0, 150 mM NaCl, 1 mM 
EDTA, 10 mM MgCl2) to a final volume of 9 µL. Binding reactions took place at 37°C 
for 15 min. For RNase footprinting, 1 µL of dilute RNAse A, T1, or V1 (Ambion) was 
added to each binding reaction. For RNA-OUT, 0.04 ng RNase A, 0.03 units or 0.04 
units of RNAse T1 (− or + Hfq, respectively), and 0.00005 units or 0.0001 units of 
RNase V1 (− or + Hfq, respectively) were added. For RNA-IN, 0.004 or 0.01 ng of 
RNase A (− or + Hfq, respectively), 0.01 units of RNase T1, and 0.00005 units or 0.0001 
units of RNase V1 (− or + Hfq, respectively) were added. G-lanes were produced by T1 
digestion of RNA following the manufacturer’s directions (Ambion). RNase reactions 
proceeded for 15 min at 25°C before RNA was ethanol-precipitated and resuspended in 7 
µL formamide load dye (97.5% deionized formamide (v/v), 10 mM EDTA, 0.5 x TBE, 
3% xylene cyanol [w/v]), and ~2 µL was loaded onto a high-resolution 10% 
polyacrylamide denaturing gel. Hydroxyl radical footprinting was performed as 
previously described (Jain and Tullius 2008). Briefly, following binding reactions, 1 µL 
of freshly prepared H2O2 (2.5% [v/v]), Fe(II)EDTA (32 mM ferrous ammonium sulphate, 
88 mM EDTA; Bio Basic), and sodium ascorbate (60 mM; Bio Basic) were added to each 
9 µL binding reaction. The final concentrations of hydroxyl radical reagents in each 12-
µL reaction were as follows: H2O2, 0.21% (v/v); Fe(II), 2.67 mM; EDTA, 7.33 mM; 
sodium ascorbate, 5 mM. Following incubation at 25°C for 10 min, samples were 
processed as described above for RNase treatment. For footprinting reactions, RNA-OUT 
was at a final concentration of 65 nM, RNA-IN at 45 nM, and Hfq6 at a final 
concentration of 99–4380 nM. Gels were dried and imaged with a phosphorimager (GE 
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Healthcare). A sample of each binding reaction (RNA-IN and RNA-OUT, each Hfq 
concentration) was run on a 6% polyacrylamide gel to monitor complex formation under 
the conditions used (Figure 3.4). Quantitation of RNA-IN hydroxyl radical footprinting 
was performed using ImageQuant software. 
3.4.6 Determination of RNA-OUT:RNA-IN pairing rates 
RNA-IN:OUT pairing reactions were carried out by spotting 3.5 µL of 32P-labeled RNA-
IN and RNA-OUT onto separate faces of an Eppendorf tube, mixing them with 24.5 µL 
of Hfq storage/binding buffer, and immediately removing 9 µL to separate tubes 
containing 1 µL of Hfq (or Hfq storage buffer), as indicated. Mixing was achieved by 
rapid pipetting. Final concentrations of reactants were: RNA-IN*, 0.85 nM; RNA-OUT*, 
8.5 nM; Hfq, 45 nM. Incubation was at 37°C, and after the indicated times, each 10-µL 
reaction was added to tubes containing 30 µL H2O and 40 µL phenol:chloroform:isoamyl 
alcohol. These were immediately vortexed (8 sec) and centrifuged (3-sec pulse-spin) 
before removing 10 µL of the aqueous phase and loading it directly on a 6% native 
polyacrylamide gel at 7 V/cm. After the last sample was loaded, electrophoresis was 
continued at 13 V/cm for 45 min. Gels were dried and imaged as described above. Bands 
representing RNA-OUT:IN paired species or free RNA-IN were quantified 
(ImageQuant). The percentage of paired species (relative to total RNA-IN counts) was 
plotted on the y-axis and time on the x-axis (Prism). The resulting curves were fit by 
nonlinear regression to the equation: 
A:B! = A:B!"#(1− !!!!"#∙!) 
where A:Bt is the percentage of binary complex at time t and kobs is the observed rate 
constant. 
3.4.7 Mating out assay 
Mating out experiments were carried out with DBH33 (hfq+) and DBH16 (hfq-) as donor 
strains and HB101 as the recipient strain. Plasmids encoding IS10-Kan (pDH602) and 
Hfq (pDH700, 701, 713, and pWKS30 as the “empty vector” control) were co-
transformed into donor strains, and transformants were selected on M9-Glucose plates 
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supplemented with arginine, kanamycin (50 µg/mL), and ampicillin (50 µg/mL). Donors 
and recipient strains were grown in liquid media as previously described in Ross et al. 
(2010), and mating was allowed to proceed for 1 h, whereupon mating mixes were 
pelleted and resuspended in 0.85% saline. Resuspended mating mixes were then plated 
on M9 media supplemented with glucose, leucine, and streptomycin (150 µg/mL) or 
streptomycin plus kanamycin (50 µg/mL). Plating on the former gave the mating 
frequency and plating on the latter gave the number of transposition events. Relative 
transposition frequencies were calculated by dividing the number of colonies present on 
streptomycin/kanomycin plates by the number of colonies on streptomycin plates. For 
statistical analysis, we first carried out an F-test to demonstrate that the variances 
between the hfq+ control group and the other treatments were not equal (hfq+ vs. hfq-
/hfqWT, P = 0.001; hfq+ vs. all other treatments, P < 0.0001). We then conducted a two-
tailed t-test with Welch’s correction (does not assume equal variances) to compare the 
various treatments to the hfq+ control group. All statistical analyses were carried out in 
Prism. Sample numbers and P values for the t-test are reported in Figure 3.13. 
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Chapter 4  
4 Tn5 transposition in Escherichia coli is repressed by 
Hfq and activated by nutrient stress3 
4.1 Introduction 
 Transposase proteins catalyze the chemical steps in bacterial transposition 
reactions. It follows that the regulation of expression of these genes is a critical feature in 
dictating the transposition frequency of most transposons. In many instances, including 
Tn10/IS10 and Tn5/IS50, transposase gene promoters are inherently weak. In addition, 
Dam methylase limits initiation of IS10 and IS50 transposase gene transcription by 
methylating promoter elements (Roberts et al, 1985; Yin et al, 1988). These factors 
together make transcription initiation a limiting step in Tn10/IS10 and Tn5/IS50 
transposition reactions (Krebs & Reznikoff, 1986; Raleigh & Kleckner, 1986). There are 
also examples where translation of transposase transcripts is subject to both intrinsic and 
host levels of regulation. In the case of IS10 transposase, the ribosome binding site is 
inherently weak and the transposon encodes an antisense RNA that binds the translation 
initiation region (TIR), blocking ribosome binding (Ma & Simons, 1990; Simons & 
Kleckner, 1983). There is also evidence that the ‘host’ protein Hfq helps mediate the 
pairing interaction between the antisense RNA and the IS10 transposase transcript (Ross 
et al, 2013; Ross et al, 2010). 
 Hfq is a global regulator of gene expression in bacteria. It typically functions at 
the post-transcriptional level by influencing translation initiation and/or transcript 
stability by various mechanisms (reviewed in (Vogel & Luisi, 2011)). In contrast to the 
many examples of Hfq acting in a post-transcriptional capacity to impact gene 
expression, there is (to our knowledge) only one example in the literature of Hfq acting at 
the level of transcription to influence gene expression. In the case of ribosomal proteins 
                                                
3
 A version of this chapter has been submitted for publication: Ross,J.A., Trussler,R.S., Black,M.D., 
McLellan,C.R. and Haniford,D.B. (2014) Tn5 transposition in Escherichia coli is repressed by Hfq and 
activated by nutrient stress. RNA. 
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rpsO, rpsT and rpsB-tsf, Hfq was shown to increase transcript levels without influencing 
transcript stability. It was suggested that this is accomplished through Hfq binding to 
secondary structure elements in the respective transcripts that form early in the elongation 
phase of transcription and that this interaction reduces RNA polymerase pausing (Le 
Derout et al, 2010). 
 As noted above, Hfq has been implicated in the regulation of Tn10/IS10 
transposition. Under conditions of hfq deficiency, a large increase in both Tn10/IS10 
transposition (up to 80-fold) and transposase expression (up to 7-fold) were observed. 
The existing evidence is consistent with Hfq acting as a negative regulator of IS10 
transposase expression by both antisense dependent and independent pathways. In 
support of the latter, it was found that hfq deficiency had a significant impact on Tn10 
transposition even when the level of antisense RNA was insufficient to impact on 
transposase expression (i.e. when Tn10 is present in single copy in the bacterial 
chromosome). In addition, there was a synergistic increase in transposase expression 
when both hfq and the antisense RNA were knocked out, implying that Hfq does not 
function exclusively in the same pathway as the antisense RNA (Ross et al, 2010).  
 Taking the above results into account, and considering that most bacterial 
transposition systems are not regulated by antisense RNAs, we wondered if Hfq might 
play a more general role in regulating transposition systems. In the current work we 
tested this hypothesis by asking if Tn5 transposition is also regulated by Hfq. Like Tn10, 
Tn5 is a composite transposon (Figure 4.1). The two transposons are closely related but 
Tn5 lacks an antisense RNA regulatory system (Bhasin et al, 1999; Kennedy et al, 1998; 
Mahillon & Chandler, 1998). Instead, it encodes an inhibitor protein that limits Tn5/IS50 
transposition by dimerizing with the transposase protein, forming an inactive complex. 
Transposase and the inhibitor protein are expressed from overlapping promoters, P1 and 
P2 (color coded in Figure 4.1), with the inhibitor transcript (T2) being expressed at a 
much higher level than the transposase transcript (T1). T1 expression is down-regulated 
by Dam methylase (reviewed in (Reznikoff, 2008)). There is some evidence that P1 is 
also negatively regulated by LexA, an SOS-inducible transcriptional repressor  
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Figure 4.1. Tn5/IS50 structure and gene expression. 
The structure of Tn5 is shown along with transcription units within IS50-Right. There are 
two distinct promoters defined by -35/-10 regions that control transposase (black) and 
inhibitor (blue) expression. T1 is the transposase (t’ase) transcript and T2 is the inhibitor 
transcript. The Shine-Dalgarno sequence of T1 is also shown. Expression of T1 but not 
T2 is regulated by Dam methylation at two GATC sequences (red) and potentially LexA 
binding (dotted line defines a putative LexA binding site). Mutations in the Dam sites 
used in this work are shown. After translation, transposase protein binds transposon ends 
(outside ends [OE] for Tn5 transposition and an OE and an inside end [IE] for IS50 
transposition) and forms a transpososome (t’some). The inhibitor protein (Inh) blocks this 
...CGGAACCTTTCCCGTTTTCCAGGATCTGATCTTCCAGGTGACCTCTTAAGATGGTAACGTTCATGATAACT...
T1AA
-35 -10
T2
SD T’ase start
KanR
OE IEIS50L IE OEIS50R
BleR StrR
180°
5‘
T‘ase
Transcription
Translation
T’some 
formation
Chemical 
steps in 
transposition 
T1
Inh
-35 -10
DAMLexA
...........................................
+
IS50L IS50R
139 
 
step by forming a mixed dimer with transposase. All of the chemical steps in 
transposition take place in the context of the t’some. KanR, BleR and StrR are kanamycin, 
bleomycin and streptomycin resistance genes, respectively. 
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(Kuan & Tessman, 1991). However, there is little else known with regard to host proteins 
that influence either transposase transcription or translation.    
In the current work, we show that both Tn5 transposition and IS50 transposase 
expression increase significantly in E. coli under conditions of hfq deficiency. However, 
unlike the situation in Tn10/IS10 transposition, the up-regulation of IS50 transposase 
expression is mainly due to an increase in transposase gene transcription. As Hfq does 
not typically function directly in transcription, we looked at the possibility that Hfq 
regulates IS50 transposase expression by controlling the expression of a transcription 
factor. Towards this end, we provide evidence that Hfq acts in a regulatory network with 
Crp (cyclic AMP receptor protein) to down-regulate IS50 transposase transcription. 
Finally, we demonstrate that over-expression of the sRNA SgrS activates expression of 
the IS50 transposase gene specifically when cells are grown with glucose as the sole 
carbon source. Evidence is presented that this up-regulation is a consequence of nutrient 
starvation, demonstrating that the IS50 transposase promoter (and Tn5 transposition) is 
responsive to the nutrient status of the cell. 
4.2 Results 
4.2.1 Hfq is a potent negative regulator of Tn5 transposition 
We asked if Hfq regulates Tn5 transposition in E. coli by measuring the frequency of Tn5 
transposition under conditions of hfq deficiency (hfq-). Two different transposition assays 
were used, mating out and papillation, each employing a WT strain and an isogenic strain 
in which the hfq gene was disrupted.  
In the mating out assay we measured transposition of ‘native’ Tn5 from the 
chromosome into an F factor. In this assay, an F+ donor strain harboring Tn5 was mated 
to an F- recipient strain and the mating efficiency and number of transposition events 
were measured by plating mating mixes on the appropriate selective media (see Materials 
and Methods). We chose to follow the response of native Tn5 (as opposed to a 
genetically manipulated Tn5 derivative) to hfq deficiency because we didn’t want to bias 
the results by disabling any of the natural Tn5 regulatory pathways. Also, by using a 
donor strain with Tn5 in the chromosome, as opposed to in a multi-copy plasmid, we 
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hoped to reduce the ‘background’ that sometimes occurs in mating out assays due to 
fortuitous donor plasmid transfer. This can be particularly problematic when measuring 
low frequency transposition events, as is expected for the native Tn5 element; Tn5 has 
been reported to transpose at a frequency of less than 1 event per 105 cells per generation 
(Reznikoff, 2002).  
We show in Figure 4.2A that in one donor strain background (DBH179) Tn5 
transposition, as measured by the mating out assay, increased by close to 75-fold under 
conditions of hfq deficiency. By comparison, when the parent strain was transduced to 
dam- instead of hfq-, transposition increased about 7.5-fold. This increase in transposition 
in dam- was expected based on previous work in the Tn5 system and served as a positive 
control for our experimental system (Yin et al, 1988). Note that we did not have a 
defective copy of Tn5 to act as a negative control in this experiment. In lieu of this, we 
carried out physical mapping on a sampling of colonies present on ‘hop’ plates to ensure 
that bona fide transposition events were being measured in both hfq+ and hfq- strains 
(Appendix C). 
We also performed a complementation assay in the DBH179 strain background to 
further test that the increase in transposition reported above in hfq- was actually due to the 
absence of Hfq, as opposed to possible polar effects of the hfq disruption allele. Towards 
this end, we introduced hfq on a low-copy plasmid (pDH700) into the hfq- strain and 
measured Tn5 transposition as above. We observed nearly complete complementation by 
plasmid-borne hfq, as transposition was reduced approximately 45-fold relative to when 
no hfq was present (Figure 4.2A). Furthermore, plasmid-encoded variants of Hfq, 
including K56A and Y25A, which are impaired for RNA-binding at the ‘proximal’ and 
‘distal’ surface, respectively, failed to complement hfq deficiency (Mikulecky et al, 
2004). This confirms that specific functions of Hfq, namely interaction with RNA via 
known RNA-binding surfaces, are required for effective repression of Tn5 transposition.    
We also tested the impact of hfq deficiency on Tn5 transposition in a second 
donor strain background (DBH261) via the mating out assay (Figure 4.2B). In this  
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Figure 4.2. Frequencies of Tn5 transposition in hfq- versus hfq+ strains of E. coli. 
(A) Tn5 transposition from the chromosome of DBH179 and derivatives (hfq- and dam-) 
was measured by the conjugal ‘mating out’ assay as described in Materials and Methods. 
For purposes of trans-complementation, strains contained an empty vector or a low-copy 
plasmid encoding either wild type hfq or mutant forms of hfq (K56A or Y25A) expressed 
from the hfq P3 promoter. The data was compiled from 4 independent experiments, each 
with at least three isolates of each strain. The average transposition frequency was 8.33 x 
10-5 events per mL of mating mix for the WT strain (no ‘hfq plasmid’) and for purposes 
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of comparison this value was set at 1 and all other values normalized to this. (B) Tn5 
transposition from the chromosome of DBH261 and derivatives (hfq- and dam-) was 
measured as in (A). The data shown is from one experiment with 5 independent isolates 
of each strain. The average transposition frequency for the WT strain was 2.57 x 10-6 
events per mL of mating mix. In (A) and (B) the error bars indicate standard error on the 
mean. 
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experiment hfq- also caused an increase in Tn5 transposition, although the magnitude of 
the effect was smaller (~ 9-fold) than reported for the DBH179 strain background.  
The papillation assay provided an independent means of assessing the impact of 
hfq deficiency on Tn5 transposition. In this assay, transposition of a single-copy Tn5-
derivative (miniTn5LT) present on an F’ plasmid was measured. MiniTn5LT contains a 
promoter-less LacZ gene flanked by Tn5 outside end sequences and as such the LacZ 
gene is not expressed. However, transposition of miniTn5LT into an actively expressed 
transcription unit can result in LacZ expression from read-through transcription into the 
LacZ gene (Krebs & Reznikoff, 1988). Transposition events are scored as the 
development of LacZ+ papillae on a background of LacZ- cells. In the experiment 
presented below, transposase was provided from a plasmid containing the IS50 
transposase gene under the control of its native promoter. Accordingly, it was trivial to 
introduce mutations into the transposase gene to provide appropriate controls.  
We transformed 3 different transposase plasmids into WT and hfq- versions of the 
papillation strain, including WT, a catalytically inactive transposase mutant (cat-) and 
WT under the control of a Dam methylase-insensitive promoter mutant (Dam-
insensitive). Transformants were grown up to six days on MacConkey-lactose plates and 
the number of papillae formed was counted over this period. We show in Figure 4.3 that 
hfq deficiency caused an increase in Tn5 transposition, as at the end of six days there 
were on average 2.5-fold more papillae per colony in transformants expressing WT 
transposase in hfq- versus hfq+. As expected, papillae were not detected in either hfq+ or 
hfq- when the source of transposase included the cat- mutation. Also, the frequency of 
papillae formation increased about 50-fold in hfq+ when WT transposase was expressed 
from the Dam-insensitive promoter compared to the Dam-sensitive promoter. 
We also transformed the Dam-insensitive transposase into hfq- to ask if the 
mutations exhibited synergy. The average number of papillae per colony for the double 
mutant strain did not differ substantially from that observed in the hfq+ strain containing 
the Dam-insensitive transposase promoter, indicating a lack of synergy between the 
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Figure 4.3. Papillation assay for Tn5 derivatives in hfq+/- strains. 
Isogenic hfq+/- strains (DBH55 and DBH124) containing mini-Tn5 lac tetR 
(‘miniTn5LT’) were transformed with plasmids encoding either WT transposase (WT 
t’ase), a catalytically defective transposase (Cat- t’ase) or WT t’ase in which the 
transposase promoter was mutated to be insensitive to Dam methylase (Dam-Ins). Note 
that all versions of transposase, including ‘WT’, encode the M56A mutation to prevent 
translation of the inhibitor protein. Transformants were grown on MacConkey-lactose 
plates containing Ampicillin (100 µg/mL) for up to 6 days. Images of representative 
colonies for each of the strains at different stages are shown. The dark spots are LacZ+ 
papillae. The total number of papillae counted for the indicated number of colonies at day 
6 is tabulated on the right-hand side. Note that the Tn5 transposition frequency is 
expected to be roughly proportional to the number of papillae formed (Krebs & 
Reznikoff, 1988). 
Cat-
t’ase 
WT t’ase
Dam-Ins. 
t’ase
hfq+
hfq-
hfq+
hfq-
hfq+
hfq-
Day 4 Day 5 Day 6 Papillae/Colony 
0 / 125 = 0 
0 / 172 = 0 
7 / 72 = 0.097 
37 / 152 = 0.243 
110 / 21 = 5.24 
220 / 78 = 2.82 
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mutations. This result is consistent with Hfq and Dam methylase affecting the same step 
in transposition (see below). 
4.2.2 Hfq negatively regulates expression of Tn5 transposase 
We next asked if Hfq inhibits Tn5 transposition by down-regulating transposase 
expression. In one approach, we measured transposase expression by constructing IS50-
lacZ transcriptional and translational fusions (‘TCF’ and ‘TLF’, respectively; see Figure 
4.4A for schematics), integrating these reporters into the chromosome of a lac- strain 
(DBH107), and then performing β-galactosidase assays. This was done for each reporter 
in isogenic strains that were either WT, dam- or hfq-. As expected for a promoter that is 
Dam-sensitive, transposase expression increased in the context of both transcriptional and 
translational fusions in the dam- strain relative to WT (~19- and 25-fold, respectively; 
Figure 4.4B). The increase in transposase expression for both constructs in dam- is 
indicative of expression coming predominantly from the P1 promoter (Yin et al, 1988). 
Transposase expression in TCF and TLF constructs also increased in hfq- cells (11-fold 
and 7.4-fold, respectively), indicating that Hfq represses Tn5 transposase expression. As 
the TCF encodes only 15 nucleotides of the transposase transcript (T1), the strong up-
regulation of expression in hfq- is consistent with Hfq acting primarily at the 
transcriptional level to down-regulate transposase expression, although we cannot rule 
out that a small component of the up-regulation of transposase expression in the TLF 
construct is post-transcriptional.     
The above reporter constructs were also put into one of the mating out strains 
(DBH33 background) so that the impact of hfq deficiency on Tn5 transposition and 
transposase expression could be studied in the same genetic background. Consistent with 
the results in the DBH107 background, transposase expression increased approximately 
14-fold for both reporters under conditions of hfq deficiency (Appendix D).  
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Figure 4.4. Transposase-lacZ translational and transcriptional fusion reporter 
assays in WT, dam- and hfq- strains. 
(A) Schematic of the IS50-lacZ transcriptional fusion (TCF; upper) and translational 
fusion (TLF; lower) reporters used in this study. The TCF reporter encodes the first 80 bp 
of IS50-Right (white rectangle) fused to lacZ (light blue rectangle). This fusion encodes 
only the first 15 nucleotides of the transposase (T1) transcript, which is expressed from 
the native promoter; the -35/-10 elements are shown in black.  The inhibitor transcript is 
not expressed as the promoter for the inhibitor is missing its -10 region. The TLF encodes 
the first 128 bp of IS50-Right. This includes up to the 12th codon of T1, which is fused 
in-frame to the 10th codon of lacZ (purple rectangle). T1 and T2 and their respective 
promoter elements (-35/-10 sequences) are color-coded. Note that the start codon for the 
inhibitor protein has been mutated so that only transposase expression will give rise to β-
galactosidase activity. Also note that the transposase promoter in both the TCF and the 
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TLF is sensitive to Dam methylation. (B) β-Galactosidase activity (given in Miller Units) 
for isogenic strains (WT, dam- or hfq-) harboring either the TCF or TLF in single-copy in 
the chromosome of E. coli. For each fusion, the activity was normalized to that of the WT 
strain. The data sets shown for the TCF and TLF were compiled from 2 and 3 
independent experiments, respectively, with each experiment including at least 3 
replicates. Mean and standard error values are shown. 
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4.2.3 Hfq impacts steady-state levels of full-length IS50 
transposase mRNA 
To further assess the impact of Hfq on transposase gene expression, we looked at both the 
steady-state level and the stability of the transposase transcript (T1) under conditions of 
hfq deficiency. For the steady-state analysis, total RNA was isolated from various strains 
(DBH33 background) containing a multi-copy plasmid encoding the full-length 
transposase gene under the control of its native promoter. Primer extension was used to 
detect both T1 and T2 transcripts. Of the two transcripts, the steady-state level of T1 
increased the most in hfq- (60-fold versus 6.6-fold for T2; Figure 4.5A,B). By 
comparison, the T1 level increased 9.6-fold when P1 was Dam-insensitive. As in the 
papillation assay, we failed to see evidence of synergy between Dam-insensitivity and hfq 
deficiency, as T1 increased to the same level in the double mutant compared to hfq- 
alone. These results are fully consistent with the inference from the previous section that 
Hfq represses IS50 transposase transcription. 
 To directly test if a component of Hfq-directed repression of IS50 transposase 
expression is post-transcriptional, we compared the stability of the IS50 transposase 
mRNA (T1) in isogenic WT and hfq- strains. Total RNA was isolated from a pair of 
rifampicin-sensitive strains (TM338 and TM618) containing a plasmid encoding IS50 
transposase (pDH533) before and after rifampicin treatment as shown in Figure 4.5C. 
Transposase mRNA was detected by primer extension as in Figure 4.5A. The results 
presented in Figure 4.5C show that hfq deficiency increased the half-life of the T1 
transcript by ~ 1.7-fold. This is consistent with Hfq having a small but significant 
destabilizing effect on the transposase transcript.  
4.2.4 Regulation of Tn5 transposase expression by global 
transcriptional regulators 
As the primary impact of hfq deficiency on IS50 transposase expression is at the level of 
transcription and Hfq does not typically function directly in transcription, it is likely that 
Hfq suppression of transposase expression is indirect. In an attempt to define a regulon 
that impinges on IS50 transposase expression, and might be affected by hfq-, we surveyed 
2 global transcription factors, Crp and Lrp (Martinez-Antonio & Collado-Vides, 2003),  
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Figure 4.5. Steady-state levels and half-life of IS50 transposase mRNA in hfq+/- cells. 
(A) Primer extension analysis of steady-state transposase mRNA levels. Isogenic hfq+/- 
derivatives of DBH33 were transformed with a high-copy plasmid encoding either WT 
T’ase expressed from its native promoter (pDH533) or Dam-Ins T’ase (pDH752) and 
grown to mid-log phase before harvesting total RNA. Primer extension reactions were 
carried out using 32P-labeled primers complimentary to IS50 transposase (primer 
oDH230) or lpp (primer oDH231) mRNA; the latter served as an internal control. The 
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corresponding cDNAs were analyzed on denaturing polyacrylamide gels. Transposase 
RNA, T1; Inhibitor RNA, T2. (B) Quantification of primer extension analysis. T1 levels 
from two independent isolates for each of the indicated strains are plotted after 
normalization to the amount of lpp transcript expression, the latter of which is known to 
be insensitive to hfq status (Le Derout et al, 2010). Mean and standard error values of 
duplicate experiments are shown. (C) Transposase mRNA half-life analysis. Strains 
TM338 (hfq+) and TM618 (hfq-) were transformed with transposase encoding plasmid 
pDH533 and total RNA was isolated either before or after the addition of rifampicin (at 
the indicated time points). Transposase RNA was detected as described in (A). The bands 
were quantified (ImageQuant) and T1 normalized to un-extended primer before plotting 
the proportion of RNA remaining after rifampicin addition (time zero=1.0). The data was 
fit to a one-phase exponential decay curve by non-linear regression (Prism) to determine 
the half-life (t1/2). The data shown is a compilation from two independent experiments. 
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for effects on IS50 transposase gene expression. Towards this end, we constructed strains 
that contained the IS50 TCF described in Figure 4.4 (in single copy) and disruptions of 
either the crp or lrp genes and measured transposase expression under a variety of growth 
conditions. We show in Figure 4.6A that crp- but not lrp- had a substantial impact on 
transposase expression. For example, in cells grown to exponential phase in LB, both crp 
and hfq deficiency caused a ~ 4-fold up-regulation of transposase expression, while lrp- 
gave a ~ 1.2-fold reduction. The impact of crp- on transposase expression was slightly 
weaker (2.2-fold versus WT) when cells were grown in M9-glucose. We also performed 
semi-quantitative RT-PCR and show in Figure 4.6B that crp and hfq deficiency caused an 
increase in transposase-lacZ transcript level of a comparable magnitude (Figure 4.6B and 
Appendix E). 
Given that hfq and crp deficiency increased transposase-lacZ levels to a similar 
degree (in at least some growth conditions), we wondered if both Crp and Hfq might 
impinge on the same pathway in order to repress IS50 transposase expression. To this 
end, we performed a Western blot with an anti-Crp antibody on cell lysates from the WT, 
hfq- and crp- strains used in Figure 4.6A. We show in Figure 4.6C that Crp protein levels 
decreased ~ 2.5-fold in hfq- relative to hfq+, consistent with the possibility that Hfq 
influences transposase expression, at least in part, by up-regulating Crp expression. 
Notably, it has been shown that Hfq positively regulates Crp expression ~ 5-fold in 
Yersinia pestis (Lathem et al, 2014). 
4.2.5 IS50 transposase expression and Tn5 transposition are up-
regulated by nutrient starvation 
Over-expression of sRNAs can alter Hfq-regulated networks by limiting the availability 
of Hfq (Hussein & Lim, 2011; Moon & Gottesman, 2011). Given our findings that Tn5 
transposition and transposase gene expression are regulated by Hfq, we asked if IS50 
transposase expression might similarly be sensitive to Hfq-titration. Towards this end, we 
measured transposase expression from the TLF under conditions where a single sRNA 
was over-expressed from an inducible promoter (pLlacO) in DBH33. Our initial screen 
included four different Hfq-dependent sRNAs, including RybB, RyeB, MicC and SgrS, 
all of which are expected to tightly bind Hfq in vivo; apparent equilibrium dissociation  
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Figure 4.6. Transposase-lacZ transcriptional fusion reporter assays in strains 
harboring disruptions of global transcriptional regulators. 
(A) β-Galactosidase activity (given in Miller Units) for isogenic strains (WT, hfq-, crp- 
and lrp-) harboring the TCF in single-copy in the chromosome (DBH303 and 
derivatives). Cells were grown to mid-log phase either in M9-Glucose or LB (white and 
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blue bars, respectively). WT, crp- and lrp- cells were also grown to saturation in M9-
Glucose (purple bars).  For each growth condition, the activity was normalized to that of 
the WT strain. Mean and standard error values of duplicate experiments, each of which 
included at least 3 replicates, are shown. (B) Summary of the analysis of IS50-lacZ 
transcript levels. Total RNA was extracted from cells described in panel (A), and 
subjected to RT-PCR as detailed in Appendix E. (C) Western blot analysis of Crp levels 
in cellular extracts from hfq+/- cells grown in LB as described for panel (A). Crp levels 
were normalized to GroES, which is known to be insensitive to hfq status (Guisbert et al, 
2007). Mean and standard error values from at least three independent isolates are shown. 
A representative image is inset. As a negative control, crp- cells were also analyzed. 
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constants of ~ 3.3 nM and < 20 nM have been measured for MicC and SgrS, respectively 
(Fender et al, 2010; Ishikawa et al, 2012; Wassarman et al, 2001). Importantly, cells were 
grown in M9-glucose. We show in Figure 4.7A that only one of the sRNAs tested, SgrS, 
has a large impact on transposase expression. Induction of SgrS increased transposase 
expression close to 4-fold. Given the comparable Hfq binding affinities of these sRNAs, 
it seemed unlikely that SgrS expression was increasing transposase expression through an 
Hfq-titration mechanism.  
Knowing that SgrS down-regulates expression of the glucose transporter ptsG 
(Vanderpool & Gottesman, 2004) and given that the experiment was carried out in M9-
glucose media, we considered the possibility that up-regulation of transposase expression 
reported in Figure 4.7A was a response to nutrient starvation. We show in Appendix F 
that induction of SgrS in M9-glucose resulted in a substantial slowing of bacterial growth 
as would be expected if nutrients had become growth-rate limiting. To further test the 
nutrient starvation hypothesis, we performed a similar experiment (in this case using a 
TCF in the DBH107 background) in rich media (LB) and in M9-glucose supplemented 
with glycerol, a carbon source whose import is not dependent on glucose transporters 
(Agre et al, 1998). We also tested the response of the reporter to over-expression of an 
sgrS mutant, sgrS1, that is incapable of down-regulating glucose import (Rice & 
Vanderpool, 2011). We show in Figure 4.7B that SgrSWT induced close to a 5-fold 
increase in reporter expression relative to a ‘vector’ control, when cells were grown in 
M9-glucose. In contrast, SgrS1 was incapable of up-regulating reporter expression, 
suggesting that SgrS must be able to down-regulate glucose import in order to increase 
transposase transcription. When cells were grown in M9-glucose supplemented with 
glycerol, expression of SgrSWT caused only a ~ 2-fold increase in transposase expression, 
indicating that glycerol addition was sufficient to overcome much of the starvation 
phenotype. Importantly, the reduced effects of SgrS on transposase expression under 
‘glycerol’ conditions cannot be explained by differential expression of the respective 
sRNAs as levels of SgrSWT and SgrS1 were similar in M9-glucose with or without 
glycerol (Figure 4.7C). Also, we failed to see significant transposase induction when 
SgrS was over-expressed in LB media where there are multiple carbon sources. Finally, 
consistent with the nutrient starvation hypothesis, we also show in Figure 4.7B that 
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Figure 4.7. Transposase-lacZ expression assays in cells over-expressing sRNAs. 
(A) Transposase expression from a TLF present on a low-copy plasmid (pDH798) was 
measured in the presence of a compatible plasmid expressing one of the indicated sRNAs 
from the inducible pLlacO promoter in DBH33. Cells were grown in M9 glucose and 0.1 
mM IPTG was added to subcultures to induce sRNA expression. Transposase expression 
was measured 6 hours after IPTG addition. Expression levels were normalized to the 
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strain with the vector only control. (B) The impact of different growth conditions on 
SgrS-induced up-regulation of transposase expression was evaluated using a single-copy 
TCF fusion present in the chromosome of DBH265. Note that the sgrS1 allele of SgrS 
contains a two-nucleotide mutation that inhibits its ability to down-regulate expression of 
the ptsG glucose transporter. Subcultures were grown in either M9 glucose, M9 glucose + 
glycerol, or LB, as indicated. Transposase expression was measured approximately 4 to 6 
hours after subcultures were started or when cells reached an OD600 of ~ 0.6.  In (A) and 
(B) mean and standard error values of duplicate experiments, each of which included at 
least 3 replicates, are shown. (C) Northern blot of RNA isolated from cells in (B). RNA 
was extracted from cells immediately before starting the Miller assay and visualized with 
32P-labeled RNA probes complementary to either SgrS or the 5S rRNA (internal control). 
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increased transposase expression resulting from SgrS expression in M9-glucose is the 
only condition that inhibited cell growth.   
Given that transposition frequency is expected to be roughly proportional to 
transposase expression, we also asked if glucose starvation had an impact on Tn5 
transposition. Cells encoding a chromosomal copy of Tn5 were transformed with an 
SgrS-expressing plasmid (or vector only control) and the frequency of Tn5 transposition 
was measured using the mating out assay. Note that cells were grown in M9-glucose 
media and SgrS expression was induced only when donor strains were subcultured on the 
day of mating. We show in Figure 4.8 that induction specifically of SgrSWT resulted in a 
5-fold increase in Tn5 transposition relative to the vector only control. Notably, when 
cells were grown in M9 supplemented with glucose and glycerol, induction of SgrSWT did 
not result in a significant increase in Tn5 transposition. Also, we observed a reduced 
growth rate only in cultures where SgrSWT was induced in M9-glucose media (data not 
shown). The results of the mating out analysis are thus entirely consistent with the gene 
expression experiments presented in Figure 4.7.  
Taken together, the results in this section are consistent with nutrient starvation 
leading to both increased transposase transcription and Tn5 transposition. 
4.3 Discussion 
Hfq is a global regulator of gene expression in bacteria. However, until recently Hfq had 
not been linked to the control of transposable elements. Work in the Tn10/IS10 system 
provided the first example of Hfq playing a protective role against a mobile DNA 
element (Ross et al, 2010). In the current work, we asked if a second transposon, 
Tn5/IS50, is also regulated by Hfq. We show that Hfq strongly down-regulates Tn5 
transposition and present evidence that the primary mechanism of regulation is through 
the inhibition of transposase transcription. Additional genetic analysis identified: (i) Crp 
as a negative regulator of IS50 transposase transcription and (ii) Hfq as a positive 
regulator of Crp expression. Taken together, these results are consistent with Hfq and Crp 
working in the same pathway to limit IS50 transposase expression. We also show that 
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Figure 4.8. Impact of SgrS expression on Tn5 transposition. 
Transposition of a chromosomal copy of Tn5 was measured in DBH179 using the mating 
out assay. DBH179 containing one of the indicated plasmids was grown overnight in M9-
Glucose and then sub-cultured in either M9-Glucose or M9-Glucose plus Glycerol as 
described in Materials and Methods before mating with the recipient strain and plating on 
selective media as described in Figure 2. IPTG was added to the subculture (to 0.1 mM) 
to induce SgrS expression, except where indicated (-IPTG). The average transposition 
frequency for the ‘no SgrS’ control was 5.52 x 10-5 events per mL of mating mix. All 
other transposition frequencies were normalized to this value. Mean and standard error 
values of duplicate experiments, each of which included at least 5 replicates for each 
experimental group, are shown. 
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IS50 transposase transcription is induced by nutrient starvation, providing this mobile 
element with a means of responding to environmental stress. 
4.3.1 Hfq negatively regulates Tn5 transposition 
Two different transposition assays were used to determine if hfq deficiency impacts on 
Tn5 transposition. The results of both mating out and papillation experiments were 
consistent with Hfq acting as a negative regulator of this transposon. Importantly, the two 
assays employ different outputs for measuring transposition. As such, we can be 
confident that the observed increases in transposition frequency are not systematic errors 
in the assays linked to the elimination of a pleiotropic regulator. It should also be 
recognized that the two assays measure transposition under different growth conditions. 
In the papillation assay, prolonged growth on plates results in nutrient limitation and the 
majority of cells in a colony grow essentially under anaerobic conditions (Twiss et al, 
2005). In contrast, most of the growth in the mating out assay is performed without 
nutrient limitation and with good aeration. These factors can significantly affect the 
magnitude a mutation has on transposition frequency (Swingle et al, 2004). In the results 
presented in this work, we found that hfq deficiency caused a much greater increase in 
Tn5 transposition in the mating out compared to the papillation assay. At present we have 
no clear explanation for this result. One trivial possibility is that hfq- colonies in the 
papillation assay appear to have stopped growing relatively early in the 6 day time course 
and this could have limited papillae formation relative to the hfq+ strain. An alternative 
possibility relating to σS expression is discussed below. 
 We also found that the magnitude of the Tn5 transposition increase was 
dramatically different for hfq- in two different strain backgrounds. Both DBH179 and 
DBH261 are K12-derived strains, but like many laboratory strains of E. coli their 
histories are quite different. We routinely found that hfq- had a greater negative impact on 
growth rate in the DBH261 strain background and this may have increased the likelihood 
of picking up partial suppressors of hfq deficiency. If this were the case, the impact of 
hfq- on Tn5 transposition could be dampened. However, it may be useful in the future to 
perform expression profiling on the two strains in an attempt to define genes that modify 
the impact of hfq deficiency on Tn5 transposition.  
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 Another feature of the transposition assays worth pointing out is that hfq- caused a 
larger increase in Tn5 transposition versus dam- (mating out assay), but a smaller increase 
versus mutations that made the transposase promoter Dam methylase-insensitive 
(papillation assay). A possible explanation for this observation is that the two basepair 
mutations that confer Dam methylase-insensitivity have secondary effects (positive in 
nature) on the transposase promoter. In this regard, the net effect of both mutations is to 
increase the A-T content in the -10 region of the transposase promoter and this could 
increase promoter strength. Alternatively, dam deficiency could have additional effects 
on the transposase promoter that indirectly counteract the positive effects of relieving 
promoter methylation. For example, the expression of a repressor that acts on the 
transposase promoter might be increased in dam- cells.  
 Two final aspects of the transposition assays worth mentioning relate to the trans-
complementation results. First, detecting trans-complementation with HfqWT established 
that the observed increase in Tn5 transposition was in fact due to hfq deficiency as 
opposed to possible polar effects of the hfq-disruption allele used in this work. Second, 
the failure of RNA binding face mutants of Hfq to provide trans-complementation 
suggests that Hfq-directed inhibition of Tn5 transposition relies on functions of Hfq 
required in canonical Hfq-directed regulatory pathways (Mikulecky et al, 2004). That is, 
Hfq must retain the ability to bind both mRNAs and sRNAs to influence Tn5 
transposition. Genetic analysis in the Tn10/IS10 system led to the same conclusion (Ross 
et al, 2013).      
4.3.2 Hfq and IS50 transposase gene expression 
Evidence that Hfq down-regulates IS50 transposase expression came from two types of 
experiments. First, the expression of transposase-lacZ reporter genes in both 
transcriptional and translational fusion constructs increased significantly under conditions 
of hfq deficiency. Second, the steady-state level of the native transposase transcript also 
increased significantly in hfq deficiency. Importantly, the large increase in steady-state 
transcript level coincided with only a minor increase in transposase stability. Taken 
together, these results provide strong evidence that Hfq predominantly suppresses IS50 
transposase transcription, with only minor post-transcriptional effects. 
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 As Hfq does not typically act directly in gene transcription, we think it likely that 
it acts indirectly on the IS50 transposase promoter. In addition to Dam methylase, only 
one other factor, LexA, has been implicated as a regulator of transposase transcription. 
LexA is a transcriptional repressor and part of the SOS-response regulon (Walker, 1984). 
There is a weak LexA-binding site in the transposase promoter (Figure 4.1), however, 
lexA deficiency was shown to increase transposase transcription only 2 to 3-fold (Kuan & 
Tessman, 1991). As we have seen increases in transposase expression of up to 14-fold in 
hfq deficiency, it seems unlikely that Hfq would be working through LexA. We also do 
not think that hfq deficiency impacts Dam methylase expression. This comes from a 
previous observation where we assessed the impact of hfq- on IS10 transposase 
expression in a TCF. If hfq deficiency reduced Dam methylase levels or activity, then it 
would be expected that IS10 transposase expression in this fusion would also increase. In 
fact, no increase in transposase transcription was observed, although hfq deficiency did 
increase IS10 transposase expression in a TLF (Ross et al, 2010).   
 We searched for a potential Hfq target by looking at the impact of gene 
disruptions of two global transcription factors, Crp and Lrp, on IS50 transposase 
expression using our TCF construct. While lrp deficiency had almost no impact, crp 
deficiency increased transposase expression to approximately the same level as hfq 
deficiency when cells were grown in rich media. Given the similar magnitude of up-
regulation observed for hfq- and crp-, we considered the possibility that Hfq might be 
working through Crp. Preliminary evidence supporting this possibility was provided 
when we looked at the impact of hfq deficiency on Crp protein levels. This experiment 
revealed that the steady-state Crp protein level decreased approximately 2.5-fold in hfq- 
cells grown in rich media. This finding is consistent with Hfq acting as a positive 
regulator of Crp expression. Notably, in recent work it was shown in Yersinia pestis that 
Hfq positively regulates Crp (~ 5-fold) at the post-transcriptional level (Lathem et al, 
2014). There is also an example in the literature of Crp down-regulating the transcription 
of a transposase gene. In the case of IS2, crp deficiency increased transposase 
transcription close to 200-fold. It was also shown through protein-DNA footprinting that 
Crp binds directly to the IS2 transposase promoter (Hu et al, 1998). We have not yet 
looked at the possibility that Crp binds directly to the IS50 transposase promoter. 
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 In addition to defining new negative regulators of IS50 transposase transcription 
(and transposition), we also identified in this work a stress condition that activates 
transposase expression and Tn5 transposition. Glucose starvation, induced by over-
expression of the sRNA SgrS in M9-glucose media, induced transposase expression and 
transposition ~ 4- to 5-fold. This response has not yet been characterized in detail but as 
glucose starvation is known to induce expression of the stationary phase sigma factor (σS) 
(Mandel & Silhavy, 2005), we suggest that an imbalance of σS to σ70 could be driving 
this up-regulation. Notably, both σS and σ70 recognize similar promoter sequences, but σS 
is more tolerant of sequence variations from the consensus (Landini et al, 2014). The 
IS50 transposase promoter matches somewhat poorly to the consensus sequence of σ70 
and σS, so it is possible that certain deviations would be better tolerated by σS. In 
particular, the IS50 promoter matches poorly to the -35 consensus sequence, which is an 
important determinant of σ70 but not σS recognition. Additionally, a guanine at the -14 
position (where the first nucleotide of the -10 hexamer is arbitrarily designated -12) is a 
distinguishing feature of σS promoters (Landini et al, 2014) and there is a guanine at this 
position in the IS50 transposase promoter. It follows that if the IS50 transposase promoter 
is better suited for σS-bound RNA polymerase (RNAP), an imbalance in σS to σ70 would 
increase expression from this promoter. 
4.3.3 Working model for regulation of the IS50 transposase gene 
Based on results provided in this work, we present a working model for how IS50 
transposase transcription is regulated (Figure 4.9). In this model, Hfq and Crp are 
components of a self-regulating (feed-back) loop wherein Crp, or a protein controlled by 
Crp, directly binds the transposase promoter to inhibit transcription. Hfq positively 
regulates Crp to maintain a repressed state, but under conditions of low glucose, Crp (in 
its cAMP-bound form) would limit Hfq expression (Lin et al, 2011), thereby permitting 
up-regulation of transposase transcription. Under conditions of severe glucose limitation, 
induction of σS expression would further activate the transposase promoter by 
outcompeting σ70 for RNAP holoenzyme formation and conferring the holoenzyme with 
a higher intrinsic binding affinity for the transposase promoter compared to RNAP-σ70.  
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Figure 4.9. Working model for Hfq-directed regulation of IS50 transposase 
expression. 
The basic model is described in the text. The pathway on the far right (dashed red line) 
indicates that Hfq has a minor impact on IS50 transposase expression at the post-
transcriptional level. The dashed green line indicates that possibility that Crp may not act 
directly on the transposase promoter to inhibit transcription. 
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The system would of course be sensitive to other factors that influence Crp and cAMP-
Crp levels. For example, the global transcription factor Fis is an important negative 
regulator of Crp expression (Ninnemann et al, 1992) and accordingly would be expected 
to act in opposition to Hfq to promote transposase expression. In fact, Fis is a positive 
regulator of Tn5 transposition, although a mechanism for how it promotes Tn5 
transposition was never established (Weinreich & Reznikoff, 1992).  
 Our working model can explain the observation that hfq deficiency caused a 
smaller increase in transposition in the papillation versus mating out assays. As 
previously noted, growth conditions in the papillation assay are expected to be more akin 
to stationary phase growth. It follows that transcription of transposase (and thus 
transposition) would be dependent on σS in the papillation assay. Importantly, Hfq is 
required for efficient translation of σS (Soper & Woodson, 2008). While the large 
increase in transposition in the mating out assay reflects the absence of inhibition by hfq, 
the smaller increase in the papillation assay could reflect a balance between the loss of 
Hfq-imposed repression and reduced expression of σS.  
 With regard to the possibility that σS is a key factor in up-regulating IS50 
transposase expression under glucose starvation conditions, it has previously been shown 
that entry into stationary phase (where nutrients are growth limiting) induced 
transposition of Tn4652 in Pseudomonas putida by up-regulating transposase 
transcription. This response was found to be dependent on σS, although it was not 
established if σS bound directly to the transposase promoter under these growth 
conditions (Ilves et al, 2001). To further test the idea that σS plays a key role in induction 
of the IS50 transposase transcript under glucose starvation conditions, it will be important 
to determine if this response is abrogated in a strain containing an rpoS disruption. As 
well, to further test the idea that Crp is a central player in the IS50 transposase regulatory 
network, it will be important to test the possibility that Crp binds directly to the 
transposase promoter. 
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4.3.4 Hfq and genome defense 
It is now clear that, like eukaryotes and archaea, bacteria have evolved self-defense 
systems that utilize small non-coding RNAs to provide protection against foreign DNA, 
including transposons. This includes the CRISPR and the newly discovered Argonaut-
based surveillance systems (Olovnikov et al, 2013; Wiedenheft et al, 2012). In this 
context, we find it striking that Hfq, a mediator of non-coding RNA response pathways, 
strongly down-regulates two different transposition systems. If additional transposition 
systems are likewise down-regulated by Hfq, this would be suggestive of a general role 
for Hfq in host defense against transposons. Considering that transposons have drastically 
influenced the evolutionary trajectory of their hosts, including contributing to the 
assembly and modulation of RNA-based gene expression networks (Feschotte, 2008), it 
is possible that Hfq-dependent small RNA regulatory networks actually evolved from 
Hfq-directed host defense mechanisms. In this regard it is relevant that repression of both 
IS50 and IS10 transposase expression does require that Hfq possess functional mRNA- 
and sRNA-binding surfaces. Conversely, linking transposon mobilization with Hfq could 
enable transposons to mobilize in response to various stress signals that ultimately reduce 
the concentration of available Hfq in cells.   
4.4 Materials and Methods 
4.4.1 Plasmids, bacteriophage and strains 
Plasmids used in the papillation assay (pDH533, WT; pDH828, cat-; pDH752, Dam-
Insen) are derivatives of pRZ9905, which encodes M56A transposase under the control 
of the native IS50 promoter (P1). The IS50 translational fusion plasmid (pDH798) is a 
pWKS30-derivative containing basepairs 1-431 of IS50 (nucleotides 1-366 of T1) fused 
to codon 10 (Agrawal et al, 1998) of the E. coli lacZ gene. The IS50 transcriptional 
fusion plasmid (pDH682) is a pUC18-derivative containing basepairs 1-80 of IS50 
(nucleotides 1-15 of T1) fused to nucleotide -16 (relative to the translational start codon) 
of lacZ. Plasmids encoding sRNAs (pDH764, sgrS; pDH766, rybB; pDH768, micC; 
pDH772, ryeB) and the corresponding empty vector control (pDH763) were kindly 
provided by S. Gottesman. The plasmid encoding sgrS1 (pDH895) was kindly provided 
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by C. Vanderpool. Plasmids encoding Hfq (pDH700, WT) and mutant derivatives 
(pDH701, K56A; pDH713, Y25A) are described in Ross et al (2013). Details of plasmid 
constructions are provided in Appendix G (Supplemental Methods). A list of 
oligonucleotides is provided in Appendix H.  
Lambda phages encoding IS50 transcriptional (λDBH849 and λDBH888) and 
translational (λDBH812) reporters were generated by cloning IS50 expression cassettes 
marked with an antibiotic resistance gene (either kanR or cmR) into the his operon of 
pNK81 and then infecting a strain harboring one of these plasmids with λNK1039, which 
also contains the his operon. Antibiotic resistant lysogens from the above crosses were 
selected by replica plating and subsequently phage released from the lysogens were 
purified, giving rise to λDBH849 (IS50-lacZ-kanR TCF), λDBH888 (IS50-lacZ-CmR 
TCF) and λDBH812 (IS50-lacZ-KanR TLF). 
E. coli strains for the mating out assay were constructed by P1 transduction of 
Tn5 from ER2507 (NEB) into DBH33 and DBH259. Strains containing chromosomal 
IS50-lacZ fusions were generated by lysogenizing DBH107 with λDBH849 (DBH265), 
λDBH888 (DBH303) or λDBH812 (DBH281). Mutant derivatives of these strains were 
generated by P1 transduction. A list of all of the strains, plasmids and bacteriophage used 
in this work is presented in Table 4.1. 
4.4.2 Mating out assay 
Conjugal mating out experiments were performed essentially as described for single-copy 
chromosomal transposons in Ross et al (2010), except that donor growth was carried out 
in M9 glucose media supplemented with kanamycin (25 mg/mL) and amino acids, 
instead of LB. DBH13 was used as the recipient. Total exconjugants and transposition 
events with DBH179 and derivatives were scored by plating mating mixes on M9 
Glucose plates supplemented with leucine, thiamine and streptomycin (150 mg/mL) or 
streptomycin and kanamycin (25 mg/mL), respectively. Total exconjugants and 
transposition events with DBH261 and derivatives were scored by plating mating mixes 
on M9 Glucose plates supplemented with leucine, thiamine, streptomycin (150 mg/mL) 
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and gentamycin (12.5 mg/mL) or streptomycin, gentamycin and kanamycin (25 mg/mL), 
respectively. 
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Table 4.1. List of E. coli strains, plasmids and phage used in this study. 
Strain or 
Plasmid 
 
E. coli 
DBH13 
 
ER2507 
DBH179 
DBH184 
DBH270 
DBH228 
DBH233 
 
DBH259 
DBH261 
DBH271 
DBH272 
DBH55 
 
DBH124 
DBH107 
DBH265 
DBH267 
DBH268 
DBH281 
DBH283 
DBH285 
DBH303 
DBH306 
DBH307 
DBH315 
DBH33 
DBH16 
DBH241 
DBH238 
DBH239 
DBH240 
DBH208 
DBH210 
DBH237 
TM338 
 
TM618 
 
DH5α 
 
Plasmids 
pWKS30 
 
pDH700 
pDH701 
pDH713 
pDH533 
 
Relevant genotype 
 
 
 
HB101 [F- leu- pro-]; StrR 
 
zjc::Tn5; KanR 
NK5830 [recA- arg-  / F’ lacpro+] zjc::Tn5; KanR 
DBH179 hfq-1::Ωcat; KanRCmR  
DBH179 dam::Tn9cat; KanRCmR 
RZ211/pOX38Gen 
HW-5 [phoA4(Am) his-45 recA1 rpsL99 met-54 F-]; 
StrR 
DBH233 / pOX38Gen; StrRGenR 
DBH259 zjc::Tn5; StrRGenRKanR 
DBH261 hfq-1::Ωcat; StrRGenRKanRCmR 
DBH261 dam::Tn9cat; StrRGenRKanRCmR 
DH10B / pOX38Gen miniTn5lactetR; TetR 
 
DBH55 hfq-1::Ωcat; TetRCmR 
MC4100 [F- Δ(argF-lac)169* rpsL150]; StrR 
DBH107/λDBH849; StrRKanR 
DBH265 hfq-1::Ωcat; StrRCmRKanR 
DBH265 dam::Tn9cat; StrRCmRKanR 
DBH107/λDBH812; StrRKanR 
DBH281 hfq-1::Ωcat; StrRCmRKanR 
DBH281 dam::Tn9cat; StrRCmRKanR 
DBH107/λDBH888; StrRCmR 
DBH303 Δhfq722::kan; StrRCmRKanR 
DBH303 Δcrp765::kan; StrRCmRKanR 
DBH303 Δlrp787::kan; StrRCmRKanR 
NK5830 [recA- arg-  / F’ lacpro+] 
DBH33 hfq-1::Ωcat; CmR 
DBH33 dam::Tn9cat; CmR 
DBH33/λDBH849; KanR 
DBH238 hfq-1::Ωcat; KanRCmR 
DBH238 dam::Tn9cat; KanRCmR 
DBH33/λDBH812; KanR 
DBH208 hfq-1::Ωcat; KanRCmR 
DBH208 dam::Tn9cat; KanRCmR 
W3110mlc rne-Flag-cat; rifSCmR 
 
W3110mlc rne-Flag-cat Δhfq; rifSCmR 
 
recA-  
 
 
pSC101-derived; low copy-number ori ; ApR 
 
pWKS30-P3-hfqWT ; ApR 
pWKS30-P3-hfqK56A ; ApR 
pWKS30-P3-hfqY25A ; ApR 
pUC18-derivative; Tn5 t’ase M56A; ApRCmR 
 
Use 
 
 
 
Mating out recipient 
 
Source of zjc::Tn5 
Mating out donor 
Mating out donor 
Mating out donor 
Source of pOX38Gen 
Parent strain 
 
Parent strain 
Mating out donor 
Mating out donor 
Mating out donor 
Papillation Assay  
 
Papillation Assay 
Parent strain 
Miller Assay 
Miller Assay 
Miller Assay 
Miller Assay 
Miller Assay 
Miller Assay 
Miller Assay 
Miller Assay 
Miller Assay 
Miller Assay 
Parent strain 
Parent strain 
Parent strain 
Miller Assay 
Miller Assay 
Miller Assay 
Miller Assay 
Milller Assay 
Miller Assay 
RNA half-life 
measurements 
RNA half-life 
measurements 
Plasmid propagation 
 
 
‘Empty vector’ for 
Hfq expression 
HfqWT expression 
HfqK56A expression 
HfqY25A expression 
Source of Tn5 
transposase (No Inh.) 
Source or reference 
 
 
 
(Bolivar & Backman, 
1979) 
NEB 
This study 
This study 
This study 
(Cuzon et al, 2011) 
(Hoffman & 
Wilhelm, 1970) 
This study 
This study 
This study 
This study 
(Whitfield et al, 
2009) 
This study 
(Casadaban, 1976) 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
(Foster et al, 1981) 
(Ross et al, 2010) 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
(Morita et al, 2004) 
 
(Morita et al, 2005) 
 
Invitrogen 
 
 
(Wang & Kushner, 
1991) 
(Ross et al, 2013) 
(Ross et al, 2013) 
(Ross et al, 2013) 
(Whitfield et al, 
2009) 
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pDH752 
pDH828 
pNK81 
pDH682 
pDH838 
pDH883 
pDH849 
 
pDH888 
 
pDH658 
pDH795 
 
pDH804 
pDH812 
 
pDH753 
 
pDH798 
pDH763 
 
pDH764 
 
pDH895 
 
pDH766 
 
pDH768 
 
pDH772 
 
 
Phage 
λNK1039 
λDBH812 
 
λDBH849 
 
λDBH888 
pDH533 with t’ase mutated to G53A,C61A; ApRCmR 
pDH533 with t’ase mutated to D97A; ApRCmR 
pBR333-derivative; encodes his operon; ApR 
pUC18-derivative; IS50-lacZ TCF; ApR 
pDH682-derivative; TCF ‘marked’ with kanR 
pDH682-derivative; TCF ‘marked’ with cmR 
TCF-kanR from pDH682 cloned into BclI-cut 
pNK81; ApRKanR 
TCF-cmR cloned onto BclI-cut pNK81; ApRCmR 
 
pRZ9905-derivative; full-length IS50-lacZ TLF; ApR 
pDH658-derivative; ‘deletion’ TLF used in this 
study; ApR 
pDH795-derivative; TLF ‘marked’ with kanR 
TLF-kanR cloned into BclI-cut pNK81; ApRKanR 
 
pWKS30-derivative; contains IS50-lacZ TLF from 
pDH658; ApR 
pDH753-derivative; ApSKanR 
pBR-plac; ApR 
 
pBR-plac-sgrSWT; ApR 
 
pBR-plac-sgrS1; ApR 
 
pBR-plac-rybB; ApR 
 
pBR-plac-micC; ApR 
 
pBR-plac-ryeB; ApR 
 
 
 
Encodes his operon 
IS50-lacZ translational fusion (TLF) from pDH812 
marked with kanR 
IS50-lacZ transcriptional fusion (TCF) marked with 
kanR 
IS50-lacZ transcriptional fusion (TCF) marked with 
cmR 
 
 
 
 
Dam-insensitive t’ase 
Catalytic- t’ase 
Lambda crosses 
Source of TCF 
Parent of pDH849 
Parent of pDH888 
For crossing TCF 
onto λ 
For crossing TCF 
onto λ 
Parent of pDH795 
Parent of pDH804 
 
Parent of pDH812 
For crossing TLF 
onto λ 
Parent of pDH798 
 
Miller Assay 
Vector for sRNA-
induction 
SgrS-induction 
 
SgrS1-induction 
 
RybB-induction 
 
MicC-induction 
 
RyeB-induction 
 
 
 
Parent phage 
Chromosomal TLF 
construction 
Chromosomal TCF 
construction 
Chromosomal TCF 
construction 
This study 
This study 
(Way et al, 1984) 
This study 
This study 
This study 
This study 
 
This study 
 
This study 
This study 
 
This study 
This study 
 
This study 
 
This study 
(Guillier & 
Gottesman, 2006) 
(Vanderpool & 
Gottesman, 2004) 
(Wadler & 
Vanderpool, 2009) 
(Mandin & 
Gottesman, 2010) 
(Mandin & 
Gottesman, 2010) 
(Mandin & 
Gottesman, 2010) 
 
 
(Haniford et al, 1989) 
This study 
 
This study 
 
This study 
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4.4.3 Papillation assay 
Isogenic hfq+/- strains (DBH55 and DBH124) encoding mini-Tn5 lac tetR on the F’ were 
transformed with plasmids encoding either WT IS50 transposase (pDH533), a 
catalytically ‘dead’ transposase (pDH828) or a Dam-insensitive transposase (pDH752). 
Transformants were selected on MacConkey agar plates supplemented with lactose (1% 
w/v) and ampicillin (100 mg/mL). Plates were incubated at 37˚C for up to 6 days.  
4.4.4 β-galactosidase assays 
Cells were grown in M9 glucose (with arginine and thiamine) or LB. In situations where 
strains contained plasmids, plasmids were maintained by including the appropriate 
antibiotic. Overnight cultures (0.05 mL) were used to seed subcultures (1.5 mL), which 
typically were grown to mid-log phase before being processed for the Miller assay as 
previously described (Ross et al, 2010).  
4.4.5 RNA isolation, primer extension and Northern blot analysis 
Total RNA was isolated essentially as described in (Garrey & Mackie, 2011). For steady-
state analysis, cells were grown to mid-log phase in LB before RNA isolation. For half-
life analysis, rifampicin (dissolved in DMSO) was added to cell cultures (to 200 µg/mL) 
to arrest transcription and RNA was isolated immediately before and after rifampicin 
addition at the indicated time intervals. Primer extension analysis was carried out using 
32P-labeled primers oDH230 or oDH231, end-labeled with OptiKinase (USB) according 
to manufacturer’s instructions. Extension reactions used 5 µg of RNA, and Superscript III 
reverse transcriptase essentially as described in (Wilkinson et al, 2006), except that 
annealing was performed at 65°C (with no ice treatment) before extending at 55°C for 45 
minutes. Extension products were resolved on a 6% denaturing polyacrylamide gel. For 
Northern blot analysis, 2 µg of RNA was mixed with an equal volume of denaturing load 
dye (95% deionized formamide [v/v], 10 mM EDTA, 0.5x TBE, 3% xylene cyanol 
[w/v]), heated to 95°C for 2 minutes, and resolved on a 6% polyacrylamide gel 
containing 7 M urea. Separated RNAs were electro-transferred to Hybond N (GE 
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Healthcare) in 0.5x TBE and fixed with UV. Annealing and washing was performed in 
ULTRAhyb buffer (Ambion) according to the manufacturer’s instructions, using RNA 
probes complimentary to SgrS or the 5S rRNA (internal standard). To construct the 
radiolabeled RNA probes, DNA templates for in vitro transcription were made by PCR 
with primers oDH232/233 (SgrS) and oDH234/235 (5S rRNA)—note that, for each 
primer pair, the forward primer includes the T7 core promoter. These templates were 
transcribed in vitro in the presence of 32P-UTP to generate uniformly labeled RNA 
probes. In vitro transcription reactions were performed in 25 µL volumes with ~ 1 µg 
DNA template, 1x T7 RNA polymerase buffer (NEB), 20 units RNasin (Promega), 4 mM 
DTT, 0.16 mg/mL BSA, 0.4 mM each of rGTP, rCTP and rATP, 0.01 mM rUTP, 50 µCi 
[α-32P]UTP, and 100 units of T7 RNA polymerase. 
4.4.6 Western blot 
Cells were centrifuged (2 minutes at 21,000 x g), resuspended in SDS load mix (2% 
[w/v] SDS, 10% [v/v] glycerol, 50 mM Tris-HCl pH 6.8, 0.25% [w/v] bromophenol blue, 
0.8 M β-mercaptoethanol) and heated at 95°C for 5 minutes. To normalize for differences 
in growth between the various samples, the OD600 of each sample was measured and the 
volume spun normalized to give an equivalent to OD600 ≈ 0.35. The resulting lysates were 
subjected to SDS-PAGE on a 12% polyacrylamide gel, proteins transferred to PVDF 
(Roche) and Crp was detected by Western blot with a polyclonal rabbit anti-Crp antibody 
(kind gift of H. Aiba). The primary antibody was diluted 1:20,000 in TBST; the 
secondary antibody (anti-rabbit IgG-HRP conjugate; Promega) was used at 1:5000. Crp 
was visualized with a Pierce ECL 2 Western blotting substrate (Thermo Scientific) and 
PhosphorImager. The membranes were stripped and GroES detected (rabbit anti-GroES 
antibody from Sigma-Aldrich at 1:10,000) for use as an internal standard; GroES is not 
sensitive to hfq status (Guisbert et al, 2007). Bands were quantified (ImageQuant) and 
Crp levels plotted relative to GroES. 
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Chapter 5  
5 General Discussion 
The work presented in this thesis expands on the knowledge of host-factor involvement 
in transposition, establishes host-imposed post-transcriptional regulation as a mechanism 
for potent repression of transposition, and investigates transposon mobilization during 
stress-response. I show that the global post-transcriptional regulator Hfq plays a 
previously unknown role as a negative regulator of two separate transposons, and that this 
regulation is imposed at the level of transposase expression. In the case of Tn10/IS10, 
Hfq down-regulates transposase expression at the post-transcriptional level. Conversely, 
Hfq down-regulates Tn5/IS50 transposase expression at the transcriptional level, possibly 
through the Crp regulon. Finally, investigation of Hfq-dependent sRNAs as mediators of 
stress-response pathways led to the finding that nutrient starvation activates IS50 
transposase transcription and stimulates Tn5 mobility, linking the Tn5 system to this 
form of environmental stress for the first time. My insights into the regulation imposed 
on Tn10 and Tn5 transposase expression by Hfq and Crp are summarized in Figure 5.1. 
In this section, I further discuss the general implications of linking mobility of 
transposable elements to the global regulatory protein Hfq, which is also central to many 
pathways for bacterial stress-response. 
5.1 Transposase expression is a major point of host-
imposed regulation 
It is beneficial to a given transposon to mobilize frequently enough to be maintained 
without unnecessarily harming the host cell by causing destructive levels of genomic 
instability. This evolutionary pressure has resulted in tight negative control of 
transposons. Transposase proteins catalyze the chemical steps in bacterial transposition 
reactions. It follows that the regulation of expression of these genes is a critical feature in 
dictating the transposition frequency of most transposons (Kleckner, 1990). The 
endogenous promoters of bacterial transposase genes are typically transcribed 
inefficiently. Examples include IS10 (Simons and Kleckner, 1983), IS21 (Reimmann et  
180 
 
 
?SNutrient Starvation
Hfq
Crp
cAMP
cAMP-Crp
OE IS50OE IS10
pIN
pOUT
p1
Transcription
5‘T1:5‘RNA-IN:
Hfq
**TIR
?sRNA?
Hfq
Destabilizes?
Antisense Pairing
5‘ 3‘
RNA-OUT
5‘ 3‘
RNA-IN
AUG*
*SD
5‘
3‘
3‘
5‘
*
*SD
AUG
5‘
3‘
5‘
3‘
5‘
3‘
**
SD
AUG
5‘ 3‘** AUGSD
- Hfq + Hfq
RNA Folding
?
181 
 
Figure 5.1. Summary of major insights into host-imposed regulation of Tn10/IS10 
and Tn5/IS50 gained in this work. 
Dashed lines indicate unverified potential points of regulation. Green and red arrows 
indicate positive and negative regulation, respectively. The IS10 and IS50 transposase 
promoters may be transcribed by RNAP-σS during starvation (and other forms of stress). 
Hfq is expected to be required for efficient translation of σS (and therefore starvation-
induced transcription of transposase); however, starvation experiments were not 
conducted in an hfq- strain for technical reasons. Hfq positively regulates Crp (probably 
at the post-transcriptional level) while Crp-cAMP negatively regulates hfq transcription 
(Lin et al., 2011), completing a regulatory feedback loop. Crp negatively regulates 
expression of IS50 transposase, either directly or via some other component of the Crp 
regulon. Through Crp, Hfq negatively regulates IS50 transposase transcription. Hfq also 
exerts a small regulatory effect on IS50 transposase mRNA (T1) stability. Hfq negatively 
regulates IS10 transposase expression at the post-transcriptional level. Hfq might act 
indirectly on the transposase mRNA (RNA-IN) via an unknown component of the Hfq 
regulon, or it might act directly to block translation initiation (with or without an sRNA 
partner). Hfq also enhances antisense regulation by RNA-OUT. This probably entails 
increasing the rate of initial RNA-IN/OUT interaction by binding both species and 
increasing their relative local concentrations. Hfq can also restructure both RNA-IN and 
RNA-OUT (at least in vitro), revealing the appropriate sequences in each species to 
maximize the number of inter-molecular base pairs that can form in a minimal amount of 
time (i.e. without requiring the intra-molecular base pairs to melt spontaneously). A 
summary of the predicted structures of RNA-IN and RNA-OUT, as well as their base 
pairing interaction, is highlighted in green and red for the absence versus presence of 
Hfq, respectively. Increased antisense pairing will yield less translation of transposase 
and thus, less frequent transposition. The TIR is denoted by asterisks representing the 
Shine-Dalgarno (SD) sequence and the AUG codon.  
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al., 1989), IS30 (Dalrymple and Arber, 1985) and IS911 (Duval-Valentin et al., 2001). 
Host-encoded factors can also be co-opted to facilitate repressive mechanisms. There are 
at least two host proteins known to limit Tn5 transposase expression. The IS50 
transposase promoter contains sequences for Dam methylation that overlap the -10 
sequence; when fully methylated, transcription initiation is repressed (Yin et al., 1988). 
The same mechanism is used for IS10 and IS903. LexA, a transcriptional repressor of the 
SOS regulon, has also been implicated in repressing IS50 transposase expression, with 
modest increases in transposase transcription and Tn5 transposition in a lexA-deficient 
strain (Kuan and Tessman, 1991; Kuan et al., 1991). As described in Chapters 2 and 4, 
the impact of Hfq on transposase expression in the Tn10 and Tn5 systems is greater than 
that of either Dam methylase or LexA. Notably, these are the first instances in which a 
host-factor involved in post-transcriptional regulation has been implicated in transposon 
mobility. Based on the magnitude of the transposition increase seen in hfq-null strains, 
Hfq is the strongest host-encoded repressor of Tn10 or Tn5 transposition described to 
date. As discussed below, Hfq exerts this negative regulation via multiple mechanisms, 
including post-transcriptional regulation (through both an antisense dependent and 
independent pathway) for Tn10/IS10 and transcriptional regulation (possibly involving 
the Crp regulon) for Tn5/IS50.  
5.2 Post-transcriptional regulation of Tn10/IS10 
transposase expression 
Intrinsic mechanisms for post-transcriptional transposon regulation have been well 
established (reviewed in Nagy and Chandler, 2004). For instance, Tn10 and Tn5 (and 
probably other transposons) encode DNA sequences that protect them from readthrough 
transcription by forming translationally repressive secondary structures only in the 
context of mRNA expressed from an exogenous promoter (Davis et al., 1985; Krebs and 
Reznikoff, 1986). In the case of Tn10/IS10 (and a few others, e.g. IS30), a transposon-
encoded antisense RNA blocks translation initiation by sequestering the TIR in base-
pairing interactions between perfectly complementary regions of the asRNA and 
transposase mRNA (Arini et al., 1997; Ma and Simons, 1990). However, my work 
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constitutes the first demonstration that a bacterial host factor has been co-opted to help 
impose translational silencing of a transposase.  
5.2.1 Hfq participates in regulation by a cis-encoded antisense 
RNA 
Genetic evidence in Chapter 2 suggests that Hfq down-regulates IS10 transposase 
translation, in large part, by enhancing antisense regulation by RNA-OUT. The 
magnitude of repression of transposition by Hfq appears to correlate with the expected 
levels of RNA-OUT-imposed negative regulation (i.e. the higher the IS10 copy number, 
the larger the de-repression when hfq is disrupted). Further evidence in Chapters 2 and 3 
suggests that Hfq functions in the RNA-IN/OUT system in analogous fashion to its 
canonical role in sRNA/mRNA systems. To this point the general perception has been 
that, due to the perfect complementarity between cis-asRNAs and their targets, the 
regulatory function of asRNAs will not be dependent on Hfq (Waters and Storz, 2009). In 
the case of RNA-OUT, and other systems, the presence of base pairing discontinuities in 
structured regions of asRNAs has been shown to be critical for antisense regulation, 
likely because they provide a thermodynamic incentive for breaking intra-molecular base 
pairs (e.g. 23 in RNA-OUT) in order to form inter-molecular base pairs (e.g. 35 between 
RNA-IN and RNA-OUT) (see Chapter 3 and Wagner et al., 2002). Nevertheless, it is 
unclear if these discontinuities are sufficient for a robust antisense response in vivo. 
RNA-OUT, for instance, forms a stable secondary structure (see Chapter 3 and Case et 
al., 1989), and we also show in this work that RNA-IN possesses secondary structure that 
could impede RNA-IN/OUT pairing. Though it might be favourable to melt these 
structures in order to allow extensive base pairing between RNA-IN and RNA-OUT, it is 
conceivable based on the results in Chapter 3 that Hfq would enhance the rate and/or 
stability of antisense regulation by bringing RNA-IN and RNA-OUT into close proximity 
(to enhance the rate of initial interaction) as well as to increase the number of unpaired 
bases in the IN/OUT pairing region of each RNA. In this regard, it will be interesting to 
see if the effectiveness of other antisense systems shows any reliance on Hfq. Hfq has 
been shown to function in one other antisense system by stabilizing the asRNA (GadY), 
but it was not determined if Hfq played any role in antisense pairing (Opdyke et al., 
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2004). My work represents the first report of binding determinants and other mechanistic 
insights into Hfq-aided base pairing in a classical antisense system. Overall, Hfq treats 
the mRNA and asRNA components of this system like a canonical mRNA/sRNA system. 
The demonstration that Hfq can play an active remodeling role for both the mRNA and 
asRNA (at least in vitro) in order to facilitate pairing supplements the existing sRNA 
literature, in which only a few such examples have been investigated (Geissmann and 
Touati, 2004; Soper et al., 2011).  
This work raises the possibility that Hfq participates in antisense regulation of 
other transposition systems, as well as other antisense regulatory systems in general. 
Notably, genome-wide RNA sequencing has begun to shed light on the quantity and 
diversity of cis-antisense RNAs in the bacterial genome. For instance, a recent study in E. 
coli used deep sequencing of double-stranded RNAs—on the basis that functional 
asRNAs should base pair to their cognate target—to identify 316 potentially functional 
asRNAs expressed from the E. coli genome. These putative asRNAs were further 
characterized based on their location relative to annotated genes; most were found to be 
encoded opposite the 5’ end of mRNAs, but several were also found opposite 3’ ends, 
non-coding RNAs and gene junctions (Lybecker et al., 2014). A role for Hfq in 
regulation by cis-encoded asRNAs would thus greatly expand the already extensive 
repertoire of this highly pleiotropic regulator. 
5.2.2 Hfq can silence IS10 transposase expression by an 
antisense-independent pathway 
Genetic evidence presented in Chapter 2 also indicates that Hfq can post-transcriptionally 
repress transposase expression independently of antisense regulation: hfq-disruption still 
caused increased transposition and transposase translation—albeit with a reduced 
magnitude—when the asRNA was either destabilized or titrated. Since hfq deficiency 
caused no significant increase in steady-state levels of transposase mRNA as measured 
by semi-quantitative RT-PCR (Chapter 2) or RT-qPCR (R. Trussler, unpublished data), it 
does not appear that this alternative pathway for repression involves destabilization of the 
transposase mRNA. I have not investigated this antisense-independent mechanism of 
repression in this thesis, but I discuss here the formal possibilities.  
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 Given the large number of Hfq-regulated proteins (Ansong et al., 2009), it is 
possible that repression of transposase translation is indirect, resulting from Hfq-
regulation of an unknown factor that itself regulates translation of RNA-IN. For instance, 
Hfq might activate (or repress) the expression of some translational repressor (or 
enhancer). In this regard, Hfq has been shown to regulate components of the translational 
machinery. For example, several ribosomal proteins including RpsM, RpsG, RpmD, and 
RplN exhibit a marked reduction in protein levels under conditions of Hfq-deficiency in 
Salmonella enterica. Moreover, Hfq was shown to down-regulate expression of 11 
aminoacyl-tRNA synthetases at the post-transcriptional level (Ansong et al., 2009). It has 
also been proposed that Hfq might compete with the ribosomal protein S1 for binding to 
some mRNAs, as both proteins bind similar A/U-rich sequences (Hajnsdorf and Boni, 
2012; Hook-Barnard et al., 2007). Reduced S1-binding due to competition with Hfq 
would be expected to reduce the efficiency of translation initiation.  
On the other hand, Hfq could still play a direct role in transposase repression that 
involves regulation by a trans-encoded sRNA. There are many non-coding RNAs in E. 
coli. Given the fact that sRNAs can have multiple mRNA targets (due to their ability to 
impose efficient regulation via imperfect base pairing along short stretches or ‘seed 
regions’) (Lease et al., 1998; Repoila and Darfeuille, 2009), it is conceivable that at least 
one Hfq-dependent sRNA fortuitously contains enough sequence complementarity to 
repress transposase expression. This possibility is supported by a bioinformatics search 
using the program INTARNA, which revealed several sRNAs that might base pair to the 
IS10 mRNA; however, base pairing between RNA-IN and several of these sRNAs was 
not verified in vitro (Smith et al., 2010; Munshaw, 2012). Either indirect regulation or 
sRNA-based regulation of transposase translation by Hfq is consistent with the 
observation that both proximal and distal-impaired mutants of Hfq were unable to repress 
IS10 transposition in vivo (Chapter 3).   
 Alternatively, Hfq has been shown to directly interfere with ribosome binding and 
translation initiation of some messages. Little is known about this form of regulation 
other than that it requires Hfq to bind the mRNA near the TIR (Desnoyers and Masse, 
2012; Salvail et al., 2013). Preliminary evidence shows that Hfq can efficiently interfere 
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with a 30S ribosome ‘toeprint’ of RNA-IN in vitro (M. Ellis, unpublished data), strongly 
suggesting that Hfq can act independently of antisense regulation, at least in part, by 
directly interfering with translation initiation. Analysis is currently underway to 
determine which of the Hfq-binding sites identified in Chapter 3 are important for this 
form of repression in vitro and in vivo. This raises the possibility that Hfq can directly 
interfere with translation of transposase in other transposition systems. Most transposons 
lack antisense regulatory systems and direct translational repression provides a means by 
which Hfq could regulate these elements. Notably, transposase genes tend to have 
suboptimal Shine-Dalgarno (SD) sequences (Jain and Kleckner, 1993; Krebs and 
Reznikoff, 1986). As guanine is the nucleotide that is least amenable to Hfq-binding 
(Link et al., 2009; Sauer and Weichenrieder, 2011), deviations from the consensus SD (5’ 
AGGAGGU in E. coli) (Shine and Dalgarno, 1974) would tend to bind more tightly to 
Hfq. One intriguing possibility is that the deviations that make transposase SD sequences 
less optimal for translation also make these sequences into better Hfq-binding sites, 
linking suboptimal translation with Hfq-imposed repression. 
In the case of Tn10/IS10, multiple mechanisms of repression could be relevant to 
two opposing situations in vivo. When the transposon is present in the chromosome (in 
single copy), RNA-OUT levels are low and regulation by the mci pathway is negligible. 
However, given the high affinity of Hfq for the 5’ region of RNA-IN (Chapter 3), Hfq 
would still be an effective repressor of transposition in single copy by interfering with 
translation initiation. If the element transposes into a multi-copy plasmid, RNA-OUT and 
Hfq cooperate to ensure that transposition per copy stays low, thus avoiding detrimental 
effects of increased transposition on the host. Antisense regulation becomes more potent 
as the copy number of Tn10/IS10 increases. Recall that Hfq actively cycles on sRNAs, 
such that sRNA concentration in the cell is the primary determinant of which RNAs bind 
to the proximal surface of Hfq at a given time (Fender et al., 2010; Hussein and Lim, 
2011; Moon and Gottesman, 2011; Wagner, 2013). It follows that Hfq would more 
efficiently facilitate RNA-IN/OUT pairing (and thus, more potently repress transposition) 
as the copy number of Tn10/IS10 increases within a given cell.        
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5.3 Transcriptional regulation of Tn5/IS50 transposase 
expression 
Hfq regulation in the Tn5/IS50 system appears to be exercised primarily at the level of 
transcription initiation (Chapter 4), although an extensive search of the literature 
confirmed that Hfq is not expected to directly repress transcription. In the search for a 
transcriptional repressor or activator of IS50 transposase transcription that is itself 
regulated by Hfq, I found that Crp repressed transcription to a similar degree as Hfq. 
Further work showed that Hfq is a positive regulator of Crp protein levels. While it was 
already known that Crp-cAMP can negatively regulate hfq expression (Lin et al., 2011), 
this was the first demonstration in E. coli that Hfq also positively regulates Crp 
expression, thus completing a self-regulatory feedback loop. It has been shown in 
Yersinia pestis that Hfq positively regulates crp expression at the post-transcriptional 
level (Lathem et al., 2014). As Crp-cAMP levels increase in stationary phase (as glucose 
is depleted), one consequence of this regulatory loop could be the slight reduction in Hfq 
levels that has been reported upon entry into stationary phase (Ali Azam et al., 1999).  
 Interestingly, this is not the first time that Hfq has been shown to play a role in 
catabolite repression. In Pseudomonas putida, Hfq was shown to cooperate with a post-
transcriptional regulatory protein (Crc) which silences translation of target mRNAs as a 
component of catabolite repression. Evidence suggests that Hfq recruits Crc to the ‘CA’ 
motif in the 5’ UTR of targeted genes (Moreno et al., 2014). While my data strongly 
suggest that Hfq and Crp act in the same pathway to repress IS50 transposase 
transcription, they do not rule out the possibility that Hfq can act independent of Crp to 
exert some negative regulation on transcription. Nonetheless, I note that Hfq-regulation 
of Tn5/IS50 transposition requires both the canonical sRNA- and mRNA-binding 
surfaces to be intact (Chapter 4), which is entirely consistent with Hfq regulating 
transposase expression via Crp if Hfq regulates Crp post-transcriptionally.  
5.4 Hfq might be a general repressor of mobile DNA 
This thesis has established that Hfq is a potent negative regulator of at least two 
transposition systems, Tn10 and Tn5. Preliminary data indicate that Hfq represses 
188 
 
transposase expression in two additional systems, IS200 (R. Trussler, unpublished data) 
and IS1413 (Munshaw, 2012). Furthermore, a bioinformatics search for Hfq-binding 
sequences corresponding exactly to the 5’ AAYAAYAA motif—which is known to 
confer tight Hfq-binding affinity (Lorenz et al., 2010)—revealed several IS elements 
encoding such sequences, suggesting that Hfq can tightly bind the mRNA of other 
transposases (Munshaw, 2012). Hfq might also repress other forms of mobile DNA. For 
instance, Hfq is also a negative regulator of F-plasmid transfer in E. coli. In this case, Hfq 
destabilizes the transcripts encoding TraJ and TraM, which are encoded by the E. coli F 
factor and important for positive regulation of the F-encoded transfer genes (Will and 
Frost, 2006).  
 Given that Hfq can apparently down-regulate mobility directly (e.g. RNA-
IN/OUT pairing; destabilizing traJ and traM transcripts; probably interfering directly 
with IS10 transposase translation) or indirectly (e.g. Tn5 transposase transcription via the 
Crp regulon), it seems likely that Hfq will be revealed as an important host factor for 
regulating other mobile genetic elements. Since Hfq is present in roughly half of 
proteobacterial species and these Hfq homologues tend to have similar structure and 
function (Sun et al., 2002), these findings raise the intriguing possibility that mobile 
genetic elements can be subject to post-transcriptional or other Hfq-mediated silencing 
mechanisms in many bacterial species. These findings provide a link between bacterial 
post-transcriptional regulation and silencing of mobile genetic elements—an interesting 
link, given that eukaryotic RNAi may well have evolved to perform a similar function.  
It is tempting to speculate that Hfq provides a general means of silencing 
‘foreign’ DNA, allowing the bacteria to gradually integrate the invaders into existing E. 
coli regulatory networks. Could one of its original functions have been to repress 
expression of mobile DNA? It has been proposed that H-NS acts in Gram-negative 
bacteria to generally repress incoming ‘foreign’ DNA at the transcriptional level; the 
phenomenon is dubbed ‘xenogeneic silencing’ (reviewed in Ali et al., 2012). It is 
hypothesized that the identifier of foreign DNA is A/T-richness (Gordon et al., 2011; 
Navarre et al., 2006). Along these lines, Hfq preferentially binds A/U-rich RNA and this 
binding tends to lead to enhanced turnover and/or translational silencing. 
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5.5 Bacterial stress-response is linked to transposon 
mobility 
It has been proposed that mobile genetic elements are sensitive to the environmental 
conditions of their hosts. Perhaps the oldest and best-characterized example of 
mobilization due to external stress is the bacteriophage lambda (λ), which responds to 
stress stimuli by virtue of the ‘λ-switch’. There are two possible outcomes when lambda 
injects its DNA into E. coli. In one scenario (lysogeny), only the repressor gene is 
expressed. The repressor protein activates transcription of the repressor gene in a positive 
feedback loop, even as it down-regulates expression of the remaining fifty phage genes. 
The bacteria multiply as usual, and the phage DNA (present in the bacterial chromosome) 
replicates passively as the bacteria divide. Lysogeny is perpetuated over many 
generations of the host cell until a signal (e.g. UV light) inactivates repressor, switching 
the phage to the lytic phase. Expression of the repressor gene is down-regulated while the 
previously silenced phage genes are expressed. Lambda DNA replicates rapidly, its 
structural proteins are produced and the bacterium is destroyed, releasing a new crop of 
phage (reviewed in Ptashne, 2011).  
I show in Chapter 4 that IS50 transposase expression and Tn5 transposition 
increase in response to glucose starvation, and I speculate that this might be mediated 
through the stationary phase sigma factor (σS). Glucose starvation is known to induce 
expression as well as stabilization of σS (Mandel and Silhavy, 2005). Both σS and σ70 
recognize similar promoter sequences, but σS is more tolerant of sequence variations 
from the consensus (Landini et al., 2014). The IS50 transposase promoter matches 
somewhat poorly to the consensus sequence of σ70 and σS, so it is possible that certain 
deviations would be better tolerated by σS. In particular, the IS50 promoter matches 
poorly to the -35 consensus sequence, which is more important for σ70 than σS 
recognition. Additionally, a guanine at the -14 position (where the first nucleotide of the -
10 hexamer is arbitrarily designated -12) is a distinguishing feature of σS promoters 
(Landini et al., 2014) and there is a guanine at this position in the IS50 transposase 
promoter. It follows that if the IS50 transposase promoter is better suited for σS-bound 
RNA polymerase (RNAP), an imbalance in σS to σ70 would increase expression from this 
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promoter during glucose starvation or growth in deep stationary phase. If this is true, then 
glucose starvation might not be the only nutrient deficiency that triggers transposase 
expression. For instance, during the stringent response, amino acid starvation triggers 
production of (p)ppGpp. The region between the -10 element and the transcriptional start 
nucleotide (in particular the -3 to +1 bases) is called the ‘discriminator’ since its 
nucleotide composition affects sensitivity to (p)ppGpp, which favours transcription by 
alternative sigma factors (Condon et al., 1995; Magnusson et al., 2005; Travers, 1980). 
One difference between the promoters preferentially transcribed in vitro by RNAP-σS is 
higher A/T content in the discriminator, while promoters more efficiently transcribed by 
RNAP-σ70 tend to be have G/C-dinucleotides (Maciag et al., 2011). A G/C-rich 
discriminator is a signature of promoters negatively affected by (p)ppGpp (Zacharias et 
al., 1989), in agreement with its role as a selective inhibitor of transcription by RNAP-σ70 
during amino acid starvation (Bernardo et al., 2006). The IS50 transposase promoter has 
50% G/C content in this -3 to +1 region, suggesting it would not be strongly repressed 
during the stringent response. In terms of the aforementioned attributes for discrimination 
of σ70 versus σS recognized promoters, the promoters for IS50 and IS10 transposase are 
very similar. Notably, an experiment showed that IS10 transposition increased roughly 
tenfold when E. coli cells were grown to a deep stationary phase, but this increase was 
not seen in rpoS- cells, suggesting that IS10 transposase is transcribed at increased levels 
by RNAP-σS during starvation (Munshaw, 2012).  
 Hfq and Crp are also important for responding to fluctuations in environmental 
conditions. Crp is activated by cAMP when glucose levels are low, leading to 
transcriptional activation or repression of many genes involved in carbon usage (e.g. 
activates expression of the lac operon) (reviewed in Busby and Ebright, 1999; Kolb et al., 
1993). Hfq-dependent regulation during stress-response is exercised via several 
pathways. For instance, indirect regulation results from enhanced translation efficiency of 
the rpoS mRNA encoding σS (Muffler et al., 1996; Muffler et al., 1997), the down-
regulation of σE-mediated envelope stress response (Figueroa-Bossi et al., 2006; Guisbert 
et al., 2007) and the maintenance of σH-mediated cytoplasmic stress response (Guisbert et 
al., 2007). As previously discussed, the regulation of many genes depends on the 
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differential induction of Hfq-dependent sRNAs during specific stress responses. As 
regulators of transposons and integral factors in responding to changes in growth 
conditions, Hfq and Crp may provide a link between environmental stimuli and 
transposition rates.  
There are relatively few examples demonstrating the direct impact of 
environmental stimuli on transposition. For example, transcription of the transposase 
genes of various IS elements is increased in response to high levels of certain metals, 
resulting in metal tolerance (Brocklehurst and Morby, 2000) and Mu has been implicated 
in transposon-based adaptive mutations by forming araB-lacZ fusions in nutrient-starved 
cultures (Casadaban, 1976; Shapiro, 1997). There are also few examples of host factors 
that regulate transposition in response to growth conditions. Nevertheless, host proteins 
involved in metabolism, transport and other cellular pathways have been proposed to link 
the status of the cell to transposition (Twiss et al., 2005). 
The biological significance of Hfq regulation of mobile genetic elements could be 
multi-faceted. As a potent repressor of transposition, Hfq might protect the cell from 
harmful genomic instability. As a protein central to stress-response, Hfq might link 
external stimuli to transposition rates. 
5.6 Conclusions and future directions 
5.6.1 What other mobile genetic elements are regulated by Hfq? 
It will be interesting to see what other transposons are regulated by Hfq. To date the 
impact of hfq deficiency on four transposition systems has been investigated, and in all 
four cases Hfq was found to play a repressive role in transposase expression. If other 
transposition systems are negatively regulated by Hfq at the level of transposase 
expression, it will support the notion that a major role of Hfq is to generally repress 
transposition. These transposon targets of Hfq might be broken into two functional 
groups: those that are subject to post-transcriptional regulation of transposase expression, 
and those that are indirectly regulated. Regarding the latter group, it will also be 
interesting to determine whether Tn5 transposase transcription is directly regulated by 
cAMP-Crp and, if so, how many other transposases are subject to Crp-regulation. For the 
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former group, a further sub-classification might well be appropriate based on the 
presence versus absence of a cis-encoded antisense RNA. For instance, IS200 encodes an 
asRNA (Sittka et al., 2008) that likely represses transposase translation and experiments 
are currently underway to examine whether Hfq facilitates this regulation (R. Trussler, 
unpublished data). IS1413, on the other hand, lacks any known asRNA-imposed 
regulation but does possess a putative Hfq-binding site in the vicinity of its TIR (Hubner 
and Hendrickson, 1997; Munshaw, 2012); further experiments are required to confirm 
whether Hfq regulates translation initiation or turnover of the IS1413 transposase mRNA. 
 A search for mobile genetic elements that are subject to regulation by Hfq need 
not be limited to transposons and insertion sequences. As previously discussed, Hfq plays 
a repressive role in the conjugal transfer of F plasmids, and Hfq itself was originally 
identified as a host factor essential to replication of the RNA phage Qβ (August et al., 
1970).  
 Although Hfq is not an essential protein under optimal growth conditions (which 
are, of course, atypical for bacteria outside of the laboratory), it is strictly required for 
stress-response and virulence. If a major role for Hfq is indeed to generally repress 
mobile genetic elements (and perhaps link them to the host’s environment), this would 
expand the regulon of this pleiotropic regulator and provide another clue as to the 
importance of Hfq to bacterial fitness.  
5.6.2 Hfq, Crp and transposase transcription 
A logical follow-up regarding Crp regulation of IS50 transposase expression is to confirm 
that in vivo transposition of Tn5 increases in crp- cells. Does Hfq regulate IS50 
transposase expression solely in concert with Crp? This could be tested genetically: if 
Crp and Hfq regulate IS50 transcription by independent pathways, then expression of an 
IS50-lacZ transcriptional fusion (or transposition of Tn5) should increase synergistically 
in an hfq-/crp- double mutant.  
Does Crp directly bind to and repress the IS50 promoter? In vitro binding assays 
and footprinting of IS50 promoter DNA with purified Crp-cAMP would be a reasonable 
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starting point. If Crp does bind the promoter, point mutations should impair this binding 
in vitro, and abrogate regulation in vivo.  
By what mechanism does Hfq positively regulate Crp levels? In Yersinia pestis, 
regulation was shown to be post-transcriptional, as protein levels of Crp decreased in hfq-
null cells and a similar drop was not seen for the crp transcript. Moreover, Hfq regulation 
was exercised on the 5’ UTR of the crp transcript. However, it was not established 
whether Hfq participates in a canonical (i.e. sRNA-mediated) form of positive regulation 
(Lathem et al., 2014). In E. coli, one could measure the half life and steady-state levels of 
crp mRNA in hfq+/- cells to establish whether positive regulation is exercised via 
transcript stabilization. In order to investigate whether an sRNA is involved, one could 
use a bioinformatics approach (e.g. INTARNA) (Smith et al., 2010) to find sRNAs that 
might target the Crp mRNA. If any putative Crp-regulating sRNAs are found, they can be 
validated genetically as Crp protein levels are expected to decrease in strains wherein the 
putative positive regulator is disrupted. Alternatively, one could screen a library of 
plasmids constructed for the individual over-expression of known Hfq-dependent sRNAs 
(Mandin and Gottesman, 2010); if any of these sRNAs is responsible for positively 
regulating Crp translation, then Crp protein levels should increase significantly during 
induction of the appropriate sRNA(s).    
Does Crp regulate other transposable elements? Interestingly, Crp has already 
been shown to negatively regulate expression of one transposase (IS2) by binding the 
transposase promoter and potential Crp-recognition sequences were identified in (or near) 
several other transposase promoters, including IS50 (Hu et al., 1998). However, in the 
case of IS50, the putative Crp-binding site is located at bp 78 to 98; only the first 80 bp of 
IS50 were included in the IS50-lacZ transcriptional fusion used in Chapter 4, and the 
Crp-binding consensus was absent from the lacZ sequence included, meaning the putative 
Crp-binding site was absent from the transposase-lacZ fusion and therefore not 
responsible for the negative regulation imposed by Crp. This does not rule out the 
possibility that Crp acts directly on IS50 transposase expression by binding an alternative 
site located within the first 80 bp of IS50. It would be worthwhile to investigate whether 
other transposons are regulated by Crp, as this would represent another previously 
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unrecognized mechanism for host-factor regulation of transposase expression and provide 
a potential link between catabolite repression and transposition.  
5.6.3 Nutrient stress and transposition 
A logical extension of starvation-induced Tn5 transposition is to observe transposition or 
transposase transcription as cells transition into a deep stationary phase, with the 
expectation that prolonged growth in stationary phase leads to a similar starvation-
induced phenotype. If increased transposase expression is abrogated by disruption of the 
σS-encoding rpoS gene, this will confirm the notion that transposase is preferentially 
transcribed by RNAP-σS during nutrient starvation. Similar experiments should be 
conducted in the Tn10/IS10 system, as this promoter is similar to the IS50 promoter in 
terms of σS-recognition determinants and Tn10 transposase expression should therefore 
also be induced by nutrient starvation or prolonged stationary phase growth. Moreover, in 
vitro binding assays and in vitro transcription assays with RNAP-σS versus RNAP-σ70 
would confirm whether the IS50 and IS10 promoters are preferentially recognized by σS 
over σ70. Additionally, one could mutate the IS50 promoter in order to abrogate σS-
recognition (e.g. bring the -35 and -10 elements closer to the σ70 consensus, or mutate the 
-14 Guanine nucleotide) and observe whether this impairs transposase expression during 
nutrient stress in vivo.   
It would also be worthwhile to investigate whether glucose starvation induces 
transposase expression in other transposition systems, and whether any such responses 
are mediated by σS, since this could represent a general mechanism to link environmental 
stress conditions to transposon mobility. 
Overall, my work raises some intriguing questions that can be investigated in the 
years to come. Did the post-transcriptional regulator Hfq evolve, in part, to repress 
mobile genetic elements? If so, can Hfq-dependent regulatory networks in bacteria be 
viewed as analogous to si/miRNA-mediated regulation in eukaryotes? Do global 
regulators of gene expression like Hfq, Crp and alternative sigma factors provide a means 
to link transposition to the environmental conditions of bacterial cells? The future 
promises exciting revelations into the nature of host-transposon interactions in bacteria.   
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Appendices 
 
Appendix A. RNA-IN-160 RNase footprinting. 
5’ 32P-IN-160 (65 nM) was incubated in the absence (-) or presence (+) of Hfq (365 nM) 
before digestion with RNase A, T1, or V1 (lanes 5-10) or hydroxyl radical (3,4). A G-
lane (G, 1) and untreated RNA (UT, 2) are shown. Changes in reactivity in the presence 
of Hfq are indicated by upward- or downward-facing triangles (increased or decreased 
reactivity, respectively). Sensitivity to single-strand specific nucleases A/T1 are indicated 
in red, while sensitivity to double-strand specific V1 is indicated in blue.   
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Figure S2. RNA-IN-160 RNase footprinting. 5’ 32P-IN-160 (65 nM) was incubated in the absence (-) or presence 
(+) of Hfq (365 nM) before digestion with RNase A, T1, or V1 (lanes 5-10) or hydroxyl radical (3,4). A G-lane 
(G, 1) and untreated RNA (UT, 2) are shown. Changes in reactivity in the presence of Hfq are indicated by 
upward- or downward-facing triangles (increased and decreased reactivity, respectively). Sensitivity to single-
strand specific nuclease A/T1 are indicated in red, while sensitivity to double-strand specific V1 is indicated in 
blue. 
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Appendix B. Hfq expression and purity. 
(A) Hfq expression in donor strains used in mating out assays. Just prior to mating, 
aliquots of donor cultures were pelleted and resuspended in denaturing SDS load mix 
(2% SDS, 10% glycerol, 50 mM Tris-HCl pH 6.8, 0.25% bromophenol blue and 0.8 M β-
mercaptoethanol). After heating at 95°C for 5 minutes, cell lysates were subjected to 
SDS-PAGE on a 14% polyacrylamide gel. Proteins were transferred to a PVDF 
membrane (Roche) and Hfq was detected by Western blot with polyclonal rabbit anti-Hfq 
antibody (gift of G. Storz). The primary antibody was diluted 1:4000 in TBST; the 
secondary antibody (anti-rabbit IgG-HRP conjugate; Promega) was used at 1:10,000. Hfq 
was visualized with a SuperSignal West Pico kit (Thermo Scientific) and an 
AlphaImager. The position of monomeric Hfq and species (X) that cross react with the 
antibody are shown. Samples analyzed are described in Figure 3.13. (B) SDS-PAGE to 
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Figure S6. (A) Hfq expression in donor strains used in mating out assays. Just prior to mating, aliquots of 
donor cultures were pelleted and resuspended in denaturing SDS load mix (2% SDS, 10% glycerol, 
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5 minutes, cell lysates were subjected to SDS-PAGE on a 14% polyacrylamide gel. Proteins were 
transferred to a PVDF membrane (Roche) and Hfq was detected by Western blot with a polyclonal rabbit 
anti-Hfq antibody (Gift of G. Storz). The primary antibody was diluted to 1:4000 in TBST; the secondary 
antibody (anti-rabbit IgG-HRP conjugate; Promega) was used at 1:10,000. Hfq was visualized with a 
SuperSignal West Pico kit (Thermo Scientific) and an AlphaImager. The position of monomeric Hfq and 
species (X) that cross react with the antibody are shown. Samples analyzed are described in Figure 9. 
(B) SDS-PAGE to assess the purity of Hfq preparations. Purified Hfq at the indicated 
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R250 and destained with 10% Acetic acid/30% Methanol (v/v). The species corresponding to monomer, 
and a species we presume to be hexamer, are indicated to the right of the image. The Hfq in lanes 9-11, 
denoted “CP”, were purified by cobalt column chromatography and polyA resin as described in Materials 
and Methods.   
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assess the purity of Hfq preparations. Purified Hfq at the indicated concentrations was 
mixed with an equal volume of denaturing SDS load mix, heated to 95°C for 5 minutes, 
and 20 µL were run on a 12% SDS polyacrylamide gel. The gel was stained with 
Coomassie R250 an destained with 10% Acetic acid/30% Methanol (v/v). The species 
corresponding to the monomer, and a species we presume to be hexamer, are indicated to 
the right of the image. The Hfq in lanes 9-11, denoted “CP”, were purified by cobalt 
column chromatography and polyA resin as described in Materials and Methods (section 
3.4.2).  
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Appendix C. Screening colonies selected on ‘hop plates’ for transposition events. 
(A) Genomic DNA isolated from five KanR SmR colonies selected on ‘hop plates’ (Figure 
4.2A) from DBH184 (hfq-) or DBH179 (hfq+) was digested with AccI, which cuts once 
within Tn5 (in the kanR gene). The digested DNA was subject to Southern blot analysis 
using a Tn5-specific probe. For a positive control (+), the analysis was carried out on 
plasmid DNA encoding Tn5. For the negative control (-), the analysis was performed on 
DNA isolated from DBH33, which does not encode Tn5. (B) Overview of the ST-PCR 
approach for mapping Tn5 insertion sites. (C) Partial DNA sequences deduced using ST-
PCR for two colonies selected on ‘hop plates’ is shown. Tn5 sequence is shown in red, 
with flanking DNA in black. Note the presence of a 9 basepair target-site duplication 
+
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(underlined), typical of Tn5 transposition (Berg et al, 1983). The flanking DNA matched 
sequence at the indicated positions of the MG1655 reference sequence; these sequences 
are from the F’ episome present in the donor strains, which includes the lac-pro region. 
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Appendix D. Transposase expression from IS50-lacZ translational and 
transcriptional fusions in DBH33 and derivatives. 
Transposase expression was measured in the indicated strains grown to stationary phase 
(A) or mid-log phase (B) using a β-galactosidase assay. Values shown are the mean and 
standard error from 3 independent experiments, each of which contained at least 3 
replicates for each experimental group. 
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Appendix E. Transposase transcript profiling in DBH303 and derivatives. 
RT-PCR analysis was used to assess the ratio of transposase transcripts originating from 
the transposase promoter (T1) in Tn5 TCF strains versus promoters upstream of the Tn5 
TCF (i.e. read-through transcripts – ReT). Total RNA was isolated from DBH303 (WT), 
DBH306 (hfq-) and DBH307 (crp-) cells used in the transposase expression assay 
reported in Figure 4.6. As shown in (A) primer oDH238 was used to make cDNA. After 
cDNA synthesis, primers oDH239 and oDH238 were used to make an amplicon 
indicative of T1 plus ReT transcripts and primers oDH240 and oDH238 were used to 
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make an amplicon indicative of ReT transcripts only. (B) An ethidium bromide stained 
agarose gel containing RT-PCR samples from the indicated strains is shown. Note that 
the first two lanes on the left-hand side contain RT-PCR reactions performed with a 
plasmid (pDH682) encoding the Tn5 TCF, as opposed to purified RNA (all other lanes). 
As an internal control RT-PCR was also performed on 16S RNA using primers oDH204 
and oDH205 (5 cycles). (C) Bands from (B) and other gels were quantified and plotted 
versus cycle number, to indicate that signal increased with cycle number, as expected. 
Signal at 24 cycles (for IS50-lacZ) and 5 cycles (for 16S rRNA) was used for the 
quantitation shown in Figure 4.6B in the main text. 
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Appendix F. Cell growth and SgrS levels after SgrS induction. 
(A) Growth curve for DBH33 cells harboring the SgrS-encoding plasmid pDH764 with 
and without IPTG treatment. Cells from a saturated culture were sub-cultured (in 
duplicate) into M9-glucose and grown for 4 hours, at which point 0.1 mM IPTG was 
added to one of the sub-cultures. Cell density (OD600) was measured at the indicated time 
points. (B) Northern blot demonstrating SgrS induction. Cells from the cultures in (A) 
were removed at the indicated times after sub-culture and RNA was extracted. Northern 
blot analysis with 32P-labeled RNA probes complementary to SgrS or the 5S rRNA 
(internal standard) was performed. 
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Appendix G. Supplemental Methods for Chapter 4. 
Plasmid constructions 
IS50 transposase expression plasmids: Plasmids for in vivo expression of transposase 
from its native promoter are derivatives of pRZ9905 (Naumann & Reznikoff, 2000), 
obtained from W.S. Reznikoff. The transposase gene has the M56A mutation, which 
blocks translation of the inhibitor protein. In addition, a mini-Tn5 encoding the 
chloramphenicol resistance gene from IS1 was cloned into the BglII site just downstream 
from the transposase stop codon to create pDH533. Mutant forms of this plasmid 
including cat- transposase (D97A — pDH828) and Dam-Insen transposase (G53A; C61A 
— pDH752) were generated by site-directed mutagenesis. We used the mini-Tn5 element 
to test the functionality of various transposase-producing genes. 
IS50-lacZ translational fusion plasmids: A PCR fragment containing a portion of the 
lacZ gene (starting at codon 10 and terminating at the stop codon) was generated with 
primers oDH185 and oDH186 and E. coli genomic DNA. Primer oDH185 includes a 
SacII site and oDH186 includes a BglII site. After digestion with SacII and BglII, the 
lacZ PCR fragment was cloned into pRZ9905, which had also been digested with SacII 
and BglII, generating pDH658. The IS50 translational fusion from pDH658 was also 
cloned on an XmnI-SalI fragment into XmnI-SalI digested pWKS30 (Wang & Kushner, 
1991) to create pDH753. The IS50 transposase coding sequence in pDH658 (includes up 
to codon 122 of transposase) was further truncated to include only the first 12 codons of 
transposase by digesting pDH658 with XmnI and SacII and cloning a PCR fragment 
generated with primers oDH187 and oDH188 (and cut with XmnI and SacII) into the 
aforementioned backbone to generate pDH795. The IS50-lacZ translational fusions 
pDH753 and pDH795 were linked to a kanamycin resistance gene from IS903 (generated 
by PCR using primers oDH189 and oDH190) by cloning the kanR gene present on a 
SpeI-XbaI cut PCR fragment into the XbaI site just downstream of the lacZ gene to 
create pDH798 and pDH804, respectively. The IS50-lacZ-kanR fragment in pDH804 was 
PCR amplified with primers oDH191 and oDH192, each of which includes a BamHI site, 
and cloned into the large fragment (~ 6 kb) of pNK81 (Foster et al, 1981) generated by 
BclI digestion, creating pDH812. In this context, the IS50 transposase-lacZ-kanR 
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fragment is flanked by his operon sequences and can be crossed onto λNK1039 (Bender 
et al, 1991), which also contains his operon sequences. 
IS50-lacZ transcriptional fusion plasmids: A PCR fragment including the 5’UTR to the 
stop codon of the lacZ gene, generated with primers oDH193 (includes an AflII site) and 
oDH194 (includes a BamHI site) was cloned into pRZ9905, which had also been cut with 
AflII and BamHI, to create pDH682. The IS50-lacZ transcriptional fusion in pDH682 
was then linked to either the kanR gene of IS903 (pDH838) or the cmR gene of 
pACYC184 (pDH883); the latter was generated with primers oDH195 and oDH196, each 
of which contains an XbaI site. The IS50 transposase-lacZ-kanR and the IS50 
transposase-lacZ-cmR segments of pDH838 and pDH883 were then PCR amplified using 
primers oDH191 and oDH192 and, each of which contains a BamHI site, and cloned into 
BclI-digested pNK81 as previously described, generating pDH849 and pDH888. The 
latter plasmids were used to cross the transcriptional fusions onto λNK1039. 
Southern blot analysis of colonies selected on ‘hop plates’  
Genomic DNA was isolated from KanR SmR colonies selected on ‘hop plates’ using 
Sigma Genomic DNA kit; 1.5 µg of genomic DNA was digested with AccI (cuts once in 
Tn5 in the kanR gene) and resolved on a 1% agarose gel, before capillary transfer to 
Hybond N membrane (GE Healthcare) as follows: the gel was soaked in alkaline 
denaturing buffer (1.5 M NaCl, 0.5 M NaOH) for 40 minutes, neutralized (30 minutes 
and then 15 minutes) in neutralizing buffer (250 mM Tris-HCl, pH 7.5, 750 mM NaCl), 
and transferred overnight in 10x SSC. The membrane was UV cross-linked and then 
incubated with a 32P-labeled RNA probe (complementary to the 5’ portion of the Tn5 
kanR gene) in UltraHyb buffer (Ambion) according to the manufacturer’s protocol for 
RNA:DNA hybridization. The probe was generated by in vitro transcription, as described 
for Northern blot analysis, from a DNA template made by PCR with primers oDH236 
and oDH237.  
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Mapping Tn5 tranposition events 
Putative transposition events from mating out assays were characterized using a semi-
random, two-step PCR protocol (ST-PCR) for uncharacterized transposon-linked 
sequences (Chun et al, 1997). Briefly, genomic DNA from KanR SmR colonies selected 
on ‘hop plates’ was PCR-amplified with a Tn5-specific primer (oDH225) and a partially 
randomized primer (oDH167). The resulting amplicons were ligated into the pGEM T-
easy vector (Promega), transformed into DH5α by electroporation and transformants 
were selected on LB plates containing kanamycin (50 µg/mL). Plasmid DNA was 
isolated (Sigma miniprep kit) and the inserts were sequenced using M13 primers. 
Sequences thusly obtained were aligned to the E. coli MG1655 reference genome 
(BLAST) to identify the ‘target’ sequence immediately flanking one host-OE junction. 
This information was used to design ‘insert-specific’ primers (different for each insertion 
event), complementary to DNA flanking the Tn5 insertion site. These primers were used 
to amplify and sequence DNA flanking Tn5 in each of two colonies.  
β-Galactosidase assay 
WT cells (DBH33) were lysogenized with λDBH849 or λDBH812 (described in the main 
text) to produce DBH238 (TCF – single copy) and DBH208 (TLF – single copy). 
DBH238 was transduced to hfq-1::Ωcat (DBH239) and dam::Tn9cat (DBH240) and 
DBH208 was transduced to hfq-1::Ωcat (DBH210) and dam::Tn9cat (DBH237).  Cells 
were grown in M9-glucose media to mid-log or stationary phase and a β-galactosidase 
assay was performed as described in the main text. To compensate for endogenous lacZ 
expression in DBH33 derivatives (which contain the lac operon under the control of 
lacIQ), the number of Miller units obtained from each strain lacking the transposase-lacZ 
reporter gene (DBH33 — WT; DBH16 — hfq- and DBH241 — dam-) was subtracted 
from that of the isogenic strains containing the reporter gene.  
RNA-extraction, RT-PCR and Northern analysis 
Cellular RNA was extracted as described in the main text. For RT-PCR, 4 µg of RNA 
was reverse transcribed with primers oDH238 and oDH205 essentially as described for 
primer extension analysis in the main text. The resulting cDNA was purified with a PCR 
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cleanup column (Quiagen) and PCR amplified using Taq DNA polymerase (Promega) 
and primer pairs oDH238 and oDH239 (for T1 and read-through IS50-lacZ transcripts), 
oDH238 and oDH240 (for read-through IS50-lacZ transcripts), or oDH204 and oDH205 
(for 16S rRNA). The PCR parameters for IS50-lacZ were: 95°C, 30 s; 60.5°C, 30 s; 
72°C, 60 s and 24, 26 or 28 cycles were run. The PCR parameters for 16S rRNA were as 
above, except that the annealing temperature was 61.5°C and 4, 5 or 6 cycles were run. 
Northern analysis for monitoring SgrS induction during the growth curve was performed 
as described in the main text. 
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Appendix H. List of oligonucleotides used in Chapter 4. 
Name Sequence (5’ to 3’) Use 
oDH167
oDH183
oDH184
oDH185
oDH186 
oDH187
oDH188
oDH189
oDH190 
oDH191
oDH192
oDH193
oDH194
oDH195
oDH196
oDH204
oDH205
oDH225
oDH230
oDH231
oDH232 
oDH233
oDH234
oDH235
oDH236 
oDH237
oDH238 
oDH239 
oDH240 
GGCCACGCGTCGACTAGTACNNNNNNNNNNGATAT 
NNAAGCTTNNTTATTCGGTTTCTTCGCT 
NNTCTAGANNCAGGTTGTTGGTGCTATC 
NNNCCGCGGAGTCGTTTTACAACGTCGTGACTGGGAAAACCC 
NNNAGATCTTTATTTTTGACACCAGACCAACTGGTAATGGTAG
CG                                                 
CATCATTGGAAAACGTTCTTCGGGGCG 
AACGACTCCGCGGCTGTCGGCCGCACGATGAAGAGC 
GGACTAGTGCCAGTGTTACAACCAATTAACCAATTCTGA 
GCTCTAGACTGAGAGATCCCCTCATAATTTCCCCTCAGCAAAA
GTACGATTTATTCAAC 
GCCCCCCGGATCCCCTGACTCTTATACACAAGT 
ATTTTTGGATCCGCGAGGAAGCGATGCCTGC 
NNCTTAAGCACACAGGAAACAGCTATGACCATGATTACGG 
NNGGATCCCACCTGGAAGATCAGATCCTGGAAAACG 
GAATAATCTAGACCTGGTGTCCCTGTTGATACC 
GCTTATTCTAGATTATTCAGGCGTAGCACCAGG 
CGTGTTGTGAAATGTTGGGTTAAGT 
AACCCACTCCCATGGTGTGACGGGC 
GTCATTTCGAACCCCAGAGTCC 
CGTTGGGATTGCGGATAAATCGGTAAG 
TATTTAGTAGCCATGTTGTCCAGACGC 
TAATACGACTCACTATAGGGAAAAAAAACCAGCAGGTATAAT
CTGCTG                                                         
GATGAAGCAAGGGGGTGC 
TAATACGACTCACTATAGGCCTGGCAGTTCCCTACTCTCG 
CGGCAGTAGCGCGGTG 
TAATACGACTCACTATAGGGCATCGGCAGGGTCATC  
AGGTGACCTCTTAAGATGGTAACGTTC 
AGGCTGCGCAACTGTTGGG         
AGGTGACCTCTTAAGCACACAGG  
CTGACTCTTATACACAAGTAGCGTCCTG 
Partially-randomized primer                     
pDH700-construction 
pDH700-construction 
pDH658-construction 
pDH658-construction  
pDH795-construction 
pDH795-construction 
pDH798/804-construction 
pDH798/804-construction 
pDH812-construction 
pDH812-construction 
pDH682-construction 
pDH682-construction 
pDH883-construction 
pDH883-construction          
RT-PCR, 16S rRNA            
RT-PCR, 16S rRNA           
Tn5-specific primer             
IS50 Primer Ext.                   
lpp Primer Ext.                    
SgrS in vitro transcrip. 
template                         
Reverse primer for above      
5S in vitro transcrip. Template                            
Rev primer for above         
T’ase in vitro transcrip. 
Template                       
Reverse primer for above    
Reverse primer, RT-PCR of 
IS50-lacZ TCF             
Forward primer for above: 
Readthrough+T1          
Forward primer for above: 
Readthrough only 
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